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Summary of the PhD-thesis 
A broad range of new properties is emerging from supramolecular aggregates. Self-assembled 
structures of purely peptidic amphiphiles exploit these properties to produce biocompatible, 
biodegradable, smart materials for drug administration. This thesis explores the design, synthesis, 
purification, characterization of purely peptidic amphiphiles, and the evaluation of potential 
applications. 
The first chapter provides a general introduction to the field of self-assembly and drug delivery as 
compared to nature’s delivery mechanisms. Further, the advantage of amino acid based molecules 
in producing smart materials for drug delivery applications is highlighted via biocompatibility and 
biodegradability considerations. Next, synthetic strategies and purification methods are discussed. 
Finally gramicidin A (gA) – a naturally occurring, short, hydrophobic, membrane-integrating 
peptide used to produce the amphiphilic peptides presented here – is introduced.  
Chapter two presents an initial approach to produce self-assembled structures by purely peptidic 
amphiphiles. The undecamer used features a repetitive L-tryptophan and D-leucine [LW-DL] motif 
representing the hydrophobic block, and an N-terminally attached hydrophilic (lysine or acetylated 
lysine) section. Besides solid-phase peptide synthesis and purification, the process that self-
assembles micelles and spherical peptide particles, termed “peptide beads”, was characterized as 
a function of temperature and solvent composition by means of electron paramagnetic resonance 
(EPR), dynamic and static light scattering, fluorimetry and electron microscopy. An equilibrium 
process between single peptide molecules, micelles and peptide beads is then presented. 
Chapter three examines the structure of self-assembled peptide beads of diameters between 200 
to 1500 nm. The beads were analyzed by electron and atomic force microscopy (AFM), static and 
dynamic light-, and small angle X-ray scattering. The beads are seen to result from hierarchical 
organization of micellar-like subunits and confirm the concept of multicompartment micelles. An 
improved understanding of the beads’ capacity to embed hydrophobic and hydrophilic payloads 
and perspectives for drug delivery applications emerge. 
Chapter four presents a library of longer peptides, based on the full sequence of gA. The peptide 
design includes three parts: (a) a charged lysine part, (b) an acetylated lysine part and (c) a 
constant hydrophobic rod-like helix, based on gA. Stepwise replacement of free lysine (K) with 
acetylated lysine (X) generated the ten peptides Ac-X8-gA and KmX8-m-gA (m ranging from 0 to 8). 
With the change in the primary sequence, a change in secondary structure was observed. The 
transition reflected a change in the self-assembled structures from fibers to micelles. This 
demonstrates how even small point mutations influence the supramolecular outcome and serve 
as an important step to understanding and controlling self-assembly. 
In chapter five, the knowledge gained on gA-based peptides is applied to produce purely peptidic 
vesicles. The work here demonstrated that, to form such structures with short amphiphiles, 
additional stabilizing factors were necessary. Thus, we exploited different dimerization strategies 
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to form stable peptide membranes and developed a general recipe to form purely peptidic 
vesicles. The vesicles demonstrated pH responsiveness as well as the capacity to embed 
hydrophilic and hydrophobic payloads in their structure. 
Chapter six presents the potential of self-assembled peptide beads in drug delivery applications. 
The hydrophobic and hydrophilic payload-filled peptide beads are shown to be internalized by 
human cells. Further, a method to increase embedding efficiency for RNA/DNA to 99% due to 
charge-driven complexation and embedding is presented. The internalization of the gene delivery 
vehicle into cells led to gene silencing through delivered siRNA and to antibiotic resistance, and 
siRNA production followed by gene silencing through a delivered plasmid. The delivery of co-
embedded paclitaxel and doxorubicin was then probed and proven effective. The results also 
demonstrate that the new class of drug delivery material caused no measurable toxicity during the 
experiments. Therefore, the material is suggested as a biocompatible drug delivery vehicle for 
gene therapy and multi-drug delivery. 
In chapter 7, the self-assembly capacity of the peptide is used to template the dense packing of 
gold nanoparticles. The C-terminally cysteinated peptide Ac-X3-gT-C was used to coat gold 
nanoparticles and form gold core micelles. These micelles then aggregate to composite peptide-
gold nanoparticles in which the individual gold nanoparticles remain separated from another. The 
dense packing of the gold nanoparticles offers opportunities for exceptional optical- and electronic 
properties as well as the use of composite material for a potential, triggered destruction of the 
peptide beads by the typical radiation absorption effect of gold nanoparticles. The latter could, in 
particular, be useful to control the release of embedded payloads. 
The final chapter summarizes and discusses the achievements of this work. Further, it gives an 
overview of ongoing work and an outlook for worthwhile research from the present point of view. 
This includes e.g. the development of drug delivery applications, the use of the presented peptidic 
self-assembly system as template material in nanosciences, as well as the use of the material to 
investigate cellular uptake pathways of nano-sized objects. 
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1 Introduction 
The first chapter provides a general introduction to the field covered by this PhD thesis. First, a 
view of the nanometer-sized world is afforded by means of a variety of structures that are 
obtained using the method of self-assembly. The basic principles of self-assembly are then 
explained and compared to self-assembly mechanisms as they appear in nature. Next, we switch 
to the topic of drug-delivery and compare the classical drug delivery – as is common for most 
medications – to payload delivery as designed by nature. This gives us the opportunity to combine 
drug delivery and self-assembly within new concepts to design novel smart materials for drug 
delivery applications, and to show their possible use. Subsequently, we will come to see that these 
novel materials also need to be biocompatible in order to engender as little harm to a patient as 
possible. This requirement will lead us to the synthesis of amino acid-based amphiphiles and I will 
highlight different synthetic strategies to obtain the molecular building blocks needed to produce 
self-assembled supramolecular structures. Finally, I will introduce gramicidin A, a naturally 
occurring, short and hydrophobic, membrane-integrating peptide that was used as a basis to 
produce the amphiphilic peptides that are presented in this thesis. The definition of the scope of 
the thesis closes the chapter. 
1.1 Self-assembly 
From our daily experiences we know that organization and construction requires considerable 
effort. Therefore, it would be expedient to use pre-existing building blocks that arrange 
autonomously to build a desired construct. Such a phenomenon, termed self-assembly, actually 
does exist, exemplified by a variety of different dimensions that range from the organization of 
galaxies and solar systems down to the organization of small molecules as they assemble into 
larger aggregates. In this fundamental principle, the organization of pre-existing parts or 
disordered components forms larger structures or patterns, while the process itself is reversible. 
Molecular self-assembly is the topic of this thesis and is – as the term implies – an assembly of 
molecules that leads to the formation of a variety of structures in the nanometer and micrometer 
scale, while being an important tool for the bottom-up construction in nanotechnology and 
material science.[1] 
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1.1.1 The variety of self-assembled structures 
 
Figure 1-1: A selection of common, self-assembled morphologies and their amphiphilic subunit. 
Molecular self-assembly, hereinafter referred to simply as self-assembly, produces a variety of 
structures of higher order, ranging from the nanometer to the micrometer scale. To obtain such 
structures, non-covalent intermolecular as well as intramolecular interactions take place. The 
simplest example is the intermolecular self-assembly of surfactant molecules into micelles in 
aqueous solution. However, varying the molecular properties (e.g. length, mass, shape) can lead to 
more complex supramolecular assemblies such as, for example, worm-like micelles, complex 
micelles, lamellae, vesicles, and tubes (see Figure 1-1).[2] 
1.1.2 Self-assembly of amphiphilic molecules 
Most self-assembly is enabled by using amphiphilic molecules. The amphiphilic (amphi: of both 
kinds; philic: having an affinity) properties are produced by combining at least two subunits, one 
possessing hydrophilic properties, the other having a hydrophobic character. The self-assembly 
occurring in aqueous solution is mainly driven by the low solubility of the hydrophobic part. 
Aggregation of the hydrophobic parts, and thus their shielding from the aqueous environment, 
leads to a hydrophobic surface minimization of the aggregate and results in minimized free 
energy. The structures of the thereby obtained supramolecular aggregates strongly depend on the 
position and availability of non-covalent interactions (van der Waals forces, electrostatic-, and π-π 
interactions) as well as the shape and flexibility of the molecules.[3]  
Described in more detail, the aggregation of an amphiphilic molecule can be separated into three 
terms influencing the free energy of an amphiphilic self-assembly in dilute, aqueous solutions:  
(1) the hydrophobic contribution from the hydrophobic parts that aggregate inside the structure; 
(2) the surface contribution of the hydrophilic parts, reflecting the tendency to arrange so as to  
minimize the effect of the surrounding water on the hydrophobic parts enabled by hydration, 
electrostatic repulsion, and steric hindrance and (3) a packing term, describing the geometrical 
shape of the molecule and the possibility of their spatial arrangement. Surface and packing 
contribution are expressed in the surfactant parameter Ns, defined as ν0/l0ae with ν0 for the 
volume of the hydrophobic part of the molecule, l0 being the length and ae the equilibrium area 
per molecule at the aggregate surface, which is in fact the effective area of the hydrophilic group. 
The surfactant parameter is often used to explain and predict the curvature of the assemblies and 
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the resulting structure, e.g. for spherical micelles (Ns = 0.33), infinite cylinders (Ns = 0.5), planar 
bilayers and vesicles (Ns = 1), bicontinuous structures (Ns ≥ 1) and inverted micelles (NS >1).[3-4] 
Another attempt to predict resulting structures is the hydrophilic to hydrophobic ratio (fhydrophilic), 
which expresses the tendency to form vesicles (fhydrophilic = 35% ± 10%), inverted microstructures 
fhydrophilic < 25%) and micelles (fhydrophilic > 45% ).[5] 
As mentioned above, the low solubility of the hydrophobic part is a major driving force for the 
self-assembly. Being referred to as attractive forces among apolar solutes in water, the important 
factor is actually the increase in entropy due to the liberation of water from the hydration shell 
during aggregation. However, the thermodynamic factors giving rise to this phenomenon, 
commonly referred to as the hydrophobic effect [6], are complex and still not fully understood. 
As derived from the above driving forces, the structures can also be influenced by environmental 
stimuli, e.g. pH[7], ionic strength[7d-f, 8], temperature[9], counter ions[9c, 10], light[9b, 11], and oxidative 
stress[12], which all influence either the stabilizing interactions, the shape of the molecule, or the 
molecular composition itself. This fact can either be used to control or to trigger the destruction of 
the self-assembled structures[13]. The latter, in particular, is of interest in the triggered release of 
encapsulated payloads (e.g. in drugs delivery). Due to the so produced capability of the resulting 
materials to react to environmental stimuli, the materials are often referred to as “smart”. The 
versatile variables thereby obtained enable manifold possibilities to control the self-assembly, but, 
on the other hand also make it hard to rationally predict self-assembled morphologies from 
scratch. 
1.1.3 Hierarchically organized structures in nature 
Hierarchical organization, as is often the case in self-assembly, also occurs in nature, where, for 
example, spider silks are produced by salt- and shear force-triggered self-assembly of proteins[10b]. 
But also the production of functional enzymes and of molecular machines in each cell are most 
often constructs of hierarchical organization and the key parameter for life[14]. Surprisingly, the 
variety of functions is mostly enabled by proteins and peptides that consist of only 20 natural 
amino acids (AA). These serve multiple functions as acids, bases, thiols, aromatic rings, etc., while 
spanning the wide range from hydrophilic to hydrophobic, resulting in almost endless possibilities 
of combinations in linear sequences. However, these linear sequences (primary structures) do not, 
in such state, allow for the broad functions of molecular machines. Only the folding of the 
sequence into a three-dimensional secondary structure – which is, in fact, self-assembly – imparts 
a functional structure to the biopolymers. The necessary rotations of the molecules happen on the 
N-Cα-bonds and the Cα-C-bonds, the related angles of rotation are expressed as Φ and Ψ, 
respectively. Other rotations are impossible, due to the specific electronic structure of the peptide 
bond. Steric hindrance also limits remaining possibilities to about 25%, reflected in the 
Ramachandran plot (Figure 1-2). With natural occurring L-amino acids, three secondary structures 
are possible: α-helix, β-sheet, and random coil. The alternation of L- and D-amino acids (rare) also 
enables wider β-helical confirmations, in which all residues point to the outside of the helix.[15] 
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Figure 1-2: Illustration of the peptides phi- and psi-angles with the red line forming the repeating backbone 
of the peptide (left). The Ramachandran plot representing the possible angel combinations and the 
resulting secondary structures (right). 
The complete folding of a protein – comprising several regions of different secondary structures – 
is called the tertiary structure and forms three-dimensional building blocks, which can further 
assemble into more complex tertiary structures.  
The oxygen transporter, hemoglobin, is a good example of an assembly consisting of four subunits. 
Another more complex example is the hierarchically organized thermosome, a chaperonin from 
the thermophilic organism Thermoplasma acidophilum. It is a spherical assembly, consisting of two 
stacked, eight-membered rings, where each member is built of alternating α and β subunits.[16] 
Ironically, this self-assembled construct of two half-spheres assists proteins in folding.  
Further examples are viruses, which are also the product of hierarchical organization, their sole 
task being the protection of their own DNA/RNA in the interior and delivering it into other cells. 
Recently, a self-assembled protective capsule of a virus (capsid) was produced by a synthetic 24-
mer peptide[17]. This is a good example of how nature’s self-assembly strategies can be understood 
and used in designing self-assembled structures. 
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1.2 Drug delivery  
Drug delivery is commonly known as the process of administering a pharmaceutical compound to 
humans or animals in order to obtain a therapeutic effect. 
1.2.1 The classical drug delivery approach 
Classical drug delivery uses drug molecules that are generally dissolved in and distributed by the 
blood stream. Uptake by individual cells and transport to the final place of effect is rarely a 
targeted or specific process but rather controlled by the well-known dependence on the amount 
of blood circulating as well as the hydrophilic and hydrophobic character of the bodies’ organs. 
Therefore, weak control over the final destination and the delivery pathways causes the molecules 
to also enter healthy cells or cells of different types, which leads to side-effects. Classical drug 
delivery approaches therefore rely instead on the formulation of the drug (the mixture of the 
dosage form, e.g. a pill), which, for instance, enables the active pharmaceutical ingredient (API) to 
pass through the acidic conditions of the stomach and to be liberated in the intestine. 
Nevertheless, enzymes can still decompose the API on its way to its final destination. Thus, a nano-
sized protection of the drug, that still allows or even improves the uptake by the target 
tissue/cells, would be preferred and might allow new therapies with less side-effects. 
1.2.2 Payload delivery in nature 
Nature developed a variety of ways to deliver payloads to other cells or organisms. Reproduction 
uses the sperm, an example of a complex architecture of a whole cell[18], to deliver the genome to 
the ovum. Pollen performs the same task in the life of plants, while representing a diversity of 
shapes and sizes in the micrometer range (Figure 1-3). Not only protection from environmental 
factors, but also targeted delivery and release of precious payloads are performed by such 
complex carriers.  
  
Figure 1-3: Scanning electron microscopy (SEM) of pollen from a variety of plants. Reproduced by general 
permission of the Dartmouth Electron Microscope Facility, Dartmouth College[21]. 
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A less appreciated form of payload delivery is performed by viruses. Their DNA/RNA-carrying virus 
capsids are produced by the self-assembly of peptide or protein subunits, and understanding their 
architecture has recently also gained attention[19] (cf. section 1.1.2). Equipped with target 
recognition features (e.g. sugars or channel protein recognition sites), active release mechanisms, 
and cellular uptake enhancing factors on the surface, these nano-sized constructs perform very 
specific and efficient payload delivery of their own recipe for reproduction. Good examples of high 
efficiency are the approx. 35 nm-sized noroviruses that deliver a single stranded RNA. A low 
amount of only 10 – 100 viruses is enough to infect a human[20]. 
1.2.3 Smart material drug delivery concepts 
Inspired by nature’s sophisticated delivery systems, an eagerness to minimize side-effects and 
even mere solubility problems encountered by potential drugs, several concepts for drug delivery 
using self-assembled smart materials have been developed. A good overview of these is provided 
by recent reviews[22]. In order to decrease degradation by metabolic enzymes, reduce 
immunogenicity, and to prolong persistence in the body, the covalent modification of drugs with 
poly(ethylene glycol) (PEG) has led to several new therapeutic agents. The non-immunogenic, non-
antigenic, non-toxic – and therefore biocompatible – hydrophilic polymer has recently also 
achieved FDA approval[23]. However, the covalent binding of such a large polymer is not always 
favorable when reaching the final point of action. As a result, the scientific community developed 
non-covalent shielding methods that exploit the method of self-assembly to achieve similar 
properties. 
The fact that a large fraction of APIs are hydrophobic necessitates envelops that are able to 
incorporate such a payload while presenting a hydrophilic surface to the environment. A straight 
forward approach – which does not bind the payload covalently – is micellization of hydrophobic 
payloads with amphiphilic molecules. In such a case the hydrophobic, core forming part of an 
amphiphile can be tailored to fit the needs of the payload, while the hydrophilic part can still 
present a suitable surface to the environment.  
For hydrophilic payloads, a segregated hydrophilic cavity is required. Vesicles can perform this task 
by providing cavities with sizes ranging from a few nanometers to a few micrometers. The stability 
and robustness of these nano-carriers varies depending on the materials from which they are 
built. Vesicles made of lipids (liposomes) may be integrated more easily into existing cell 
membranes; block-co-polymer vesicles, on the other hand, can adapt the thickness of the 
membrane to fit the demands of membrane proteins, which can be integrated in order to enable a 
selective release function. Variation in the molecular weight of the block-co-polymers can further 
control the thickness of the vesicular membrane, which goes along with enhanced membrane 
stability and robustness[24]. In contrast to liposomes, polymersomes offer better opportunities for 
chemical modifications that can be used to tailor their interaction with environmental factors. 
Such modifications can be a response to adhesion (used for targeting), integration into biological 
membranes, but also the reaction to environmental stimuli[13, 24-25] (cf. section 1.1.2). For example, 
nitrilotriacetic acid (NTA) functionalized block-co-polymer vesicles were recently shown[26] to 
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complex nickel to build coordination sites that bind to his-tagged proteins. But also the 
functionalization of vesicles already formed can be performed with polymersomes, as long as the 
functional groups are selected properly[27]. Including a photocleavable linker, on the other hand, 
can lead to light-triggered destruction of the polymersomes and a release of encapsulated 
payloads, as e.g. shown by Cabane et al.[28]. Recently, also the incorporation of metal 
nanoparticles into the membranes was demonstrated and may allow new possibilities in 
functionalization but also in heat- and radiation-triggered release of payloads[29]. 
Medical applications often need simultaneous treatment with several APIs of different solubilities 
and/or different release profiles[30]. Nature often provides diverse properties to different 
molecules in segregated compartments. The concept of multicompartmentization as a crucial 
factor to enable the delivery and staged release of payloads depending on different demands was 
therefore identified by Ringsdorf[31] in the late nineties. Since then, various approaches have been 
under investigation to produce micro- to nano-sized vehicles that have segregated hydrophobic as 
well as hydrophilic cavities to incorporate multiple guest molecules with different properties. Such 
concepts can use top-down strategies such as, for example, the sputtering of big compartments 
with small compartments to build raspberry-like structures[32] as well as bottom-up strategies such 
as self-assembly[31, 33].  
The combination of several of the above mentioned functionalities might finally lead to nano-sized 
sensors or drug delivery vehicles that fulfill qualitatively similar tasks as their natural paradigms 
with regard to targeted as well as triggered release of payloads. Thereby, the comparably easier 
synthesis of artificial systems may allow cost effective large scale production. 
1.3 The need for smart materials and their potential for drug delivery 
The great interest in “smart materials” is reflected in the steadily increasing number of 
publications contributing to this field of research (2005:285, 2010:467). The properties of the 
investigated materials promote various beneficial applications comprising the fields of tissue 
engineering, sensors, nanoreactors, as well as drug delivery. All of the mentioned applications 
have one main topic in common: the wish to have materials that are no longer just static, but 
rather interact with the surrounding by adapting the properties instantly when necessary, 
imitating a “smart” behavior. Such functions can be programmed at a molecular level and are 
reflected in the responsive properties of the self-assembled materials. An example is the pH 
triggered release of encapsulated payloads in vesicles formed by poly(ethylene oxide)-block-
poly(N,N-diethylamino ethylmethacrylate) diblock copolymer (PEO-PDEAMA)[34]. Due to its 
cationic character, the PDEAMA block is hydrophilic below pH 7.3; at high pH, the block is 
deprotonated, becomes hydrophobic and enables self-assembly. Further working principles and 
functions are presented in chapter 1.1.2 and 1.2.3. Such systems would deliver and liberate drugs 
only to a specific target (when equipped with a recognition pattern), or when a symptom traced 
back to the molecular level is recognized (e.g. oxidative stress due to inflammation). 
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It has been known that targeting leads to more efficiency and less side effects, since humans being 
have been using bows and arrows. Therefore, the same is also expected of novel smart material 
drug delivery systems and thus, highly aspired by academia and industry. Besides tedious 
development and optimization of new drugs with incalculable outcome, new formulations of 
existing drug molecules in smart drug delivery systems also lead to increased competitiveness and 
extended patent lifetimes, which dramatically increases market values[35]. 
1.3.1 Biocompatibility & biodegradability 
A major concern in the development of smart material drug delivery systems should be their 
biocompatibility and biodegradability. The most sophisticated, targeted, and triggered-release 
enabled system has only hypothetical value if it causes immunogenic, antigenic, or even toxic 
reactions in the body (need for biocompatibility[23, 36]) and if it accumulates in the body during 
long-term use (need for biodegradability[37]). Unfortunately, orientation towards these 
specifications is rarely done at early stages of new material research. 
Amino acid based materials, especially peptides and proteins – due to their natural origin, the 
similarity to the biological machinery, and the fact that they are subjects to natural degradation 
pathways – are generally seen as biocompatible and biodegradable. The potential unwanted 
interaction with other enzymes or functions in the body still exists, but in contrast to non-natural 
building blocks it is reduced to a very small probability. Therefore, the use of amino acid based 
materials, from a pragmatic point of view, is a smart choice. Further, degradation pathways of 
peptides and proteins can even be used to control a release from amino acid based materials[38]. 
1.3.2 Market demand for nano-sized drug delivery systems   
Controlled release polymer systems were previously estimated to have an annual worldwide 
market of $60 billion. Further, it has been estimated that novel drug delivery methods (cf. section 
1.1.2 and 1.2.3) will play a crucial role in approximately 40% of all pharmaceutical sales in the near 
future, due to the above mentioned advantages.[39] A good introduction of nano-sized drug 
delivery systems to the marked has already been shown for two oncology drugs, Abraxane and 
Doxil, which deliver paclitaxel and doxorubicin, respectively. In 2006 they generated sales of $184 
million (Abraxane) and $177 million (Doxil) and are preferred in oncology due to enhanced 
solubility and reduced side-effects.[40] These examples show the great potential for nano-sized 
drug delivery systems also from the point of view of profit. Table 1-1 provides an overview of 
potential targets for nano-sized drug delivery systems. 
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Table 1-1: Nano-sized drug delivery systems, information taken from [40]. 
Type and diameter (nm) Indication Advantages 
Polymeric nanoparticles   
(10-10 000) 
Brain tumors, bone healing, 
restenosis, diabetes 
Sustain localized drug therapeutic 
agent for weeks 
Ceramic nanoparticles (<100) Photodynamic therapy, liver 
therapy, diabetes 
Easily prepared, water-soluble, 
very stable 
Polymeric micelles (<100) Solid tumors, anti-fungal Hydrophobic core, suitable for 
water-insoluble drugs 
Liposomes (50-100) Tumors, HIV, vaccines Reduces toxicity and long lasting 
in targeted tissue 
Metallic nanoparticles (<50) Cancer Extremely small size, vast surface 
area 
Dendrimers (<19) Tumors, HIV, bacterial infection 
treatment 
Can carry hydrophobic or 
hydrophilic content 
 
1.4 Synthesis of amino acid based amphiphilic materials 
Amino acids are small molecules with a carboxylic acid and an amine function connected through 
a carbon (α-carbon), holding the residue of the amino acid (AA) that gives the unique properties to 
each of the 22 standard AAs (cf. Figure 1-2). In nature, the genetic code defines 20 stereochemical 
L-isomers; however, for synthesis, each chirality of the standard AAs as well as a large variety of 
artificial AAs can be used. The covalent connection of AAs to form peptides, proteins, and 
poly(amino acids) is enabled by an amide bond, also referred to as peptide bond, due to its 
origin.[41] To form amphiphilic materials that are based on amino acids, several methods can be 
used, comprising polymerization, the joining of peptidic and non-peptidic materials into hybrid 
materials, solid phase peptide synthesis (SPPS), and recombinant protein expression. 
1.4.1 Polymerization 
Polymerization can produce large molecules from small monomers in a very effective way. 
Sequential ring-opening polymerization of N-carboxy anhydrides (NCAs) can be used to synthesize 
a variety of AA-based block-co-polymers without racemization of chiral centers, with good 
yields[7e, 42]. Among others, Deming et al. improved the rather high polydispersity index (PD.I.) of 
the method by using organo-nickel initiators to obtain well-defined block-co-polymers or 
polypeptides[43]. Nevertheless, polymerization produces a certain molecular weight distribution 
that often varies from batch to batch; furthermore, it cannot produce precisely defined sequences 
of amino acids, as would be the case in proteins and peptides. 
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1.4.2 Hybrid materials 
For certain functions (e.g. targeting, triggering of cell function, secondary/tertiary structure 
formation, etc., cf. chapter 1.1.2) precise sequences are needed. Hybrid materials have been 
created in order to combine this precision with the efficient production method to make 
polymers. The covalent connection of polymers with peptides or proteins can be made with the 
fully available knowledge of organic chemistry. Often used methods are esterification, amide bond 
formation, or the attachment to thiols. Bioconjugates produced in this way have been shown to be 
effective in self-assembly to produce new materials in, e.g. bio-medical applications[44]. 
1.4.3 Solid phase peptide synthesis 
The production of a defined AA sequence requires advanced protective group chemistry as well as 
several reaction and intermediate purification steps. Solid phase peptide synthesis (SPPS) – 
affectionately referred to by peptide chemists as “the supreme protective group chemistry” – 
combines these tasks in a straight forward synthesis strategy.  
In general, a single AA is linked to a functionalized solid phase (resin), followed by a stepwise 
elongation with AAs and several washing (filtering) steps until the final up to ~ 50 AAs long peptide 
is cleaved from the resin. In the original Boc-strategy, protection of the single AA was performed 
with a Boc-protective group that had to be removed prior to the next coupling with trifluoro acetic 
acid (TFA). The final cleavage from the resin was then performed with HF. After about 15 years, 
the strategy was replaced by the less dangerous Fmoc-strategy, which uses piperidine in 
deprotection and TFA as the cleavage agent. A general scheme for SPPS is shown in Figure 1-4. 
Due to the coupling to a solid support, intermediate by-products can easily be removed by 
washing and filtration with appropriate solvents, which is the mayor advantage of SPPS. The high 
solvent consumption and the repetitive steps are often seen as acceptable drawbacks.[45] 
 
Figure 1-4: General scheme for SPPS. 
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The variety of available resins for SPPS is large (e.g. Merrifield, Wang, SASRIN, and Rink Amide). 
Most often beaded polystyrene, cross-linked with a low amount of m/p-divinylbenzene, is used as 
a support and functionalized with different AA linkers. The latter define the initial AA coupling as 
well as the cleavage conditions and the outcome of the peptides’ C-terminus. The low amount of 
cross-linking facilitates swelling of the beads during synthesis and, in this way, allows the reagents 
to enter into the polymer network to grow the peptide. The typical loading capacity of resins is 
between 0.1 –1.5 mmol/g and might be adjusted to fit the need of side-chain cyclization, 
sequences with intrinsic difficulties, or synthesis of long peptides.[45] 
The attachment of the initial AA is often an overall yield determining, crucial step, which requires 
conditions that differ from the elongation steps. As a result, several pre-coupled amino acid resins 
are available on the market. However, resins that use the same conditions for the initial coupling 
as for the elongation are also available (e.g. Rink Amide). 
Growing the peptide is performed with stepwise elongation of the solid-support-bound peptide. 
First, the Fmoc-protected amine is liberated using the specific deprotection agent, piperidine. 
After washing, the C-terminally activated amino acid is coupled to the free amine of the peptide, 
while the Fmoc-protection on the N-terminus of the AA prevents multiple coupling. To capture the 
liberated proton and to keep the reaction conditions above pH 9, an organic base (e.g. N,N-
diisopropylethylamine) is used. To prevent sequential errors, unreacted, free N-termini of the 
bound peptide are acetylated with acetic anhydrate, which leads to growth stoppage at this stage, 
and allows easy separation from the final product. Derived from the original activation N,N′-
dicyclohexylcarbodiimide (DCC), several faster, more soluble, racemization insensitive, and less 
irritating activation agents have been developed and are being used today. HOBt, TBTU, HCTU, 
and PyBOP are some common examples. For the protection of the AA residues, several orthogonal 
protective groups are used. The Boc protective group is commonly used for amines and 
tryptophan, and tBu for thiols, due to its easy removal during the final cleavage step. However, a 
large variety of differently protected AAs is available on the market and also allow intermediate 
deprotection.[45] 
Cleavage of the final peptide from the resin depends on the resin-linker used. Often used cleavage 
cocktails utilize concentrated TFA (95% aqueous TFA). Due to the production of highly reactive 
carbocations, scavengers to trap them are used and they depend on the used amino acids. Typical 
scavengers, besides water, are silane derivatives (triethylsilane, triisopropylsilane), or the 
malodorous ethanedithiol if sulfur containing AAs are in the sequence. Good starting conditions 
for cocktail preparation are available in literature [45] or from chemical providers. The dissolved 
peptide in the cleavage cocktail is filtered from the solid support and precipitated in organic 
solvents (e.g. diethylether, diisopropylether, tert.-buthylmethylether) and washed by filtration or 
centrifugation to obtain the crude peptide. 
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1.4.4 Recombinant protein expression 
Recombinant protein expression is a common way to produce proteins that are larger than the 
maximal available length obtained by SPPS (~ 50 AAs). The method uses genetically modified cells 
to overexpress the desired protein. To engineer such little factories, host cells – either bacteria, 
yeast, insect or mammalian – are transformed or transfected with the expression vector (plasmid) 
containing the protein's gene and adequate antibiotic-resistance genes (e.g. ampicillin, 
chloramphenicol, tetracycline, kanamycin, etc.). 
The cells are then exposed to the antibiotic(s) and only the ones with copies of the plasmid survive 
since the plasmid provides the resistance to the antibiotic. After selection, the protein, encoded by 
the gene inserted in the host cells, can be produced in a defined medium. Depending on the 
chosen expression system, the protein can be expressed either intra- or extracellularly. 
The method is a convenient way of protein production, once the expression organism is 
engineered. However, for large-scale production, the low yield/space ratio of the reactors is costly 
if compared to chemical reactors. Nevertheless the method represents the only way to produce 
large proteins under controlled conditions and has been used to produce self-assembling peptides 
for new materials.[10b, 46] 
1.4.5 Purification of amphiphilic peptides 
Crude peptides/proteins as produced by SPPS or expression are usually purified by size exclusion 
or reversed phase high pressure/performance liquid chromatography (RP HPLC). The latter is 
preferred, because it provides good yields, high purities, and easily adjustable purification 
protocols, as well as a high separating capacity for crude products containing several impurities 
with molecular masses in the same range as the target molecule. However, amphiphilic molecules 
and hydrophobic peptides in particular are difficult to purify, due to exactly these wanted 
properties. Because the products have low solubility in pure aqueous or organic solvents but are 
soluble in mixtures thereof, problems are often already encountered during dissolving. However, 
often these can be handled with sophisticated solubility trials[47]. 
If the crude product is dissolved in a compatible solvent for RP HPLC, it can be separated on, e.g. 
endcapped C18 reversed-phase materials, using one of the established eluent systems. Common 
eluent systems are shown in Table 1-2. 
After the separation, the pure peptide/protein carries the counter ion of the corresponding buffer 
used. These can be replaced/removed using ion exchange chromatography or, in case of volatile 
components, lyophilization (ammonium acetate) to obtain the final product. 
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Table 1-2: Common eluent systems for RP HPLC purification of peptides 
ACN / H2O (0.1%TFA) 
ACN / H2O (2% acetic acid) 
ACN / H2O (0.5% formic acid) 
ACN / H2O (1% triethyl ammonium phosphate, pH 2.3 or pH 7) 
ACN / H2O (0.4% NH4OAc, pH 6.5) 
ACN / H2O (0.3% H3PO4-NaClO4, pH 2.8) 
ACN = acetonitrile; alternatively methanol, isopropanol, or tetrahydrofuran can be used 
 
1.5 Gramicidin – a short, hydrophobic, and membrane-integrating peptide 
Gramicidin is a pentadecapeptide, consisting of alternating and completely hydrophobic D- and L-
amino acids. Its origin is the soil bacterial species Bacillus brevis, which is still used to produce 
gramicidin in a biotechnological way. The sequence of 15 amino acids is N-terminally modified 
with a formyl residue and C-terminally functionalized with an ethanolamine residue:  
formyl-L-Val-Gly-L-Ala-D-Leu-L-Ala-D-Val-L-Val-D-Val-L-Trp-D-Leu-L-Trp-D-Leu-L-Trp-D-Leu-L-Trp-
ethanolamine 
Originally occurring gramicidin D is a mixture of gramicidin A, B, and C, that interchanges the 
tryptophan at position 11 with either phenylalanine or tyrosine, respectively. Isomers with 
isoleucine in position one also exist. The gramicidin K family is an esterified variation with different 
fatty acids on the ethanolamine terminus. Gramicidin S, in contrast to its analogues, is not a linear 
but a cyclic peptide. However, gramicidin A, at a fraction of 80%, remains the most frequently 
occurring isomer.[48] 
Gramicidin is known for its antibiotic effect on gram positive bacteria, caused by its ion channel 
formation for monovalent cations, and also owes its name to this feature. Ion channel formation is 
enabled by a β-helical-like secondary structure, causing two molecules to dimerize and span a 
present lipid bilayer. Several states of dimerization exist: double helical dimers, helical dimers, in 
parallel and antiparallel fashion, as well as in left- and right-handed orientations. The degree of 
dimerization as well as the dimerization itself depend on the polarity of the surrounding, and can 
be influenced by the presence of ions (see Figure 1-5).[48] 
In the present thesis, gramicidin A plays an important role in the formation of a purely peptidic 
amphiphile, because the unique structure hides the hydrophilic backbone in the interior of the 
helix while presenting the hydrophobic residues to the exterior, making it an ideal sequence for 
the hydrophobic part of an amphiphile. 
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Figure 1-5: Stereographic illustrations of gramicidin a) structure of Cs+ complexed, right-handed antiparallel 
double stranded double helical (DSDHR) dimer crystal structure, b) H+ complexed DSDHR dimer from glacial 
acetic acid crystal structure, c) methanol solvated DSDHL gramicidin structure as major conformer in polar 
solvents. From Burkhart et al.[49] reprinted by permission of John Wiley and Sons. 
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1.6 Scope of the thesis 
The aim of the present thesis is the generation of new, nano-sized materials that are produced by 
the delicate method of self-assembly. In order to interact with biological systems in a most 
effective way, the underlying chemically designed building blocks should be based on purely 
peptidic amphiphiles. 
The first task is to find a peptide system in which a peptide is segregated into an hydrophilic and a 
hydrophobic region to enable self-assembly, as is known from other amphiphilic but rarely 
biocompatible/biodegradable systems. These conceptual steps will need to be transferred into 
practice by finding an adequate synthesis route as well as purification steps, which can then be 
used to produce different peptides, based on this new class of self-assembly materials.  
The variation of the sequence – representing designed point mutations of the molecular building 
block’s architecture – combined with the characterization of the resulting nanostructures in 
solution will lead to an iteratively understanding of the hierarchical, purely peptidic self-assembly. 
Furthermore, the use of defined amino acids will induce possible molecular anchor points for 
environmental stimuli such as, for example, the pH-dependence of the nanostructures. This will 
finally lead to a tunable, purely peptidic self-assembly system, and result in new “smart” materials. 
These are then tested for potential applications in the field of drug delivery, but might also be 
useful as templates to produce three-dimensional, nano-patterned materials with new optical and 
electronic properties. 
  
Dirk de Bruyn Ouboter Introduction 
28 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
1.7 References 
[1] G. M. Whitesides and M. Boncheva, Proceedings of the National Academy of Sciences of the 
United States of America 2002, 99, 4769-4774. 
[2] a) A. Katsuhiko and et al., Science and Technology of Advanced Materials 2008, 9, 014109; b) I. 
W. Hamley, Introduction to Block Copolymers, John Wiley & Sons, Ltd, 2004, p. 1-29. 
[3] D. F. Evans, The Colloidal Domain: Where Physics, Chemistry, Biology, and Technology Meet, 
2nd, 1998, p. 640 pp. 
[4] a) R. Nagarajan, Langmuir 2001, 18, 31-38; b) M. Antonietti and S. Förster, Advanced Materials 
(Weinheim, Germany) 2003, 15, 1323-1333. 
[5] G. Srinivas, J. C. Shelley, S. O. Nielsen, D. E. Discher and M. L. Klein, The Journal of Physical 
Chemistry B 2004, 108, 8153-8160. 
[6] a) L. R. Pratt, Annual Review of Physical Chemistry 1985, 36, 433-449; b) C. Tanford, Science 
1978, 200, 1012-1018. 
[7] a) U. Borchert, U. Lipprandt, M. Bilang, A. Kimpfler, A. Rank, R. Peschka-Suess, R. Schubert, P. 
Lindner and S. Foerster, Langmuir 2006, 22, 5843-5847; b) J. Du, Y. Tang, A. L. Lewis and S. P. 
Armes, Journal of the American Chemical Society 2005, 127, 17982-17983; c) E. G. Bellomo, M. 
D. Wyrsta, L. Pakstis, D. J. Pochan and T. J. Deming, Nature Materials 2004, 3, 244-248; d) F. 
Checot, A. Brulet, J. Oberdisse, Y. Gnanou, O. Mondain-Monval and S. Lecommandoux, 
Langmuir 2005, 21, 4308-4315; e) J. Rodriguez-Hernandez and S. Lecommandoux, J. Am. 
Chem. Soc. 2005, 127, 2026-2027; f) F. Checot, J. Rodriguez-Hernandez, Y. Gnanou and S. 
Lecommandoux, Biomolecular Engineering 2007, 24, 81-85. 
[8] M. Sauer, D. Streich and W. Meier, Advanced Materials 2001, 13, 1649-1651. 
[9] a) I. Dimitrov, B. Trzebicka, A. H. E. Mueller, A. Dworak and C. B. Tsvetanov, Progress in Polymer 
Science 2007, 32, 1275-1343; b) C. J. F. Rijcken, O. Soga, W. E. Hennink and C. F. van Nostrum, 
J Control Release 2007, 120, 131-148; c) Y. Li, B. S. Lokitz and C. L. McCormick, Angewandte 
Chemie, International Edition 2006, 45, 5792-5795; d) X. Chen, X. Ding, Z. Zheng and Y. Peng, 
New Journal of Chemistry 2006, 30, 577-582; e) S. Qin, Y. Geng, D. E. Discher and S. Yang, 
Advanced Materials (Weinheim, Germany) 2006, 18, 2905-2909. 
[10] a) L. Eisoldt, J. G. Hardy, M. Heim and T. R. Scheibel, Journal of Structural Biology 2010, 170, 
413-419; b) F. Hagn, L. Eisoldt, J. G. Hardy, C. Vendrely, M. Coles, T. Scheibel and H. Kessler, 
Nature (London, United Kingdom) 2010, 465, 239-242; c) M. Heim, D. Keerl and T. Scheibel, 
Angewandte Chemie, International Edition 2009, 48, 3584-3596; d) M. Heim, L. Roemer and T. 
Scheibel, Chemical Society Reviews 2010, 39, 156-164; e) U. K. Slotta, S. Rammensee, S. Gorb 
and T. Scheibel, Angewandte Chemie, International Edition 2008, 47, 4592-4594. 
[11] a) X. Tong, G. Wang, A. Soldera and Y. Zhao, Journal of Physical Chemistry B 2005, 109, 20281-
20287; b) Y. Zhao, Chemical Record 2007, 7, 286-294; c) W. Su, K. Han, Y. Luo, Z. Wang, Y. Li 
and Q. Zhang, Macromolecular Chemistry and Physics 2007, 208, 955-963; d) W. Su, Y. Luo, Q. 
Yan, S. Wu, K. Han, Q. Zhang, Y. Gu and Y. Li, Macromolecular Rapid Communications 2007, 
28, 1251-1256. 
[12] a) A. Napoli, M. Valentini, N. Tirelli, M. Mueller and J. A. Hubbell, Nature Materials 2004, 3, 
183-189; b) S. Cerritelli, D. Velluto and J. A. Hubbell, Biomacromolecules 2007, 8, 1966-1972. 
[13] K. Kita-Tokarczyk, J. Grumelard, T. Haefele and W. Meier, Polymer 2005, 46, 3540-3563. 
[14] B. Alberts, J. Alexander, J. Lewis, M. Raff, K. Roberts and P. Walter, Molecular Biology of the 
Cell, 4th Edition, Wiley, 2004, p. 2000 pp. 
[15] S. Durani, Accounts of Chemical Research 2008, 41, 1301-1308. 
[16] N. Bruns, K. Pustelny, L. M. Bergeron, T. A. Whitehead and D. S. Clark, Angewandte Chemie, 
International Edition 2009, 48, 5666-5669, S5666/5661-S5666/5617. 
Dirk de Bruyn Ouboter Introduction 
Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 29 
[17] K. Matsuura, K. Watanabe, T. Matsuzaki, K. Sakurai and N. Kimizuka, Angewandte Chemie 
2010, 122, 9856-9859. 
[18] K. Toshimori and C. Ito, Arch Histol Cytol 2003, 66, 383-396. 
[19] a) D. G. Angelescu and P. Linse, Soft Matter 2008, 4, 1981-1990; b) S. Andersson, Zeitschrift 
fuer Anorganische und Allgemeine Chemie 2008, 634, 2161-2170. 
[20] a) B. V. Venkataram Prasad, S. Crawford, J. A. Lawton, J. Pesavento, M. Hardy and M. K. Estes, 
Structural Studies on Gastroenteritis Viruses, John Wiley & Sons, Ltd, 2008, p. 26-46; b) K. 
Mattison, A. Shukla, A. Cook, F. Pollari, R. Friendship, D. Kelton, S. Bidawid and J. M. Farber, 
Emerg Infect Dis 2007, 13, 1184-1188. 
[21] L. Howard and C. Daghlian in Pollen from a variety of common plants, Vol.  (Ed. 
Misc_pollen.jpg), Dartmouth Electron Microscope Facility, Dartmouth College, Hanover, New 
Hampshire. 
[22] a) Y. Malam, M. Loizidou and A. M. Seifalian, Trends in Pharmacological Sciences 2009, 30, 
592-599; b) O. Onaca, R. Enea, D. W. Hughes and W. Meier, Macromolecular Bioscience 2009, 
9, 129-139. 
[23] F. M. Veronese and G. Pasut, Drug Discovery Today 2005, 10, 1451-1458. 
[24] V. Malinova, S. Belegrinou, D. de Bruyn Ouboter and W. P. Meier, Adv. Polym. Sci. 2010, 224, 
113-165. 
[25] K. Kita-Tokarczyk, F. Itel, M. Grzelakowski, S. Egli, P. Rossbach and W. Meier, Langmuir 2009, 
25, 9847-9856. 
[26] R. Nehring, C. G. Palivan, S. Moreno-Flores, A. Mantion, P. Tanner, J. L. Toca-Herrera, A. 
Thunemann and W. Meier, Soft Matter 2010, 6, 2815-2824. 
[27] a) S. Egli, B. Fischer, S. Hartmann, P. Hunziker, W. Meier and P. Rigler, Macromolecular 
Symposia 2010, 296, 278-285; b) S. Egli, H. Schlaad, N. Bruns and W. Meier, Polymers 2011, 3, 
252-280. 
[28] E. Cabane, V. Malinova and W. Meier, Macromolecular Chemistry and Physics 2010, 211, 
1847-1856. 
[29] a) R. Sachsenhofer, W. H. Binder, D. Farnik and R. Zirbs, Macromolecular Symposia 2007, 254, 
375-377; b) Y. Li, A. E. Smith, B. S. Lokitz and C. L. McCormick, Macromolecules (Washington, 
DC, United States) 2007, 40, 8524-8526; c) G. S. Cleveland Eugene Rayford II, Kevin Shuford, 
Nanoscape 2005, 2, 27-33; d) M. K. Corbierre, N. S. Cameron, M. Sutton, K. Laaziri and R. B. 
Lennox, Langmuir 2005, 21, 6063-6072. 
[30] F. Xie, M. Woodle and P. Lu, Drug Discovery Today 2006, 11, 67-73. 
[31] H. Ringsdorf, P. Lehmann and R. Weberskirch, 1999, pp. BTEC-001. 
[32] a) M. Delcea, N. Madaboosi, A. M. Yashchenok, P. Subedi, D. V. Volodkin, G. B. G. De, H. 
Moehwald and A. G. Skirtach, Chemical Communications (Cambridge, United Kingdom) 2011, 
47, 2098-2100; b) M. Delcea, A. Yashchenok, K. Videnova, O. Kreft, H. Mohwald and A. G. 
Skirtach, Macromolecular Bioscience 2010, 10, 465-474. 
[33] a) S. Kubowicz, J.-F. Baussard, J.-F. Lutz, A. F. Thuenemann, H. von Berlepsch and A. 
Laschewsky, Angewandte Chemie, International Edition 2005, 44, 5262-5265; b) J.-F. Lutz and 
A. Laschewsky, Macromolecular Chemistry and Physics 2005, 206, 813-817; c) H. von 
Berlepsch, C. Boettcher, K. Skrabania and A. Laschewsky, Chemical Communications 
(Cambridge, United Kingdom) 2009, 2290-2292; d) C. Zhong and D. Liu, Macromolecular 
Theory and Simulations 2007, 16, 141-157; e) K. Skrabania, H. von Berlepsch, C. Boettcher and 
A. Laschewsky, Macromolecules (Washington, DC, United States) 2010, 43, 271-281. 
[34] D. J. Adams, S. Adams, D. Atkins, M. F. Butler and S. Furzeland, Journal of Controlled Release 
2008, 128, 165-170. 
[35] K. V. Rajan and G. Sanjay, Pharmaceutical Technology 2001, 25, 1-14. 
Dirk de Bruyn Ouboter Introduction 
30 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
[36] a) D. Williams, Medical Device Technology 2003, 14, 10; b) F. M. Veronese, Biomaterials 2001, 
22, 405-417. 
[37] a) J. F. Kennedy and M. M. He, Carbohydrate Polymers 2005, 60, 127; b) D. F. Carmignac, Cell 
Biochemistry and Function 2003, 21, 298-298. 
[38] a) P. D. Thornton and A. Heise, J. Am. Chem. Soc. 2010, 132, 2024-2028; b) B. Romberg, F. M. 
Flesch, W. E. Hennink and G. Storm, Int. J. Pharm. 2008, 355, 108-113; c) B. Law, R. Weissleder 
and C.-H. Tung, Biomacromolecules 2006, 7, 1261-1265. 
[39] J. Venugopal, M. P. Prabhakaran, S. Low, A. T. Choon, G. Deepika, V. R. G. Dev and S. 
Ramakrishna, Current Pharmaceutical Design 2009, 15, 1799-1808. 
[40] a) B. I. Ltd. in Next Generation Protein Engineering and Drug Design, Vol. BI00020-004 
Business Insights Ltd., 2007; b) B. I. Ltd. in Innovation in Drug Delivery, Vol. BI00019-004 
Business Insights Ltd., 2006. 
[41] a) P. J. Halling, Journal of Chemical Technology and Biotechnology 1995, 62, 105; b) K. P. C. 
Vollhardt and N. E. Schore, Organische Chemie  3. Auflage, Wiley-VCH, Weinheim, Germany, 
2000, p. 1445 pp. 
[42] J. Sun, X. Chen, C. Deng, H. Yu, Z. Xie and X. Jing, Langmuir 2007, 23, 8308-8315. 
[43] a) T. J. Deming, Nature 1997, 390, 386-389; b) K. T. Kim, M. A. Winnik and I. Manners, Soft 
Matter 2006, 2, 957-965; c) C. Schatz, S. Louguet, J.-F. Le Meins and S. Lecommandoux, 
Angew. Chem., Int. Ed. 2009, 48, 2572-2575. 
[44] a) J.-F. Lutz and H. G. Boerner, Progress in Polymer Science 2008, 33, 1-39; b) J. Sun, C. Deng, 
X. Chen, H. Yu, H. Tian, J. Sun and X. Jing, Biomacromolecules 2007, 8, 1013-1017; c) J. Lin, J. 
Zhu, T. Chen, S. Lin, C. Cai, L. Zhang, Y. Zhuang and X.-S. Wang, Biomaterials 2009, 30, 108-
117; d) F. Checot, S. Lecommandoux, Y. Gnanou and H.-A. Klok, Angewandte Chemie, 
International Edition 2002, 41, 1339-1343; e) H. Kukula, H. Schlaad, M. Antonietti and S. 
Forster, Journal Of The American Chemical Society 2002, 124, 1658-1663; f) S. Kimura, D.-H. 
Kim, J. Sugiyama and Y. Imanishi, Langmuir 1999, 15, 4461-4463. 
[45] M. Mergler and J. P. Durieux, The Bachem Practice of SPPS, Bachem AG, Bubendorf, 
Switzerland, 2000, p. 1-83. 
[46] S. Kyle, A. Aggeli, E. Ingham and M. J. McPherson, Trends in Biotechnology 2009, 27, 423-433. 
[47] a) Vydac in Designing Purification Methods for Hydrophobic Peptides, Vol. AN #9802 Vydac, 
The Separations Group, Hesperia, CA, USA, 1998; b) C. T. Choma, G. T. Robillard and D. R. 
Englebretsen, Tetrahedron Letters 1998, 39, 2417-2420; c) R. Bollhagen, M. Schmiedberger 
and E. Grell, Journal of Chromatography A 1995, 711, 181-186. 
[48] a) K. Bauer, R. Roskoski, Jr., H. Kleinkauf and F. Lipmann, Biochemistry 1972, 11, 3266-3271; b) 
B. A. Wallace, Biophys. J 1986, 49, 295-306; c) B. A. Wallace, Advances in experimental 
medicine and biology 1996, 398, 607-614; d) B. M. Burkhart, R. M. Gassman, D. A. Langs, W. A. 
Pangborn and W. L. Duax, Biophysical Journal 1998, 75, 2135-2146; e) B. A. Wallace, Journal of 
Structural Biology 1998, 121, 123-141; f) D. Voet and J. Voet, Biochemistry, John Wiley and 
Sons New York, 1995, p. 519-520. 
[49] B. M. Burkhart, R. M. Gassman, D. A. Langs, W. A. Pangborn, W. L. Duax and V. Pletnev, 
Biopolymers 1999, 51, 129-144. 
 
 
Dirk de Bruyn Ouboter Reversible peptide particle formation using a mini amino acid sequence 
Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 31 
2 Reversible peptide particle formation using a mini amino 
acid sequence 
 
Thomas B. Schustera, Dirk de Bruyn Oubotera, Enrica Bordignonb, Gunnar Jeschkeb,  
and Wolfgang Meiera 
 
aDepartment of Chemistry, University of Basel, Klingelbergstrasse 80, CH-4056 Basel, Switzerland.  
bLaboratory for Physical Chemistry, ETH Zurich, Wolfgang-Pauli-Str.10, CH-8093 Zürich, Switzerland 
 
 
Phase diagram of the self-assembly process of the short peptides Ac-X3-gT and AcC-X3-gT into 
micelles and spherical peptide particles, termed “peptide beads” (left). SEM of the formed peptide 
beads (right). 
 
Parts of this chapter were published in:  
Soft Matter, 2010, 6, 5596-5604 
http://pubs.rsc.org/en/Content/ArticleLanding/2010/SM/c0sm00442a 
Reproduced by permission of The Royal Society of Chemistry 
  
Dirk de Bruyn Ouboter Reversible peptide particle formation using a mini amino acid sequence 
32 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
2.1 Abstract 
This chapter focuses on the formation of self-assembled peptide particles using an amphiphilic 
amino acid (AA) sequence derived using solid-phase peptide synthesis (SPPS) and describes the 
purification and characterization thereof. The prepared undecamer features a repetitive L-
tryptophan and D-leucine [LW-DL] motif representing the hydrophobic block, and an N-terminally 
attached hydrophilic (lysine or acetylated lysine) section. This chapter also shows the first 
approach used in this thesis to produce self-assembled structures that are based on a purely 
peptidic amphiphile. 
Peptides that contain charged lysine were observed to aggregate into micelles and a minor 
fraction of peptide particles. Charge shielding with anionic counter ions shifted the equilibrium 
towards the larger peptide aggregates, their size depending on counter ion positioning as found in 
the Hofmeister series. Similarly, the corresponding uncharged (acetylated) peptide was also 
demonstrated to assemble into micelles and subsequently into spherical peptide particles, termed 
“peptide beads”, which are hypothesized to be multicompartment micelles. The formation of 
peptide beads was studied as a function of temperature and solvent composition by means of 
electron paramagnetic resonance (EPR), dynamic and static light scattering, fluorimetry and 
electron microscopy. The results suggest an equilibrium among single peptide molecules, micelles, 
and peptide beads. Interestingly, once formed, the peptide beads show high mechanical stability 
and preserve their shape and dimensions even after isolation from solution. 
2.2 Introduction 
The increased efforts and interest in self-assembled nanostructures in recent decades, especially 
in aqueous solutions, have led to manifold morphologies as exhibited by micelles, cylindrical 
micelles and vesicles. Block copolymers have been explored to tailor-make micelles for the 
encapsulation of hydrophobic compounds[1]. Inspired by nature and imitating lipid membranes, 
block copolymer vesicles are now being used to create nanocompartments that encapsulate 
dyes[2] and active enzymes[3], insert active proteins[4], perform molecular recognition[5] and form 
stimuli-responsive nanoreactors and drug delivery systems (DDSs)[6]. Vesicular structures are 
interesting candidates for DDSs because they permit the simultaneous encapsulation of 
hydrophobic and hydrophilic compounds in their membranes and aqueous cores, respectively[7]. 
Other self-assembled structures that could serve as DDSs are large compound micelles[8] (LCM) or 
multicompartment micelles[9] (MCM). These nano-sized systems have a hydrosoluble shell and are 
characterized by segregated, incompatible subdomains that entrap drugs as a function of 
hydrophobicity, potentially followed by controlled release. MCM and LCM consist of micellar and 
inverse micellar-type subunits, respectively.  
Hybrid materials composed of polypeptides and polymers combine the advantages of the two, e.g. 
solubility and processability[10]. Polypeptides contribute positive aspects in terms of chemical 
functionality due to a diversity of amino acid (AA) side chains, combined with specific AA 
sequences that act, e.g. as a specific recognition site[11] (RGD sequence for cell adhesion or 
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arginine rich sequences for cell penetration[12]). Another characteristic feature of polypeptides is 
their secondary structure, which permits exploiting their geometry[13]. The primary sequence, 
along with environmental conditions (pH, ionic strength, temperature, solvent), i.e. intrinsic and 
external factors respectively, determine the secondary structure and therefore also control the 
overall morphology of the assembly. 
Peptide-based materials can respond to environmental triggers with sensitivity and specificity. In 
the biological context this smartness makes a multitude of applications possible, including 
triggered drug release, biosensors, tissue repair, and also patterning[14]. For example, applying 
changes in pH and temperature triggered the inversion of a micellar structure based on the 
properties of the two blocks used in a peptide-containing block copolymer[15]. In another system 
the release of a drug was controlled by the presence of poly(L-glutamic acid) within the block 
copolymer micelle’s corona, leading to a pH-triggered increase in permeability[16].  
The importance of charges was also demonstrated by the charge-driven complexation of 
oppositely charged peptide-based blocks, yielding vesicles with a semipermeable membrane[17]. 
Recently, also amphiphilic biopolymers have been reported that comprise only natural amino acids 
and hence are expected to display enhanced biocompatibility. For example, Deming et al.[12, 18] and 
Rodriguez-Hernandez et al.[19] designed block copolypeptides that self-assemble into vesicular 
structures. It should be noted that the systems described so far were generated by conventional 
polymerization techniques. Despite the fact that rather narrow molar mass distributions can be 
reached[12, 18] the resulting polymers are not monodisperse and allow only a limited control over 
the sequence. 
These problems are overcome by genetic engineering techniques that result in excellent control of 
sequence and length[20]. In this regard, Scheibel et al. reported the use of a natural 47.7 kDa spider 
silk protein to form microspheres[21].  
Solid phase synthesis also offers optimal tuning of properties by point mutation, but is limited to 
oligo and polypeptides (up to maximal 50 AA). 
Santoso et al. reported the self-assembly of small amphiphilic peptides having no defined 
secondary structure into well-defined superstructures[22] which, however, proved to be highly 
sensitive to the purity of the peptides[23]. The continued search for an essential amyloid-forming 
sequence, led to still smaller molecules containing just two amino acids capable of forming 
superstructures, i.e. nanotubes [24].  
In summary, manifold architectures of self-assembled nanostructures exist. All are intrinsically 
very interesting and have potential application not only in medicine and nanobiotechnology but 
also in solar cells and optical and electronic devices. Naturally occurring amino acids, as 
hydrophobic or hydrophilic components, contribute to the self-assembly and can respond to 
external stimuli. After performing their mission they degrade to prevent accumulation in the body. 
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Here we report the synthesis and characterization of amphiphilic oligopeptides while focusing on 
the self-assembly process. Inspired by gramicidin A (gA), the C-terminal sequence of the peptides 
consists of a truncated gA (gT) – a repetitive L-tryptophan – D-leucine [LW-DL] motif. The motif 
results in distinct phi and psi angles of the peptide backbone, whereas similarities in sequence 
between gramicidin and the amphiphilic peptides also suggest similarities in secondary 
structure[25]. Overall, the peptide is amphiphilic due to the N-terminal attached lysines (K) or 
acetylated lysines (X). 
An overview of the synthesized peptides is given in Table 2-1 (for details, see Table S 2-1). We 
investigated the amphiphilic mini (11 AA) peptides by EPR, dynamic (DLS) and static light scattering 
(SLS) as well as transmission (TEM) and scanning electron microscopy (SEM). The focus was 
centered on the process that forms the superstructures as a function of temperature and solvent 
composition. To investigate the effect of electrostatic interactions on the self-assembly, charges 
on the molecule were removed by acetylation, while shielding by the addition of counter ions also 
proved effective.  
Table 2-1: Code and sequence of charged (K) and uncharged (X = LK(Ac)) amphiphilic peptides  
Code Sequence 
K3-gT H-LK3-[LW-DL]3-LW-NH2 
C-K3-gT H-LC-LK3-[LW-DL]3-LW-NH2 
Ac-X3-gT Ac-[LK(Ac)]3-[LW-DL]3-LW-NH2 
AcC-X3-gT Ac-LC-[LK(Ac)]3-[LW-DL]3-LW-NH2 
AcC(sl)-X3-gT Ac-LC(acetamidoproxyl)-[LK(Ac)]3-[LW-DL]3-LW-NH2 
2.3 Results and discussion 
Similar to other amphiphiles, amphiphilic peptides are also expected to self-assemble into well-
defined superstructures in aqueous solution. Here, we focused on peptides with a given 
hydrophobic [LW-DL]3-LW-NH2 sequence that was coupled to a hydrophilic tripeptide either based 
on a positively charged LK3 sequence or the corresponding, electrically neutral [LK(Ac)]3. 
2.3.1 Dimerization capacity 
The repetitive [LW-DL] sequence of our model peptides derives from gA, which is known to form 
dimers in apolar environment[26]. Hence, we expected that the C-terminus of our peptides would 
also be accessible for such intermolecular organization. The nature of the building blocks 
(monomeric vs. dimeric peptides) is expected to directly influence the structure of the resulting 
self-assemblies in aqueous media. Therefore we performed model experiments in organic solvents 
to probe the dimerization capacity of the peptides by GPC and EPR. The GPC elution profile for 
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gramicidin shows separation into mono- and dimers in different solvents[27] (THF, ethanol,Figure S 
2-1). The elution profile of the amphiphilic peptide was characterized by a slightly broader peak 
with no indication of distinct dimerization. 
EPR was used to further verify possible dimerization in solution. The spin-labeled amphiphilic 
peptide AcC(sl)-X3-gT was dissolved in ethanol, in which gA is known to lead to dimerization[27]. 
Dimerization of the molecule can occur by association of the hydrophobic component in a head-
to-head or in an intertwining configuration, both well-established forms for gA[28]. Either means of 
dimerization is expected to bring the two spin labels at the hydrophilic ends of the peptide into 
close proximity (2 − 3 nm range). Dzikovski[29] et al. found direct evidence of a head-to-head gA 
dimer in the dimyristoylphosphatidylcholine (DMPC) membrane with an interspin distance of 3.1 
nm by double-quantum coherence (DQC) EPR.  
 
Figure 2-1: (A) Pulse double electron-electron resonance on 150 µM AcC(sl)-X3-gT in ethanol in the 
presence of 50 v % deuterated glycerol and (B) cw EPR spectra on AcC(sl)-X3-gT (300 µM, white line) as well 
as a AcC(sl)-X3-gT/AcC-X3-gT mixture (100 µM, black line) in ethanol. 
Here, double electron-electron resonance (DEER), which is sensitive in the 1.7 − 8 nm range[30], 
was performed on AcC(sl)-X3-gT in dd water. No DEER signal modulation from dipole-dipole 
interaction between electron spins was detected. Therefore, the trace clearly confirmed that no 
dimerization occurred (Figure 2-1A). To verify the possible presence of short interspin distances 
(< 2 nm), the spin labeled AcC(sl)-X3-gT was spin-diluted with unlabeled AcC-X3-gT. The continuous 
wave (cw) EPR spectra of AcC(sl)-X3-gT at 100 wt % and 8.7 wt % (2:23 dilution with unlabeled AcC-
X3-gT) in ethanol are superimposed in Figure 2-1B. The identical spectral shapes at room 
temperature ruled-out the presence of short interspin distances. 
In conclusion, both GPC and EPR showed that the amphiphilic peptides are monomeric in ethanol. 
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2.3.2 Charged amphiphilic peptide – C-K3-gT 
The hydrophilic building block C-K3-gT possesses free amine functionalities on the lysine residues 
as well as a free N-terminus. Therefore, at neutral pH (pK of 10.2) the peptide is charged and self-
assembly is constrained by electrostatic repulsion. 
The peptide can be directly dissolved in an aqueous environment. In such, it exhibited a confined 
critical micelle concentration of cmc (C-K3-gT) = 0.23 mmol/L (cf. Figure S 2-2), thus suggesting 
assembly into micelles and conventional surfactant behavior.  
This is confirmed by DLS, indicating spherical micelles with a hydrodynamic radius of Rh ≈ 10 nm. In 
addition – particularly at higher peptide concentrations – DLS indicated the presence of a minor 
fraction of larger aggregates with a hydrodynamic radius of approximately 160 nm. Indeed, TEM 
micrographs also showed that, besides the dominant micelle fraction, spherical objects of the 
mentioned dimension were occasionally found (Figure S 2-3). We hypothesize that these 
structures are formed by the aggregation of individual micelles into “multicompartment micelles”, 
herein termed “peptide beads”. Since the assembly of C-K3-gT is strongly influenced by 
electrostatic interactions of the positively charged oligolysine groups, we expected that an 
equilibrium between micelles and peptide beads would be directly influenced by shielding the 
charges with appropriate counter ions. The Hofmeister series orders such ions according to their 
properties at interfaces [21b, 31]. Chaotropic ions, for example, increase surface tension and protein 
stability, in contrast to cosmotropic ions having the opposite effects. 
Indeed, stepwise addition of small aliquots of concentrated salt solution to C-K3-gT increased the 
fraction and size of the beads as monitored by DLS. The growth in size was similar for the different 
ions. The size of the peptide beads increased up to a salt concentration of 0.3 mol/L. Beyond that 
value only minor size changes were observed, indicating saturation and maximum shielding. 
The final radii of the formed particles at salt concentrations of 0.6 mol/L essentially followed the 
Hofmeister series (Figure 2-2). Cosmotropic and chaotropic ions influenced the size and the 
relative fraction of the corresponding aggregates while “neutral” ions led to a minor response in 
the peptide assemblies. For chaotropic ions, we monitored salting out due to a decrease in 
solubility of the peptide, and therefore the amplification of the tendency to agglomerate.  
Chaotropic ions lowered the interfacial tension and therefore affected the curvatures and 
dimensions of the peptide beads. Exemplary SEM of peptide particles in the presence of PO43- and 
SCN- are given in Figure S 2-4. 
We found only one exception to the Hofmeister series. Despite their chaotropic nature, SCN- ions 
(Figure 2-2) still led to particles with relatively small radii. This is possibly due to a specific 
interaction that stabilizes the structure[32]. 
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Figure 2-2: Effect of cosmotropic (black), neutral (white), and chaotropic anions (grey) on the self-assembly 
(radius). 
2.3.3 Electrically neutral amphiphilic peptide – acetylated AcC-X3-gT 
It is obviously possible to manipulate self-assembly of the charged amphiphile by external factors 
(correct choice of counter ions). Therefore, we expected that a similar or even stronger effect 
could be induced by acetylation of the lysine residues, thus eliminating the electrostatic 
interactions. Consequently, the only difference between C-K3-gT and AcC-X3-gT is a lack of charges 
due to the acetylation of the primary amine functions. It should be noted, however, that 
acetylation to AcC-X3-gT reduces hydrophilicity to the extent that the entire amphiphilic molecule 
does not dissolve directly in dd water. Therefore, the self-assembly process is induced by 
dissolving the peptide in ethanol and changing the surrounding polarity by exchanging the ethanol 
with dd water. 
The self-assemblies formed by AcC-X3-gT were characterized by SEM and TEM (Figure 2-3A and B). 
Indeed, this peptide also assembled into micelles and larger peptide beads. Interestingly in TEM 
the spherical particles display an indentation as shown in Figure 2-3 for AcC(sl)-X3-gT. This 
phenomenon might be caused by solvent evaporating from the assembly during the sample 
preparation (drying). The self-assembly behavior proved to be insensitive to minor structural 
changes of the peptides. For example, for Ac-X3-gT, AcC-X3-gT (with an additional acetylated 
cysteine) or AcC(sl)-X3-gT (carrying a spin label at the hydrophilic end), no difference was observed 
with any of the methods used (Figure 2-3 and Figure S 2-5). Thus, the labeled AcC(sl)-X3-gT can be 
used as a valid “tool” to probe its self-assembly and that of its analogues.  
Furthermore, no significant difference was observed between C-K3-gT and K3-gT. Therefore, a 
transfer of the information concerning the self-assembly process of the AcC-X3-gT/C-K3-gT system 
to the Ac-X3-gT/K3-gT system appears justified. 
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Figure 2-3: Representative SEM of (A) AcC-X3-gT and (C) Ac-X3-gT and TEM of (B) AcC-X3-gT (D) AcC(sl)-X3-gT 
after solvent exchange to dd water. 
To obtain further insight into the self-assembly process upon solvent replacement, samples at 
different final ethanol concentrations (40 wt % – 0 wt % EtOH) were prepared and analyzed by 
EPR, DLS, and SLS.  
The self-assembly process for AcC-X3-gT (with 8.7% of AcC(sl)-X3-gT and total initial peptide 
concentration of 1 mg/mL to ensure sufficient signal/noise ratio) was followed using EPR. The cw 
EPR spectra performed at different final ethanol concentrations showed two distinct species 
(Figure S 2-6), one characterized by narrow lines (so-called mobile species, with fast rotational 
correlation times) and one characterized by broad lines, large pseudo hyperfine splitting, which is 
typical of powder-like spectra (so-called immobile species, with slow rotational correlation times). 
The ratio of the two species varied with temperature and final ethanol concentration (Figure 2-4): 
Increasing the temperature together with the ethanol concentration led to an increase in the 
mobile species population. The mobile species was predominant at 40 wt % ethanol, with 65% of 
the total spectral area at 273 K. The immobile species, on the other hand, was the prevalent 
species at 4 wt % ethanol, with 100 to 98% of the spectral area in the 263 to 335 K range (Figure 
2-4). The rotational correlation time (τ = 0.530 ns at 293 K and 40 wt %) calculated for the micelle 
fraction at a size of 5.65 nm matched the rotational correlation time (τ = 0.531 ns) obtained by 
simulating the spectrum with the fast motion regime EasySpin[33] “garlic” function using an 
isotropic model of motion. Thus, the mobile EPR species correlate with the micellar fraction. 
Similarly, the high correlation times of the immobile species (> 20 ns) correlate to the large 
dimensions observed for the peptide beads. The temperature and ethanol dependence of the EPR 
spectral fractions confirmed that both external factors can shift the equilibrium between the 
micelle and the peptide bead population. 
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Figure 2-4: EPR spectra of AcC(sl)-X3-gT / AcC-X3-gT mixture as a function of final ethanol concentration and 
temperature. The spectra at 40 wt % EtOH were scaled and superimposed to the spectra obtained at the 
same temperature with different EtOH concentrations. 
The self-assembly process for the same AcC-X3-gT/ AcC(sl)-X3-gT mixture (8.7%, ctot = 1 mg/mL) and 
final ethanol concentrations was monitored by DLS, which confirmed the observations from EPR. 
In the dissolved state in pure ethanol, no significantly higher scattering intensity was observed 
than for that of pure ethanol, indicating molecularly dissolved peptides. For water/ethanol 
mixtures, data were analyzed by the CONTIN algorithm and revealed up to three different species 
(correlation functions are given in Figure S 2-7). One species was found with a hydrodynamic 
radius in the range of 5 − 10 nm, which corresponds well with the size of micelles. With decreasing 
ethanol concentration an increasing fraction of larger particles at 100 − 150 nm was also present. 
At less than 20 wt % ethanol, a third species with a greater radius (e.g. Rh ≈ 350 nm at 4 wt %) 
appeared and became the dominant species. It apparently emerged from the second species, 
since we found no structurally different morphologies in the final stage of the self-assembly. 
Nevertheless these particles have an increased radius and thus are considered a “matured” 
second species. It should be emphasized that the formation of the final particles was fully 
reversible; upon addition of ethanol the fraction of the second species increased to the 
diminishment of the third. Also, the self-assembly of the synthesized peptides into micelles and 
peptide beads was found to be a reversible process and the equilibrium between the different 
species was independent of the sample preparation (for example, see Figure S 2-8). The transition 
was also able to be induced by temperature variation: absorbance measurements allowed us to 
directly track the reversible formation of the final “matured” peptide particles (see Figure S 2-9 for 
temperature dependent absorbance measured at 20 wt % ethanol). Interestingly, the formation of 
the final “matured” peptide particles in dd water also depended on the initial concentration of the 
peptide in ethanol. The hydrodynamic radius remained constant at Rh ≈ 130 nm up to an initial 
peptide concentration of approx. 0.5 mg/mL. For concentrations higher than 0.5 mg/mL the size of 
the peptide beads increased linearly with the initial peptide concentration (Figure 2-5 and SEM 
micrographs Figure S 2-10). Obviously, the onset of the second growth process requires a certain 
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“critical peptide concentration” similar to the critical micelle concentration of detergents. 
However, further experiments are needed to understand this process. 
 
Figure 2-5: Size dependency of final peptide beads in dd H2O upon initial peptide concentration. Error bars 
reflect the relative peak width from DLS (2nd cumulant analysis). 
To derive further information on the structure and composition of the different peptide particles 
we performed static light scattering for dispersions at different final ethanol concentrations. For 
all samples the initial peptide concentration in pure ethanol was 1 mg/mL. The desired solvent 
composition was adjusted by solvent exchange and kept constant during the subsequent dilution 
steps. Figure 2-6A shows a representative Guinier-Plot for a peptide dispersion in a solvent 
mixture at 4 wt % ethanol. Under these conditions the radius of gyration of the particles was only 
slightly dependent on the final solvent composition. At the same time, the molar mass (Mw) of the 
particles drastically increased (i.e. by a factor of 500) with decreasing fraction of ethanol in the 
final dispersion. At the lowest final ethanol concentration of 4 wt % the particles had an Mw of 
1.73·1010 gmol-1, corresponding to a particle composed of approximately 107 peptide molecules 
(Table 2-2).  
Table 2-2: SLS summary for peptide beads in different EtOH concentrations. 
EtOH Rg Mw A2 NAG δapp  
wt % nm g mol-1 mol dm³ g-²  g cm-3 
40 179 3.76 x 107 8.342 x 10-10 2.14 x 104 0.006 
30 189 1.61 x 108 -2.430 x 10-8 9.16 x 104 0.02 
20 201 2.44 x 109 -4.231 x 10-11 1.39 x 106 0.26 
12 210 1.01 x 1010 2.857 x 10-10 5.77 x 106 0.93 
4 218 1.73 x 1010 2.895 x 10-10 9.87 x 106 1.44 
 
 
Assuming the particles behave like homogenous hard spheres, an apparent density δapp of the 
particles can be calculated accordingly[34]. Interestingly, the apparent density of the particles 
increased from 0.006 g cm-3 at 40 wt % ethanol to 1.44 g cm-3 at 4 wt % ethanol. Molar masses and 
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apparent densities at higher final ethanol concentrations (> 20%) can only be used as a rough 
estimate, since here a considerable fraction of small micelles, coexisting with the peptide beads, 
contributed negligibly to the scattering intensity. Nevertheless our data clearly indicate a 
transition from a loosely packed, highly solvent-swollen aggregate to more homogenous particles 
mainly consisting of densely packed peptides. Indeed, the observed value is in agreement with 
typical data for peptides [35] and consistent with the observed sedimentation of the particles. 
 
Figure 2-6: (A) Guinier plot of peptide beads in 4 wt % ethanol extrapolated to zero angle and concentration 
(B) Dependence of the particle scattering factor Pz on q for hard sphere (black line) and coil (grey line) 
compared with representative experimental data for 4 wt % Guinier plot (). 
Figure 2-6B shows the angular dependence of the particle scattering factor of the peptide beads. 
For comparison, the well-established theoretical functions for homogenous hard spheres (Figure 
2-6B, black line, equation 3 in experimental part: chapter 9.5) and monodisperse polymer coils 
(Figure 2-6B, gray line, equation 4 in experimental part: chapter 9.5) have been included in the 
plot. Indeed, our data resemble the function for hard spheres, thus supporting the assumption of 
particles with a rather homogenous density distribution. It should be noted that the data for 
different final ethanol concentrations hardly differed, indicating that, during the “condensation” 
to more densely packed particles, their basic structure did not change significantly. 
Thus, we hypothesize that the particles are formed by a hierarchical assembly process, starting 
with the formation of micelles that further aggregate into “multicompartment micelles” or 
peptide beads that increase their packing density and aggregation number with decreasing 
ethanol concentration. Chapter 3 describes further experiments to clarify the inner structure of 
the particles. 
In complementary experiments we used fluorescence quenching to analyze the accessibility of 
tryptophan within the aggregates. Here, the tryptophan fluorescence of the peptide AcC-X3-gT in 
40 wt % ethanol was quenched with acrylamide. The comparison to lower ethanol concentrations 
was not possible due to scattering; therefore a pure tryptophan solution was used. The Stern-
Volmer plots (Figure 2-7) deviate from a straight line, exhibiting a distinct upward curvature. 
Therefore, the data were fitted taking the contributions from static quenching and transient 
effects into account[36]. The Stern-Volmer constant KSV for AcC-K3-gT (4.8 ± 0.3 M-1) is in good 
agreement with literature values for gA in its molecularly dissolved state, indicating that the 
Dirk de Bruyn Ouboter Reversible peptide particle formation using a mini amino acid sequence 
42 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
tryptophans are freely accessible for the quencher[35b]. Obviously, there is no significant difference 
in accessibility between molecularly dissolved Trp-OH and the peptide self-assembly at 40 wt % 
ethanol (Figure 2-7). Hence, our results show that the micelles and peptide beads at 40 wt % 
ethanol do not possess barriers to penetration by acrylamide. This is in good agreement with the 
data from SLS, indicating a low packing density of the peptides inside the particles at rather high 
ethanol concentrations. 
 
Figure 2-7: Stern-Volmer-Plot of AcC-X3-gT in 40 wt % ethanol () and tryptophan () with increasing 
quencher concentration, indicating good accessibility of the tryptophans within the peptide self-assembly 
at 40 wt % ethanol. 
2.4 Conclusion 
This chapter describes an amphiphilic undecapeptide capable of forming micelles and peptide 
particles in aqueous-ethanol mixtures as a function of ethanol concentration and temperature. A 
repetitive [LW-DL] motif was introduced, which is the essential part of the peptide and which can 
be used as a general hydrophobic contributor in an amphiphilic molecule. The sequence was 
extended with a positively charged, hydrophilic lysine-, or an electrically neutral acetylated lysine 
group. The peptide with a charged oligolysine showed a well-defined cmc in aqueous solution and 
initially formed spherical micelles. An increasing fraction of larger aggregates, presumably 
multicompartment micelles, is formed as a result of increasing charge screening with appropriate 
counter ions. The acetylated lysine of the hydrophilic component of AcC-K3-gT is less water soluble 
than the amphiphilic peptide based on the non-acetylated lysine. Generally, for the acetylated 
peptide, decreased solubility obviously favors a secondary aggregation of the individual micelles. 
The self-assembly process was initiated by solvent exchange. The experiments suggest that the 
hierarchical self-assembly of spherical aggregates from the investigated mini amphiphilic peptides 
starts in a dissolved monomeric state in pure ethanol. With increasing water concentration it 
evolves into a micellar solution. Once a threshold of solvent polarity is exceeded (i.e. decreasing 
ethanol concentration) the micelles themselves start aggregating into highly solvent-swollen 
particles or multicompartment micelles. The “open” and liquid structure of these primary 
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multicompartment micelles is also reflected by fluorescence quenching experiments with 
acrylamide, indicating free access of the quencher to the tryptophan residues within the 
aggregates. The peptide beads further condense and presumably fuse with residual small micelles 
below 20 wt % ethanol. This is reflected by a drastically increasing aggregation number and a 
considerably higher apparent density. It has to be emphasized, that a decreasing ethanol 
concentration ultimately led to rather rigid peptide particles that preserved their shape and 
dimensions even after isolation from the aqueous dispersion. 
 
Figure 2-8: Phase diagram of the self-assembly of amphiphilic peptides in the multicompartment micelle 
model deduced from EPR measurement () >95% peptide beads, () > 95% micelles, half-full squares refer 
to coexistence of micelles and peptide beads. 
Macroscopically, the system can be described as an emulsion or suspension, depending on the 
concentration of ethanol. The organic solvent acts as the softener that keeps the separated 
peptide phase in a liquid state. As it is removed the droplets harden and form a suspension. Figure 
2-8 shows a phase diagram summarizing the findings. Additional experiments are described in the 
next chapter of this thesis, to clarify the “inner” structure of the peptide beads. It should be 
emphasized that the transitions between the different species and/or their fractions in the 
mixtures were fully reversible. For the construction of the phase diagram data points from EPR 
measurements that allowed a convenient quantification of the respective species in the 
dispersions were used. Data from light scattering are in good agreement with these results. 
Furthermore, the structure of these multicompartment micelles or peptide beads at the same 
time offers hydrophilic and hydrophobic compartments that can be used to embed, for example, 
drugs (cf. chapter 6). Indeed, the system presented here was shown to encapsulate water soluble 
and –insoluble model drugs in high concentrations[25] and shows promise as a novel and bio-
compatible drug delivery tool, as it is exclusively composed of amino acids.  
Dirk de Bruyn Ouboter Reversible peptide particle formation using a mini amino acid sequence 
44 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
2.5 Supporting information  
Dimerization probed by GPC 
Figure S 2-1 illustrates GPC elution profiles of Ac-X3-gT and gramicidin in THF and EtOH, whereby a 
clear separation of monomer and dimer was visible as two peaks for gramicidin only. The 
amphiphilic peptide elution profile was characterized by a slightly broader peak and no indication 
of distinct dimerization.  
 
Figure S 2-1: A) GPC elution profiles of gramicidin monomer and dimer, and B) Ac-X3-gT monomers in 
different solvents (THF black line, EtOH grey line). 
 
Table S 2-1: Verification of mass and purity of the amphiphilic peptides used. 
Code Mass 
g/mol 
Mass  
(MALDI-ToF-MS) 
Purity 
(Area %, analytical HPLC) 
K3-gT 1485,9 1486.7 > 99 % 
C-K3-gT 1589,9 1588.6 97 % 
Ac-X3-gT 1653,9 1677.3 (M+Na+) 98 % 
AcC-X3-gT 1757,9 1779.0 (M+Na+) 96 % 
AcC(sl)-X3-gT 1947,0 1948.5 97 %   
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Behavior of C-K3-gT as a surfactant 
Amphiphilic peptides behave like surfactants. It therefore was possible to determine a critical 
micelle concentration (cmc), as illustrated in Figure S 2-2). 
 
Figure S 2-2: Cmc determination of C-K3-gT. 
 
Self-assembly of C-K3-gT into micelles 
 
Figure S 2-3: Representative TEM image of C-K3-gT micelles. The minor peptide bead fraction, which is not 
present in this micrograph, can be seen in the diagram shown in Figure 2-2 (blank) and Figure S 3-2. 
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Peptide bead formation due to charge shielding 
 
Figure S 2-4: A) SEM of C-K3-gT with NaH2PO4 (0,025mol/L) B) TEM of AcC-K3-gT with NaSCN (0.1mol/L). 
 
Self-assembly of Ac-X3-gT 
Self-assembled spherical structures – so-called peptide beads – from Ac-X3-gT were imaged using 
SEM, TEM, and AFM (Figure S 2-5). 
 
Figure S 2-5: A) SEM of Ac-X3-gT peptide beads, B) TEM stained with uranyl acetate and C) AFM. 
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Cw EPR measurements in different ethanol/water mixtures 
 
 
Figure S 2-6: cw EPR spectra of AcC-X3-gT / AcC(sl)-X3-gT mixtures depending of ethanol concentration. 
Arrows mark the characteristic features of the mobile species, which are getting dominant with increasing 
ethanol concentration. 
 
Correlation functions 
 
 
Figure S 2-7: Correlation functions of AcC-X3-gT/AcC(sl)-X3-gT mixture in A) 40 wt % ethanol and B) 4 wt % 
ethanol. 
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Equilibrium of Ac-X3-gT in ethanol mixtures 
Equilibrium between micelles and peptide beads arises in ethanol/water mixtures. Converting 
peptide solutions at 4 wt % ethanol to 40 wt % ethanol and vice versa (using dialysis) always 
produces the same characteristic DLS signals, proving the reversibility of the system. A diagram of 
the experiment and the corresponding results are presented in Figure S 2-8. 
 
Figure S 2-8: Reversibility of the system: Two different starting points (4 wt % and 40 wt %) yield the same 
DLS features at 4 wt % () and at 40 wt % () final ethanol concentration. 
 
Temperature-dependent self-assembly of Ac-X3-gT 
The self-assembly process was initiated by solvent exchange from 100 w % to 20 wt % ethanol. A 
reversible, temperature-dependent peptide bead formation was monitored at that ethanol 
concentration. Temperature-dependent UV absorption measurements tracked bead formation as 
absorption increased due to scattering. As Figure S 2-9 shows, peptide beads begin to assemble 
below 25 °C at 20 wt % ethanol. This process was reversible. The cooling (black line) - heating (red 
line) cycle exhibits a slight hysteresis due to the experimental setup. 
 
Figure S 2-9: UV measurement of temperature-dependent bead formation (heating (red line), cooling (black 
line)) using Ac-X3-gT at 20 wt % EtOH. Photographs were taken at 4 °C (left) and RT (22 °C, right). 
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Size dependency of peptide beads in dd H2O upon initial peptide concentration 
 
 
Figure S 2-10: SEM micrographs of Ac-X3-gT at A) 1.0 mol/L B) 1.5 mol/L. 
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Two models of the hierarchical self-assembly of the peptide Ac-X3-gT into peptide beads. TEM and 
SEM of the formed beads for comparison (left and right top corners). 
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3.1 Abstract 
This chapter focuses on the resolution of the inner structure of the spherical peptide particles, 
termed “peptide beads”. The beads, with diameters between 200 to 1500 nm, result from 
hierarchical organization of micellar-like structures, a fact determined by a combination of 
investigations carried out by electron and atomic force microscopy (AFM), static and dynamic 
light-, and small angle X-ray scattering. These highly ordered structures agree with the concept of 
multicompartmentization and represent the first example of supramicellar assemblies based 
purely on peptides. New structural insights, as presented here, allow a better understanding of the 
peptide beads’ capacity to embed hydrophobic and hydrophilic payloads and therefore provide 
new perspectives for drug delivery applications that may result from this new class of material. 
3.2 Introduction 
Future advanced materials will no longer rely merely on the chemical structure of a molecule per 
se but also on supramolecular chemistry, focusing on properties that emerge and are enabled by 
the assembly of a distinct number of molecular subunits. By exploiting non-covalent interactions, 
these systems come to possess new properties that reach beyond those of single molecules in 
bulk. The construction of advanced materials should exploit a bottom-up strategy that relies on 
self-assembly to allow large scale fabrication. Nature itself makes use of such systems, with 
enzymes and other proteins having well-defined secondary (α-helix, β-sheet) and quaternary 
structures (3D-assembly of individual subunits); each structure exhibiting distinct properties and 
thereby the potential for distinct functioning. Many of these possible functions may be lost 
without the well-controlled folding and assembly of a proteins’ primary structure (sequence) into 
a precise secondary and quaternary structure. Small changes in the primary structure alone can 
perturb the assembly of the protein, along with its function. The precise folding of a protein or a 
small peptide from a linear sequence to a complex machine (e.g., an enzyme) may be considered 
self-assembly[1]. 
Based on virtually unlimited synthetic control over primary structure and ease of implementing 
point mutations, peptides represent fruitful molecules for the study of how self-assembly is 
controlled by the chemical structure of individual building blocks. Furthermore, peptidic materials 
are preferred for applications in the human body, due to a high level of biocompatibility and 
established degradation pathways that eliminate unwanted accumulation.[2] 
Hybrid materials have been developed to combine the functionality of peptides with the versatility 
of hydrophobic/hydrophilic triggering of self-assembly[3]. Based on this concept, several groups 
have built peptide-based supramolecular assemblies by taking a non-peptidic hydrophobic 
contributor such as alkyl chains[4], poly(butadiene)[5] or modified amino acids (AAs)[6] and attaching 
a peptidic hydrophilic part. Other approaches use only AAs as building blocks[7], but are clearly 
inspired by macromolecular block-amphiphiles[8]. Although such systems form supramolecular 
functional materials, the polymeric character rules out the possibility of point mutations and 
therefore the ability for fine tuning. Short peptidic amphiphiles overcome this limitation. As Zhang 
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and Zhao[9] demonstrated, short peptides form various self-assembled structures, but in general it 
is difficult to build a purely hydrophobic block from peptides[10], due to the influence of the 
ubiquitous peptidic backbone and its hydrophilic amide bonds, which prevent a sequence from 
being hydrophobic throughout. The simple insertion of hydrophobic amino acids is therefore not 
enough. However, hiding the backbone within a helical secondary structure reduces influences by 
the surroundings. The influences of the backbone’s hydrogen bonds in the hydrophobic part are 
therefore restricted to intramolecular interactions. This concept already emphasizes the need for 
a particular secondary structure to enable the formation of an amphiphilic diblock peptide. 
We recently reported the synthesis, purification and characterization of purely peptidic 
amphiphiles[11] and provided insights into the process of self-assembly of the peptides into 
micelles and solid, spherical particles, termed “peptide beads” [12] (cf. chapter 2). The hydrophobic 
block, is inspired by the sequence and secondary structure of gramicidin A (gA), which is 
consistently constructed of hydrophobic amino acids that hide its backbone inside a β-helical 
secondary structure[13]. Moreover, due to its highly hydrophobic nature and its compatibility with 
the hydrophobic core of phospholipid membranes[14], gA is a suitable hydrophobic constituent. 
Governed by the affinity of gA-channels for one another, they are able to form rafts in lipid 
bilayers[15]. MacDonald et al.[15] as well as Brasseur et al.[16] suggested that this affinity originates 
as a result of the stacking of tryptophanes; they also calculated the spatial alignment by means of 
molecular dynamics simulations[16]. These considerations are additionally supported by the work 
of Kimura et al. who synthesized hybrid materials from gA and hydrophilic PEG and observed 
colloidal behavior in aqueous solution[17]. 
Although chapter 2 suggested a hierarchical self-assembly process for the peptide beads, the used 
methods were not capable – due to lack of structural insight into the beads – to indisputably prove 
a persistence of previously formed micelles within the peptide beads formed subsequently. In this 
chapter we are interested to enter into structural details of the supramolecular assemblies 
generated by hierarchical self-assembly of purely peptidic amphiphiles. Understanding the 
underlying inner structure will allow a better understanding and prediction of the capacity of the 
peptide beads to embed hydrophobic as well as hydrophilic payloads[11]. This will support further 
applications in payload embedding and triggered release mechanisms. We performed microscopic 
and scattering experiments, established to characterize multicompartment micellar structures. 
The model of hierarchical self-assembly we propose, leads to a reasonable explanation of the 
embedding features of the peptide beads that support this new class of material during the 
development towards applications in drug delivery. 
3.3 Results and discussion 
The peptide K3-gT is formed by N-terminal addition of three lysines to a truncated amino acid 
sequence of gA that corresponds to the last seven AAs of gA (Table 3-1). We already reported[12] 
that the peptide self-assembles into spherical micelles in aqueous solution, while the self-
assembly of the fully acetylated analogue Ac-X3-gT starts with the amphiphilic peptide in a 
dissolved monomeric state in pure ethanol (cf. chapter 2). Increasing water concentration induces 
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the formation process of small micelles (Rh ≈ 10 nm). During further solvent exchange the 
threshold of solvent polarity is exceeded, leading to aggregation of the micelles into highly 
solvent-swollen particles (Rh ≈ 160 nm). These particles then condense further and fuse with 
residual small micelles below ethanol concentrations of 20 wt%, ultimately leading to rigid solid 
peptide particles that preserve their shape and dimensions (Rh ≈ 350 nm) even after isolation from 
the aqueous dispersion. The final size of the solid, spherical peptide particles, termed “peptide 
beads”, can be controlled by the initial concentration of the peptide in ethanol[12]. 
Table 3-1: Code, sequence, and charge of amphiphilic peptides and the wildtype gA. 
Code Sequence [a] Charges 
wt-gA 
K3-gT 
formyl-LV-G-LA-DL-LA-DV-LV-DV-[LW-DL]3-LW-ethanolamine 
H-LK3-[LW-DL]3-LW-NH2 
0 
4+ 
Ac-X3-gT Ac-[LK(Ac)]3-[LW-DL]3-LW-NH2 0 
[a] one letter code, X = LK(Ac) 
In this chapter we are interested to enter in more details of the hierarchical self-assembly of this 
amphiphilic peptide to understand in which respect the internal structure of the peptide beads will 
influence the embedding of payloads. The self-assembled peptide beads were investigated in pure 
water by SLS and DLS and showed a narrow size distribution. Guinier-Plot analysis (Figure 3-1A) 
revealed a size of Rg = 236 nm, which is consistent with dimensions reported earlier[12], during the 
process of bead formation. The ρ-parameter (Rg/Rh) of 0.79, calculated using the measured 
hydrodynamic radius (Rh) of 300 nm from DLS data analysis, is close to the theoretical value of 
1/√(5/3) = 0.78 for solid spheres[18]. When the angular dependence of the particle scattering factor 
(Figure 3-1B) is compared to the theoretical functions for homogenous, hard spheres (black line) 
and monodisperse polymer coils (gray line), respectively, a close fit to the hard sphere model is 
obtained. The spherical shape of the formed particles was visualized by scanning electron 
microscopy (SEM) of a dried sample as well (Figure 3-2A). The typical contrast gradient of solid 
particles in the transmission electron micrographs (TEM) and the SEM micrographs of a peptide 
bead broken-up by shock freezing proved the solid sphere character (Figure 3-2B & C). 
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Figure 3-1: SLS analysis of Ac-X3-gT peptide beads in water (0.25 mg/ml); A) Guinier Plot resulting an Rg of 
236 ± 7 nm, B) form factor analysis (-) hard sphere model, (-) coil model, () experimental data. 
The earlier hypothesis, based on the investigated formation process, suggested an aggregation of 
previously formed micelles into the peptide beads. TEM of uranyl acetate stained peptide beads 
(Figure 3-2D) revealed smaller structures within the beads made visible by the contrast 
enhancement and thereby indicate an substructure, possibly composed of micelles within the final 
peptide beads. The measured radius of 10.7 ± 1.8 nm, gained from image analysis of the 
underlying smaller species within the stained peptide beads, is clearly in the range of micelle sizes 
(Figure S 3-1). 
 
Figure 3-2: Ac-X3-gT peptide beads: (A) SEM of dried sample 0.5 mg/ml; (B) SEM of shock-frozen and 
lyophilized sample 0.5 mg/ml; (C) TEM 0.25 mg/ml; (D) TEM with uranyl acetate staining 0.25 mg/ml. 
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The dimensions of the substructure were compared to micelles formed by the charged peptide 
analogue, K3-gT. CONTIN-algorithm analysis of multi angular DLS measurements revealed a 
hydrodynamic radius of 11 nm for the micelles. As deduced from AFM and TEM images, a minor 
fraction of peptide beads is formed along with the micelles (Figure S 3-2). As the intensity of the 
scattered light is proportional to the radius to the power of six, this minor fraction of larger 
particles in the sample leads to a dramatic increase in the scattering intensity, making SLS 
evaluation of the small micelles impossible, even when only high q-values are considered. 
However, TEM image analysis of the micelles indicated a radius of 11.8 ± 2.2 nm (Figure S 3-1 & 
Figure S 3-3). Consequently, TEM as well as light scattering suggest that such micelles preserved 
their size within the Ac-X3-gT peptide beads. 
To obtain topography-based data, atomic force microscope (AFM) was used to compare K3-gT 
micelles with the surface of Ac-X3-gT peptide beads. Since the image quality in AFM relies on the 
flatness of the sample, we increased the size of the peptide beads by using an initial peptide 
concentration in ethanol of 1.5 mg/ml [12]. This led to beads with diameters larger than 1000 nm 
and therefore lower surface curvature. The scans performed on top of the beads revealed an 
astonishing similarity with the scans of the micelles (Figure 3-3). 
 
Figure 3-3: Surface of Ac-X3-gT peptide beads in AFM phase contrast (A) showing structures with the same 
size as K3-gT micelles on mica in phase contrast (B) and in topographic contrast (C). Peptide beads in AFM 
topographic contrast (D) shown for illustration. 
Although the imaging techniques showed micelles within the peptide beads, they allowed only a 
limited view inside. To disturb the packing of micelles slightly, the initial peptide sequence was 
elongated with a cysteine, resulting in Ac-X3-gT-C. This modification led to a rougher surface and a 
looser packing of the formed peptide beads (Figure 3-4). Lyophilisation of these loosely packed 
beads allowed a view into partially opened beads (Figure 3-4b) and also revealed a structure 
constructed of smaller, spherical subunits. In terms of a functional model, the packing of the 
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micelles into the peptide beads can be compared to a sintering process, commonly known as 
relating to metal particles or ceramics[19]. The diminished sintering effect in the case of Ac-X3-gT-C 
can be explained by more form-stable micelles, presumably due to stronger intramicellar binding 
of newly formed disulfide bridges. 
 
Figure 3-4: SEM of self-assembled peptide beads from Ac-X3-gT-C (a); insights into a peptide bead revealing 
a structure constructed by smaller spherical subunits (b). 
Although these images qualitatively demonstrate an assembly process that makes use of small,  
spherical structures that form the resulting peptide bead structures, i.e. multicompartment 
micelles, they are not associated with significant statistical data for the inside of the peptide 
beads. Therefore, we performed small angle x-ray scattering (SAXS) on a concentrated aqueous 
Ac-X3-gT peptide bead sample, using a synchrotron source[20]. Even if the beads are larger than the 
experimentally available maximal size for SAXS – based on theory, but also indicated by a missing 
Guinier plateau and a missing Porod regime (that is, q does not scale with q-4 at higher q) – the 
collected data can be used to estimate the size of possible internal substructure. 
The scaling of the experimental data with q-3 indicates a spherical structure. The absence of a 
Porod regime also supports the presence of a diffuse interface, since a clear electron density 
difference between the dispersant and the substructure’s surface is missing. Moreover, this 
behavior is an agreement with a mass fractal behavior[21]. A classical data analysis using a single 
solid sphere distribution failed. We interpreted this as the consequence of the aggregated and 
polydisperse nature of the micelles as shown by microscopy. The use of a bimodal model is not 
possible without introducing broad errors. Therefore we turned to a two-level Beaucage fitting 
method, in which the size of the internal substructure was estimated to have a radius of gyration 
Rg of 9.8 ± 0.2 nm that corresponds to the size of aggregated micelles with a spherical radius of 
12.7 ± 0.3 nm on average (Figure 3-5). The radius corresponded well with the radii found in AFM, 
SEM, and TEM. Moreover, the pair distance distribution function (PDDF) showed the expected 
shape for solid particles[22] which, in this case, are micelles. To prove consistency, the averaged 
substructure using this model also had a diameter of approx. 12 nm. Based on the PDDF shape, the 
presence of inverted micelles with hollow core shell particles in this size can be ruled out. 
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Figure 3-5: SAXS of peptide beads showing the sizes of substructures inside the beads. Two-level Beaucage 
method (left) and PDDF (right). 
Deduced from the presented microscopic and scattering data, the peptide beads are formed by 
aggregation of smaller, spherical subunits of ~10 nm. The size is in the normal known range for 
micelles. Based on this fact, we built three-dimensional models of the peptide beads, where the 
well-known crystal structure of gramicidin-A[13b] was used for the gT part in combination with a 
simple, random coil for the three acetylated lysines. The model quickly revealed that a classical 
approach with one layer of molecules forming a micelle is not possible, since the radius of 10 nm 
cannot be spanned by one molecule. Ac-X3-gT, with a preserved gramicidin-like secondary 
structure, has a length of approximately 2 nm. Even when assuming a structural change towards 
the most space demanding β-sheet alignment of 0.35 nm per AA, the peptide has a maximum 
length of 3.5 nm. Thus, another model than the classical one-layer-approach is necessary to 
understand the creation of micelles of the measured size. As mentioned above, static light 
scattering of pure K3-gT micelles cannot be evaluated, due to the presence of a small fraction of 
peptide beads. SAXS measurements of a concentrated micelles sample were performed, but, due 
to the low contrast, gave no evaluable signal, even when using the high-flux synchrotron source. 
However, due to the similarity in size, the micelle assignment seems justified. 
Defying the lack of further methods to resolve the micellar structure within the beads, we 
performed a Total Non-Negative Least Square analysis (TNNLS) of the X-ray scattering data for the 
peptide beads. Basically, the process consists of creating a computed-generation population of 
nano-objects, calculating the corresponding scattering curve and matching it iteratively with an 
experimental curve. Results are shown in Figure 3-6. Interestingly, the size distribution curve 
shows a polydisperse system. There are three diameters visible: one at 6.8 nm, one at 15.6 nm, 
and one at 21.2 nm. The 6.8 nm fits well with the dimension of two peptides self-assembled in a 
tail-to-tail or head-to-head mode, and is commensurate with the peptide size and the classical one 
layer approach to form a micelle or an aggregate of 7 nm in size. Both the 15.6 nm and the 
21.2 nm can be interpreted as the diameter of the small species found with the other techniques, 
both being multiples of the 7 nm species. They are polydisperse, as shown by the absence of a 
clear minimum in the scattering curve. This is not surprising, as due to the aggregation, the 
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dispersant and the object lack a clearly defined border. This additional data supports a model, 
having three stages of self-assembly: first peptide with peptide in small aggregates, these then 
form larger micelles, which then aggregate up to the final peptide beads. 
 
Figure 3-6: Fitted SAXS curves of Ac-X3-gT using a TNNLS model, and the corresponding size distributions. 
With the presented data we prove the persistence of spherical micelles of approximately 20 nm in 
diameter within the peptide beads. The evaluated data allows two possible models for the 
structure of the micelles (Figure 3-7): According to the aggregated micelle model, the peptides 
first form micelles of ~7 nm diameters, these then aggregate into 21 nm objects due to reduced 
solubility of the micelles with decreasing ethanol content, which also reduces the flexibility of the 
objects. Further decrease in ethanol content leads to the aggregation of the objects into the 
peptide beads until the aggregation process ends due to maturing of the particles into solid 
peptide beads, which occurs below 20 wt% ethanol as presented earlier[12] (cf. chapter 2). 
According to the large compound micelle model, the peptides first form inverted micelles (~7 nm) 
at very high ethanol concentrations, based on the good solubility of the gT sequence in ethanol. 
With decreasing ethanol content these inverted micelles, presumably stabilized due to H-bonding 
of the lysine part, start aggregating (~14 nm) and are then surrounded by a layer of remaining 
peptide to reveal the hydrophilic part to the now aqueous environment (~21 nm). The so formed 
structure, termed “large compound micelle”, has been reported for block-co-polymers already[23]. 
Further decreasing ethanol content leads to aggregation of the 21 nm large compound micelles 
into peptide beads. Further experiments are needed to prove the structure of the micelles within 
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these hypothetical models. Nevertheless, they give two reasonable hierarchical self-assembly 
pathways. 
 
Figure 3-7: Hierarchical self-assembly into peptide beads: aggregated micelle model (left) and large 
compound micelle model (right) 
In literature, two terminologies for models with similar behavior as the presented system can be 
found. For block-co-polymers, Eisenberg et al.[23] reported “large complex micelles” (LCM), later 
also called “large compound micelles”[24], that consist of aggregated, inverted micelles, 
surrounded by a final layer of the amphiphiles to form a hydrophilic shell, in the same fashion we 
described above. The other, more generalized and structural open terminology 
“multicompartment micelles” [25], first proposed by Ringsdorf[26], describes supramolecular 
aggregates with a hydrophilic shell and segregated hydrophobic cores. Therefore it is not limited 
to morphology, but rather describes properties. We consider the terminology “multicompartment 
micelles” the best to describe our system at the present time. Multicompartment micellar 
structures are promoted to entrap and release payloads with different hydrophilic and 
hydrophobic properties and have recently been produced by self-assembly, using triblock 
copolymer systems[25-26]. The embedding of hydrophilic and hydrophobic payload, was recently 
also shown for the present peptide beads[11]. As a logical consequence, the herein presented 
hierarchical self-assembled peptide beads potentially find application in drug delivery, due to the 
combination of the multicompartmentized structure, the high performance regarding 
encapsulation efficiency[11], and the biodegradable peptide-based origin. 
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3.4 Conclusion 
This chapter reported in detail the inner structure of Ac-X3-gT peptide beads to understand the 
hierarchical organization of the purely peptidic amphiphiles inside. The peptide Ac-X3-gT is soluble 
in ethanol and forms peptide beads with controllable radii in the range of 100 to 800 nm when 
transferred to water. We showed with both, microscopic and scattering techniques, that the 
peptide beads are solid spheres, self-assembled in a hierarchical manner by aggregation of smaller 
spherical subunits of ~10 nm in radius. The size of these is comparable with micelles formed by the 
charged peptide analogue, K3-gT. We therefore confirmed a previously made hierarchical 
formation process hypothesis[12] in structural detail by proving the persistence of spherical 
subunits in the size of micelles within the matured peptide particles. We introduced two 
hypothetical models – the aggregated micelle model and the large compound micelle model –for 
the inner structure of the subunits, based on SAXS experiments (Figure 3-7). In both of these 
models, the peptide beads hold segregated hydrophobic compartments in form of the micellar 
subunits and a continuous, rather hydrophilic micellar coronae compartment. Hence, the peptide 
beads offer compartments for payloads with different affinities, a property generally advertised 
for multicompartment micelles. In contrast to vesicular structures, which offer a very large 
volume/entity for hydrophilic payloads but relatively small volume/entity for hydrophobic 
payloads, multicompartment micelles are advantageous since they offer almost equal space for 
both species. Due to the small size, and the short distances between the hydrophobic regimes, our 
multicompartment micelles also possess optimal properties to embed macromolecules that have a 
hydrophilic backbone, sputtered with hydrophobic sections/residues, like for example DNA and 
RNA. Since the peptide beads are solid in their matured form, payloads are protected from the 
environment overall until their release by, e.g. degradation of the peptide or diffusion release 
mechanisms. Nevertheless, a representation of a small fraction of the payload that is embedded 
close to the outside is not excluded and might even be useful for functionalization or recognition 
applications (e.g., targeting, vaccine). Furthermore the solid character allows lyophilization and 
storage of the peptide beads, which can be a strong advantage in contrast to vesicle systems. For 
all these reasons, as well as for biodegradability, we see great potential in drug delivery 
applications for this new kind of peptidic material. 
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3.5 Supporting information 
 
 
Figure S 3-1: TEM image analysis of the small species within the Ac-X3-gT peptide beads (left) and  
K3-gT micelles (right). 
 
 
Figure S 3-2: AFM showing presence of peptide beads in main peptide micelle fraction. Topographic and 
amplitude contrast (top), phase contrast (bottom), zoom-in of bead (bottom right). 
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Figure S 3-3: TEM of K3-gT micelles, stained with uranyl acetate. 
 
 
Figure S 3-4: TEM image of a small Ac-X3-gT peptide bead with good transparency revealing an inner 
structure. 
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4.1 Abstract 
In chapter 4, a library of purely peptidic amphiphiles is presented, leading to different self-
assembled structures as they were received from the peptide in the earlier chapters. Besides the 
successful solid-phase peptide synthesis (SPPS), the characterization of the short amino acid 
sequences with amphiphilic character are presented with the aim of gaining insight into their self-
assembled supramolecular structures. The peptide design includes three parts: (a) a charged lysine 
part, (b) an acetylated lysine part and (c) a constant hydrophobic rod-like helix, based on 
gramicidin A. By stepwise replacement of free lysine (K) with acetylated lysine (X) a library of a 
total of ten peptides Ac-X8-gA and KmX8-m-gA (m ranging from 0 to 8) was generated. By using point 
mutations, the degree of acetylation (DA) and thus the overall amphiphilicity of the peptides was 
adjusted, which led to a change in the secondary structure in the aqueous environment from a β-
sheet to an α-helix. This transition generated a significant change in the morphology of the self-
assembled structures from fibers to micelles. Two different regions where observed with the 
conformation of the hydrophilic part of the peptide: one region, a β-sheet-like secondary 
structure, inducing fiber formation (high DA), the other an α-helical-like secondary structure 
generating micelle formation (moderate and low DA). The micellar structures depended on the 
degree of acetylation, which influenced their critical micelle concentration (cmc). These 
morphology regions were determined by a combination of circular dichroism, dynamic light 
scattering, surface tension, and transmission electron microscopy that allowed correlation of the 
generated supramolecular architectures with the fine changes obtained by means of the point 
mutation strategy. 
4.2 Introduction 
Self-assembled nanostructures are attracting ever more attention, in particular in aqueous 
solution, due to fundamental aspects that concern the nature of the folding processes as well as 
the wide range of applications as carriers in drug delivery, templates for surface oriented 
applications, or nanodevices in combination with active molecules.[1] At the focus of this interest is 
the fabrication of nanostructures such as micelles, nanotubes or vesicles that can be combined 
with active molecules, such as biological entities, to generate complex hybrid systems.[2] Ranging 
from systems that are completely synthetic (polymers, inorganic compounds) to biological 
(phospholipids, polypeptides), interest in medically-oriented applications stems from the 
possibility of producing superstructures that are able to both accommodate the active entity and 
preserve its structure/function in biological conditions. Even if the diversity of the polymeric 
systems that are able to generate supramolecular structures is very extensive, biocompatibility 
plays a crucial role for any biomedical application [1-3]. This requirement limits significantly the 
types of polymers or copolymers to only those that are biocompatible, such as, for example, 
poly(ethylene oxide), poly(dimethylsiloxane) or poly(glutamic acid).[4] But this limitation does not 
apply to poly(amino acids) i.e. polypeptides, which appear ideal for the development of 
supramolecular structures, since it is anticipated that they will be both biocompatible and 
biodegradable. Furthermore, they offer broad chemical functionality due to the diversity of AA 
side chains combined with specific AA sequences that define specific recognition sites[5] (e.g. RGD 
Dirk de Bruyn Ouboter From fibers to micelles using point mutated amphiphilic peptides 
Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 69 
sequence for cell adhesion) or act similar to cell penetrating peptides (arginine rich sequences)[6]. 
Another important feature of peptides is their secondary structure, e.g. β-sheet or α-helix, 
reflecting a three dimensional conformation that supports specific interactions and properties. 
The complete folding and assembly of a protein into its quaternary structure is an outcome that 
depends on the interaction between the solvent and the protein structure, leading to often 
advantageous electrostatic interactions and hydrogen-bonding combined with the hydrophobic 
effect. Thus, in the self-assembly of natural systems the secondary, the tertiary, and the 
quaternary structures are interconnected and serve to create the final supramolecular 
conformation that favors a specific functionality. The secondary structure and the overall 3D 
conformation are encoded in the primary sequence, and these structures are then modulated via 
effects on the secondary structure arising from environmental conditions such as pH, ionic 
strength, temperature, and type of solvent. A pH-induced, so-called helix – coil transition of poly(L-
lysine) and poly(L-glutamic acid) was used to create micelles that are able to invert their corona 
and core regions in so-called “schizophrenic” behavior.[7] The same approach was used when 
polypeptides were combined with biocompatible polymers, in a co-micellated system of 
poly(glutamic acid) -b- poly(propylene oxide) -b- poly(glutamic acid)/ poly(ethylene oxide) -b- 
poly(propylene oxide) for controlled drug release [7-8]. These examples illustrate in excellent 
fashion how the self-assembly of polypeptides derived from polymerization techniques can be 
controlled by changes in a molecule’s secondary structure. However, polypeptides obtained by 
polymerization techniques bear the inherent drawbacks of polymerization that produce a 
molecular weight distribution that can differ slightly from batch to batch, and that fails to provide 
a controlled, defined sequence of differing amino acids. 
It is possible to overcome these limitations by using solid-phase peptide synthesis (SPPS), which is 
limited to peptides up to 50 AAs.[9] Zhang and co-workers produced ionic, self-complementary 
peptides by solid-phase peptide synthesis, and investigated their supramolecular architectures 
after the self-assembly process.[10] When very short amphiphilic peptides, e.g. V6K2 self-assembled 
into net-like structures of tubes and vesicles,[11] the 3D structures have been found to be highly 
sensitive to the purity of the peptides.[12] Qui et al. showed the successful assembly of catanionic 
A6K± into fibers.[13] A series of six 32-mers with a constant hydrophilic part and a variable 
hydrophobic part based on phenylalanine/alanine ratio was used to fine-tune drug and gene co-
delivery.[14] Hashimoto et al. showed that micelles using the 28-mer Pep-L12 are biodegradable 
and are a potential gene carrier system[15]. However, the mentioned studies do not include 
investigations on secondary structure. This was examined on a 24-meric peptide, designed from a 
20 kDa barnacle cement protein, and was found to be constant while self-assembling into a 
filament structure. This peptide, however, does not exhibit an amphiphilic character and self-
assembly was induced by salt addition[16]. Shera et al. compared a 15-mer designed amphiphilic 
peptide to its alternating analogue – with identical AAs but of a different sequence – and related 
its self-assembled morphologies to the observed primary β-sheet conformation, not present in the 
analogue[17]. General studies in solution that include the influence of secondary structure do exist 
– especially for polypeptides – but, to our best knowledge, a systematic study using a series of 
amphiphilic small (≤ 25 AA) defined and controlled sequences – i.e. not synthesized by 
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polymerization – for the purpose of understanding superstructures that are generated by self-
assembly have not yet been reported. 
As a key to understanding protein/peptide folding and self-assembly of the primary sequence, 
point mutation represents the best choice to induce, in a controlled way, a precise change of one 
specific AA in the primary sequence. In the present study we investigate the impact of point 
mutations on a short peptide series, on the control of amphiphilicity, on secondary structure and 
on the self-assembled morphologies. The amphiphilic peptides successfully synthesized by SPPS 
via Fmoc strategy[18] allowed us to create a library of ten peptides with progressively changing 
properties. Their constant hydrophobic part was inspired by the pentadecamer gramicidin A (gA), 
consisting of only hydrophobic AAs in an alternating D, L configuration, which generates β-helical 
membrane channels[19]. The C-terminal ethanolamine group of gA was replaced by an amide group 
and its N-terminus was used to start a hydrophilic sequence of lysine (K, pKa of 10.2) and 
acetylated lysine (X). Acetylated lysine corresponds to the removal of a charge and thus 
elimination of electrostatic repulsion, with expected impact on the secondary structure and 
morphology of the resulting assemblies. Glycine was introduced after every 3rd lysine or acetylated 
lysine to prevent a decrease in yield by creation of a homooligomer. 
The degree of acetylation (DA) directly affects the number of charges and the corresponding 
hydrophilicity. The peptides of our library can be divided into three parts in terms of increasing 
hydrophilicity: (a) a highly hydrophilic-, charged lysine part with a space-demanding hydration 
shell, (b) a moderate hydrophilic, acetylated lysine part without electrostatic repulsion of the 
amine groups, and (c) a hydrophobic rod-like helix based on gA. Depending on the hydrophilic 
character of the peptides, the self-assembly process leads to different supramolecular structures 
that have been analyzed in relation to the primary structure. 
4.3 Results and discussion 
4.3.1 Design of amphiphilic peptides 
The synthesized peptide library is based on SPPS via the Fmoc strategy, with the schematic 
structure KmX8-m-gA with: Km (K – lysine, m – number of lysines), X8-m (X – acetylated lysine), and a 
gA sequence of 14 highly hydrophobic amino acids, which remains constant and represents 56% of 
the total sequence (Table 4-1). Only one peptide, Ac-X8-gA, has an acetylated N-terminus, so that 
the peptide is completely neutral, while only one peptide, K8-gA is completely non-acetylated. As 
an example, the peptide K4X4-gA has the following sequence: H-LLys2-Gly-LLys2-(LLys-Ac)-Gly-(LLys-
Ac)3-LVal-Gly-LAla-DLeu-LAla-DVal-LVal-DVal-LTry-DLeu-LTry-DLeu-LTry-DLeu-LTrp-NH2 (Figure 4-1). 
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Table 4-1: Properties of the peptide KmX8-m-gA library with its schematic representation (DA – degree of 
acetylation). 
 
 
Figure 4-1: Schematic representation of K4X4-gA, including oligolysine (K4), acetylated oligolysine (X4), and β-
helical gA[20]. 
The design of the peptide library provides a linear increase in charge starting at neutral (Ac-X8-gA), 
until reaching a total number of nine charges/molecule, for K8-gA. This is associated with the 
changes in the degree of acetylation (DA), which thus gradually tunes the hydrophobicity. The 
library of short peptides – each consisting of only 25 AA with a precise primary sequence – was 
used to detect morphological transformations upon self-assembly in solution, based on the 
slightest changes in the amphiphilic design. Our interest concerned the study of whether and in 
what respect a very fine change to only one residue in the primary structure would affect the 3D 
conformation of the peptides. 
4.3.2 Amphiphilic character of the peptide library 
As expected from the design of the molecules, the properties of the peptides changed 
continuously within the library. For example, stepwise acetylation leads to a progressively 
increasing mass, and corresponds to a progressive increase in hydrophilicity of the peptide series. 
The variation in hydrophobicity was evidenced by the increased retention time on a RP-HPLC 
column (Figure 4-2). While hydrophobic sequences such as gA are usually very difficult to 
produce[21], the used synthesis and purification provides peptides with very high purity. 
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Figure 4-2: A) MALDI-TOF-MS and B) HPLC overlay of the peptide library. The curves are assigned with the 
degree of acetylation (cf. Figure 4-1). 
As the self-assembly process takes place by solvent exchange from molecular dissolved 
amphiphiles in solution, the solubility of the peptide library was analyzed in different solvents at 
concentration of 1 mg mL-1. In DMF all of the peptides were soluble (Figure 4-3A). We observed 
two types of behaviors with respect to solubility, in both the ACN/water mixture and in ethanol: 
peptides partially soluble (Ac-X8-gA to K2X6-gA) and peptides completely soluble for smaller DA 
(K3X5-gA to K8-gA). Thus, we observed a breakpoint in solubility between K2X6-gA and K3X5-gA (DA 
6/9 and 5/9), which was not expected due to the continuously increasing hydrophilicity of the 
amphiphiles and continuous increase in retention time. Consequently, we assume that 
conformational changes along the peptide backbone are responsible for inducing intermolecular 
interactions, thereby explaining the observed solubility behavior. Therefore, we analyzed the 
secondary structure and evaluated the folding themes in ethanol by circular dichroism (CD). Even 
though Ac-X8-gA to K3X5-gA showed low solubility in ethanol, CD spectra were measured for 
diluted solutions. All CD spectra (Figure 4-4 left) corresponding to peptides ranging from Ac-X8-gA 
(DA 8/9) to K2X6-gA (DA 6/9) exhibited a negative cotton effect around 218 nm and a positive 
cotton effect around 200 nm (Figure 4-4 right, red line) and were assigned to a β-sheet 
configuration (217 nm and 198 nm,).[22] Starting from K3X5-gA, different CD spectra were observed 
with a negative cotton effect around 208 nm and 219 nm, as well as a positive cotton effect 
around 197 nm (Figure 4-4 right, blue line). These values correspond to an α-helical character 
(208 nm, 222 nm and 192 nm).[22] K3X5-gA contains only one acetylated lysine less as compared to 
K2X6-gA, but exhibits a completely different CD-spectrum and therefore marks the breakpoint in 
the behavior of the peptide series (Figure 4-4). Thus, the abrupt change in solubility behavior of 
peptides corresponds to a different secondary structure of the peptides, namely a β-sheet for 
K2X6-gA as compared to an α-helix for K3X5-gA. The low solubility found in different solvents for 
peptides Ac-X8-gA to K2X6-gA can be explained by intermolecular interactions that are known for β-
sheet-like structures that form higher-order assemblies of ribbons, fibers, and amyloids[23]. 
It is interesting to note that the α-helical and β-sheet-like secondary structures for our charged 
and uncharged peptides differ from that usually assigned to lysine homopolymer 2.51-helical and 
α-helical conformations, respectively[24]. However this difference is not surprising and is caused by 
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the introduction of a residue other than lysine (glycine) after each third AA. The deviation from a 
homooligomeric hydrophilic part is actually 20% and thus contributes significantly to the 
secondary structure. 
 
Figure 4-3: Solubility of the amphiphiles in A) DMF B) ACN/water (1:1) C) ethanol. 
 
Figure 4-4: CD spectra of the full peptide library (left). Extracted CD spectra of K2X6-gA (red line, β-sheet) 
and K3X5-gA (blue line, α-helix) in ethanol representing the two different secondary structures (right). 
The area in CD spectra between 210 and 260 nm is strongly affected by the structure adopted by 
the gA-sequence of peptide amphiphiles, and includes a characteristic maximum at 223 nm[25]. 
This is preserved throughout the whole library, even if the signal intensity is decreased by the 
superimposed spectra of the hydrophilic part. Therefore, we found the structure of the 
hydrophobic sequence little affected by the presence of the hydrophilic part of peptides and 
equally so by the variation of their DA. This agrees with the stable structures known for gA and gA-
analogues found in different conditions of solvents or matrices[26]. Analysis of overall shape of CD 
spectra therefore indicates that the variation in the primary sequence caused a transition in the 
secondary structure of the hydrophilic part from a β-sheet to an α−helix. 
The hydrophobic contributor gA is based on the alternating D, L configuration and its secondary 
structure and self-assembly changes completely if only L-configured amino acids are used for its 
synthesis (LgA). This became evident by comparing the water soluble amphiphile K6-gA with its 
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analogue, the all L-configured K6-LgA. While K6-gA forms mainly micelles such as K3X6-gA to K8-gA 
(Figure 4-5), K6-LgA exhibits a great tendency to form gels in ethanol and water, and was only 
soluble in trifluoroethanol (TFE). The CD spectra no longer exhibit the maximum at 223 nm, as was 
observed for K6-gA, and its secondary structure, as derived from CD in TFE (Figure 4-5), was 
assigned to a β-sheet structure. Thus, the intramolecular hydrogen-bonds that stabilize the D,L 
configured gA helix are most likely intermolecular hydrogen-bonds between the β-sheet structures 
of the gA entirely L-configured. Therefore, the folding of the hydrophobic gA-helix is crucial to the 
amphiphilicity of the entire peptide and only occurs in the case of the D, L – alternating 
configuration.  
To observe the superstructures formed by the self-assembly of the peptide series in solution TEM 
was used. Self-assembly was induced by changing the surrounding polarity during the exchange of 
the organic solvent to dd water. TEM images show fibers as the main superstructure generated by 
peptides ranging from X8-gA to K2X6-gA (Figure 4-6 A to C). Fibers have a length ranging from less 
than 30 nm up to 800 nm and can even self-assemble further into a “helical superstructure,” 
although in a rather disorderly manner (Figure 4-6 B/C). 
 
 
Figure 4-5: TEM of K6-gA (left) with the CD spectra of K6-gA (solid line) and K6-LgA (dashed line) in TFE. 
Additionally, two other superstructures have been found for Ac-X8-gA: triangles and nanospheres 
with a diameter of about 100 nm. Nanospheres resemble peptide beads of related amphiphilic 
peptides[18] (cf. chapter 2 and 3), while triangles (Figure 4-6 E) represent an unexpected structure 
and experiments that should explain their formation are ongoing. The triangular superstructures 
have also been demonstrated for peptides ranging from Ac-X8-gA to K1X7-gA.  
The analysis of TEM images for peptides with an α-helical character indicates the formation of 
superstructures containing worm-like micelles and regular micelles (Figure 4-6 D). Micelles with a 
radius of 6 ± 1 nm were the major component observed for peptides ranging from K4X4-gA to K8-
gA. The excellent solubility of peptides K3X5-gA to X8-gA in aqueous solution is therefore associated 
with the α-helical secondary structure, which prevents the creation of intermolecular hydrogen-
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bonds and therefore favors the formation of micelles. Peptide nanoparticles have also been 
observed for these peptides, but at a significantly lower fraction than that of the micellar. 
  
Figure 4-6: TEM of various peptide assemblies in dd H2O: A) X8-gA, B) K1X7-gA, C) K2X6-gA, D) K3X5-gA (inset 
scale bar 50 nm), E) X8-gA triangles. 
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4.3.3 Degree of acetylation influences micellization behavior 
In order to gain greater insight into the behavior of micelles DLS was used in combination with  
ζ-potential, which provides information on the superstructures and their surface charges. DLS of 
K3X5-gA to K8-gA revealed, in addition to micelles, another superstructure population. In 
combination with TEM images, we determined that micelles at a size of 7 ± 3 nm represent the 
major component, while the second population – assigned to peptide nanoparticles at a radius of 
50 nm – represents only a minor component. 
 
Figure 4-7: Hydrodynamic radius obtained from DLS () and ζ-potential values () for micellar species of 
a) K3X5-gA to K8-gA and of b) K6X2-gA at different concentrations. 
Peptide particles and micelles exhibit a hydrodynamic radius that does not depend on either the 
degree of acetylation (DA 3/9 to 9/9) or on the peptide concentration (0.1 – 1.28 mg mL-1). 
Similarly, the ζ-potential did not change upon varying the DA and concentration. Because the 
peptide nanoparticle population is a minor component, we neglected its influence on the ζ-
potential, and only the micelle population has been taken into account. As illustrated in Figure 4-7, 
ζ-potential values lie between 52 and 64 mV and are comparable to values obtained for a 
saturated polylysine surface (60 to 80 mV).[27] Aggregation of the amphiphiles into micelles 
governs the surface charge, and likely limits the aggregation number and dissociation of the lysine-
counter ions. Therefore, the surface charge and consequently the ζ-potential values were basically 
independent of the number of amine-groups and peptide concentration. However, it is known that 
micelle formation depends on the amphiphile concentration and environmental conditions that 
include pH, T, buffer and ionic strength[28]. In this respect we noted with interest that the impact 
of DA on micelle formation could hardly be detected by DLS and the ζ-potential and therefore 
tensiometric mesurements were performed for peptides ranging from K3X5-gA to K8-gA. 
Amphiphiles decrease the surface tension of water with increasing concentration until a critical 
micelle concentration (cmc) is reached and excess molecules are assembled mainly into micelles. 
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Figure 4-8: Surface tension of aq. peptide solutions of A) K3X5-gA B) K4X4-gA C) K5X3-gA D) K6X2-gA. E) cmc of 
peptides in H2O () and in buffer, pH = 7.4 (). 
The process of micelles formation for K3X5-gA to K6X2-gA can be followed in Figure 4-8 A-D. Cmc 
values calculated for these peptides both in H2O and in buffer (pH = 7.4) indicated no difference 
related to the solvent for peptides ranging from K3X5-gA to K5X3-gA, while starting with K6X2-gA a 
different behavior was observed (Figure 6D). In water, the cmc increased slightly with the number 
of charges/molecule for the whole series of peptides, and a plateau was obtained starting with 
K6X2-gA. In buffer, K6X2-gA represents a maximum, which is followed by a decrease in cmc values 
upon increasing the number of charges/molecule. From K3X5-gA (DA 5/9) to K6X2-gA (DA 3/9) – 
with all peptides exhibiting the same hydrophobic gA part – the self-assembly was driven by the 
hydrophilic part, indicated by an equal rise in cmc per charge for both solvent media. The reason 
for the plateauing of the cmc for dd H2O with decreasing DA might be due to incomplete 
dissociation of the amine functionalities and the counter ions – defining the surface charge of the 
micelles. It is known that increasing the salt concentration of the media induces a decrease in the 
cmc, as reported for sodium alkyl sulphates[29] or 1-oleoyl-lysophosphatidic acid.[30] The presence 
of ions serves to shield the negative charges of neighboring headgroups, and thus favors micelle 
formation, i.e. leads to decreasing cmcs. However, comparing the dd H2O solution and the buffer 
solution, decrease in cmcs in buffer were only observed for K7X1-gA and K8-gA and were 
simultaneous with the cmc values on the plateau in dd H2O. Therefore counter ion exchange, from 
hydroxide to multivalent ions and organic buffer ions (EDTA, TRIS) is likely to account for this 
decrease in cmc. Similar to other systems,[31] the presented responsiveness towards ionic strength 
may find usage in biomedical applications. 
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4.4 Conclusion 
In chapter 4, a library of amphiphilic peptides (Ac-X8-gA to K8-gA) is presented, that contain three 
parts: (a) a charged lysine part (b) an acetylated lysine part, and (c) a hydrophobic gA, whereby the 
overall amphiphilicity is reflected in and controlled by the degree of acetylation or number of 
charges, respectively.  
A basic structural change was located between DA of 6/9 (K2X6-gA) and 5/9 (K3X5-gA). Variation of 
the primary sequence caused a transition in the secondary structure of the hydrophilic part from 
β-sheet to α−helix. This switch-over was found to be responsible for the change in morphology 
from fibers to micelles i.e. the secondary structure was a function of the degree of acetylation. 
These morphological changes suggested based on solubility testing, and were confirmed by CD 
and TEM measurements.  
The second change in properties was observed with a DA of less than 2/9, beyond which a 
reduction in cmc in buffer took place. A lower DA of 2/9 obviously has a negligible impact on self-
assembly but provides means to regulate the system, e.g. adjustment of the cmc by adding salt. 
The peptide library can be divided into two main regions at high DA (9/9 to 6/9) β-sheet-like 
secondary structures were found and correlated with fiber formation on the macroscopic scale 
and, at moderate and low DA (5/9 to 0/9), the peptides possessed an α-helical-like secondary 
structure and assembled into micelles. A second, minor population was found in both regions, and 
was assigned to peptide nanoparticles. Point mutation allowed tuning of the hydrophilic part of an 
amphiphilic peptide and thereby enabled to localize the origin of differences in morphologies and 
behavior on a molecular level. The importance of the secondary structure for the hydrophilic part 
(α-helix β-sheet) as a crucial parameter for the self-assembly was highlighted. Similarly, the 
alternating D, L configured gA-sequence is essential to its function as a hydrophobic contributor.  
This study represents a first step towards the creation of molecular switches such as we find in 
nature, where proteins are converted into the active or inactive state by structural changes upon 
phosphorylation. Here – a proof of concept – acetylation of K3X5-gA to K2X6-gA converted water 
soluble micelles into water insoluble fibers. Creation of an in situ reversible acetylation should be 
the next logical step and could open the door to new biomimetic smart materials and biomedical 
applications. 
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Short, purely peptidic amphiphiles self-assembled into vesicles due to dimerization; these 
additional interactions led to the formation of stable peptide membranes. The vesicles 
demonstrated pH responsiveness and the ability to encapsulate hydrophobic and hydrophilic 
moieties within their structure and therefore may be used as an advanced biodegradable drug 
delivery system. 
 
Parts of this chapter were published in:  
Small, 2011, 10.1002/smll.201100701 
http://onlinelibrary.wiley.com/doi/10.1002/smll.201100701/abstract 
From “T. Schuster, D. de Bruyn Ouboter, N. Bruns, W. Meier; Exploiting dimerization of amphiphilic peptides 
to form vesicles; Small, 2011, 10.1002/smll.201100701 reprinted by permission of John Wiley and Sons. 
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5.1 Introduction 
Medicine in the future will make use of drug delivery systems (DDSs) that transport drugs directly 
to a targeted tissue. To maximize drug efficacy and minimize side effects, the active substance 
should be segregated from physiological fluids during circulation, for example by cargo 
encapsulation. One morphology in focus for such an application is vesicles that self-assemble from 
amphiphilic building blocks, such as lipids[1], block copolymers[2], and block copolypeptides[3] – 
amino acid (AA) analogues of block copolymers. These vesicles can entrap a drug payload in their 
aqueous cavities or in the hydrophobic leaflet of their membranes and thus transport the payload 
through the blood stream.  
Materials based on AAs are preferred for applications in the human body due to their 
biocompatibility. Peptide degradation pathways that are intrinsic to the body eliminate the 
problem of accumulation, especially for patients undergoing long-term therapy. Moreover, 
peptides can be designed to fold into well-ordered secondary structures, and AAs offer a diversity 
of functional groups that can be used as chemical handles to create selectively-labelled 
nanostructures.  
Deming et al.[4] and Lecommandoux et al.[5] reported vesicles formation using peptide-based 
amphiphilic block copolymers synthesized by ring-opening polymerization of N-carboxy anhydrides 
(NCAs). This technique was also used to synthesize a variety of peptide-based polymers [6] and 
combine them with synthetic polymers to obtain block copolymer hybrids. A diversity of self-
assembling bioconjugates exist which have been shown to be useful in the field of material 
science, e.g. bio-medical applications.[7] A drawback of such polymers is their synthesis via 
polymerization, which does not allow the creation of block copolypeptides with a defined 
sequence of amino acids. 
On the other hand, peptides can be precisely synthesized by bioengineering techniques or solid-
supported peptide synthesis (SPPS). Short peptides are well-suited to control and direct the self-
assembly of amphiphiles into higher order structures such as micelles and vesicles, e.g. by 
exchanging a single AA. The use of peptide hybrids can lead to the formation of superstructures 
such as vesicles[8], also in coexistence with large compound micelles[9] and nanofibers.[10] Creating 
the necessary hydrophobic block using peptides, however, proved a difficult task, due to the 
hydrophilic character of the peptide backbone. Thus, not many suitable hydrophobic blocks exist. 
Examples of amphiphilic short peptides that were successfully designed to assemble into 
membranes and vesicles have therefore rarely been reported: Zhang et al.[11] reported self-
assembled superstructures which, however, proved to be highly sensitive to the purity of the 
peptide[11c].  
The driving force for membrane formation, the segregation in solvophobic blocks, is not strong 
enough due to insufficient, non-homogeneous hydrophilic and hydrophobic surfaces. 
Mastrobattista et al.[12] reported recombinantly produced amphiphilic peptides with an additional 
conical geometry of the hydrophobic part that directs the self-assembly towards nano-sized 
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vesicles. However the polyproline II (PP II) secondary structure displays the hydrophilic backbone 
and therefore lacks a completely hydrophobic part. 
5.2 Results and discussion 
Here, we present an approach to limit the influence of the hydrophilic backbone. Additionally we 
used localized specific points of non-covalent binding, between the short peptides in order to 
stabilize a formed membrane. Besides π−π stacking another key parameter is intermolecular 
hydrogen bonding, involved in supramolecular assemblies [10, 13] that include β-sheet[7a, 14] or cyclic 
peptides[15]. We investigate the requirements posed in the formation of peptide vesicles. By 
providing different potential dimerization sites in addition to the intrinsic inter- and intramolecular 
π−π stacking of tryptophan-rich domains (Figure 5-1a), we expected that additional interactions by 
such sites would induce and stabilize bilayer formation. The amphiphilic peptides in this work were 
designed to allow for dimerization perpendicular to the membrane via tail-to-tail dimerization 
(Figure 5-1b), or by lateral association of two peptides, via carboxyl dimerization (Figure 5-1c), or 
by charge compensation of oppositely charged hydrophilic components (Figure 5-1d).  
 
Figure 5-1: Vesicle stabilization through a) Trp-Trp interactions (π-π - stacking) b) gA-OEt-dimerization c) 
carboxyl dimerization and d) charge compensation. 
Amphiphilic design is fundamental to every supramolecular aggregation, whether in the form of 
micelles, tubes or vesicles. A hydrophilic to hydrophobic AA ratio of about 1:3 is comparable to 
lipids and appears to be favourable for membrane formation.[16]  
Thus, we chose the hydrophilic to hydrophobic ratio in our amphiphilic peptides accordingly. The 
hydrophobic part was inspired by gramicidin A (gA). This pentadecapeptide, known as antibiotic 
for gram positive bacteria, features an alternating D, L configuration, leading to a β-helix from 
which all of the hydrophobic side chains project outwardly.[17] The surface of the helix, i.e. the rod, 
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is therefore hydrophobic and the hydrophilic backbone is hidden within. Gramicidin A is a 
membrane peptide that can assemble and form patterns that are thought to stabilize both inter- 
and intra-molecularly by π−π stacking of the tryptophan-rich domains.[18] Gramicidin A is insoluble 
in aqueous solution and forms dimers in lipid bilayers. A truncated version (gT) of gA was recently 
shown by our group to be effective as a hydrophobic contributor in an amphiphilic peptide, and 
led to self-assembled structures such as micelles and solid peptide particles.[19] However, these 
peptides did not form vesicles, presumably because they lacked the opportunity to form dimers.  
For this work we synthesized new, short, amphiphilic peptides 22 and 25 AAs in length with a 
predefined sequence by means of SPPS. The produced amphiphilic peptides are shown in Table 
5-1. They were examined in terms of whether they formed vesicles by using TEM, CryoTEM, and 
static- and dynamic light scattering techniques (SLS/DLS). 
Table 5-1: Code and sequence of the amphiphilic peptides. 
Code[a] Sequence[a] 
Ac-X8-gA Ac-[LK(Ac)]2-G -[LK(Ac)]3-G-[LK(Ac)]3-LV-G-LA-DL-LA-DV-LV-DV-[LW-DL]3-LW-NH2 
Ac-X8-gA-OEt Ac-[LK(Ac)]2-G -[LK(Ac)]3-G-[LK(Ac)]3-LV-G-LA-DL-LA-DV-LV-DV-[LW-DL]3-LW-OEt 
Ac-E6-gA Ac-LE3-G-LE3-LV-G-LA-DL-LA-DV-LV-DV-[LW-DL]3-LW-NH2 
Ac-K6-gA Ac-LK3-G-LK3-LV-G-LA-DL-LA-DV-LV-DV-[LW-DL]3-LW-NH2 
  [a] one letter code, X = LK(Ac) 
Tail-to-tail dimerization that results from the formation of hydrogen-bonds between 
corresponding amino acids in the final turn of the helix is known from wild-type gA in hydrophobic 
environments (Figure 5-1b).[17] GPC led to a separation into a monomer and dimer peak. The 
conditions thereby simulate a hydrophobic membrane core and illustrated the potential 
dimerization of the modified gA structure. Ac-X8-gA exhibits a C-terminal amide function on the 
hydrophobic end, which decreases the probability of tail-to-tail dimerization,[19] most probably 
due to non-matching hydrogen bond partners, accompanied by reduced hydrophobic interactions. 
Gramicidin is known to dimerize in apolar solvents. A reduction in retention time in GPC traces 
indicated the presence of gA-dimers. Consequently, GPC showed only a single peak (Figure 5-2). 
Similar Ac-X8-gA-OEt dimers are eluted earlier compared to Ac-X8-gA. The mass difference of only 
29 g mol-1 is negligible.  
To increase hydrophobic interactions, an ethoxyl group (OEt) was used to mask the terminal amide 
function of the amphiphilic peptide. In this way, we eliminated the last remaining hydrophilic 
moiety on the hydrophobic end of Ac-X8-gA-OEt, and thus expected the facilitation of tail-to-tail 
dimerization, which would be perpendicular to the membrane (Figure 5-1b). Indeed, a decrease in 
retention time caused by dimerization was found in GPC for the esterified Ac-X8-gA-OEt (Figure 
5-2). As a result of this modification, vesicle formation was observed for Ac-X8-gA-OEt, which was 
not the case for Ac-X8-gA.[20] Figure 5-3a shows collapsed vesicles. These resulted from the drying 
effect on the TEM grid and thereby verified that the objects had a hollow structure. Perpendicular 
(relative to the membrane) dimerization of membrane subunits, is thought to support and lead to 
membrane association, most likely in a bilayer-type conformation. 
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Figure 5-2: GPC of monomeric Ac-X8-gA (dashed line) and dimerized Ac-X8-gA-OEt (solid line) compared with 
the dimer and monomer peaks of wild-type gramicidin A (dotted line). 
Another type of dimerization between amino acid residues can be caused by the formation of 
hydrogen bonds between two carboxylic acids (Figure 5-1c). Glutamic acid, more precisely the 
carboxyl functionality thereof, forms dimers and polyglutamic acids consequently associate.[21] 
They can even form a β-structure in a condensed Langmuir-Blodgett film.[22] At neutral pH, oligo- 
and polyglutamic acids are charged and adopt an extended 2.51 helix, or PP II, conformation.[23] 
We aimed to exploit this type of dimerization of the hydrophilic block by using negatively charged 
oligoglutamic acid (E, pKa of 4.7) as the hydrophilic component in an amphiphilic peptide Ac-E6-gA. 
Indeed, collapsed vesicles were observed when this peptide was allowed to self-assemble, as 
shown in the TEM micrograph in Figure 5-3b. That implies that actually a peptide membrane was 
formed. In CryoTEM thin sheet fragments were observed also illustrating the formation of thin 
peptide membranes. Its thickness deduced from the CryoTEM images is 5 ± 1 nm. The membrane 
of the vesicles formed by Ac-E6-gA cannot be stabilized by dimerization through the hydrophobic 
chain ends, as it was the case for Ac-X8-gA-OEt. Thus, the association and dimerization of the 
hydrophilic block are the essential factors that allow the formation of stable Ac-E6-gA membranes 
in a vesicle. Considering the length of an amphiphilic peptide of about 3.7 nm, the measured 
membrane thickness suggests that the hydrophobic parts of the amphiphiles share one layer 
instead of forming a bilayer, the expected morphology of membranes formed by Ac-X8-gA-OEt 
(Figure 5-3c).  
Light scattering provided further evidence of vesicle formation (Figure 5-4). Ac-E6-gA exhibited a 
radius of gyration (Rg) of 194 nm and a molecular weight (Mw) of 3.3•108 g mol-1. A Guinier plot is 
shown for Ac-E6-gA in Figure 5-4a. The measured Mw of the vesicle corresponds to 130,000 
aggregated peptide molecules. Assuming the gA helix represents the group that requires the most 
space (r=1.5 nm[17c], A=(2r)2sin60°), these values would either fit a peptide bilayer, or a single 
peptide layer where two gA form a double helix, a structure also known from wild-type gA[17]. The 
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latter arrangement would also allow two oligoglutamic parts to approach each other to a 
favourable distance for H-bonding. 
 
Figure 5-3: TEM of self-assembled structures of a) Ac-X8-gA-OEt b) Ac-E6-gA and c) CryoTEM of Ac-E6-gA. 
Rg, together with the hydrodynamic radius (Rh) of 205 nm from DLS data analysis, permits the 
calculation of the ϕ-parameter (Rg/Rh) – an indicator of the underlying structure – of 0.95. This 
value is close to the typical value for hollow spheres (1.0),[24] while differences from this might 
arise due to the presence of micelles in the system, which would lower the ϕ-parameter towards 
that of micelles (0.75). We found that the dimensions of the vesicles did not depend on the 
concentration of amphiphilic peptides, as shown by DLS (2nd cumulant fit, 90°) up to a 
concentration of 0.7 mg mL-1. Above approx. 1 mg mL-1 aggregates are formed which were also 
observed by TEM and CryoTEM. 
 
Figure 5-4: a) Static light scattering analysis (Guinier plot) and b) pH response of Ac-E6-gA (DLS). 
We expected that charge compensation would also drive the association of oppositely charged 
moieties. Mixtures of poly(L-lysine) (PLL) and poly(glutamic acid) (PGA) are known to form a β-
sheet-like structure[23a, 25] and to interact electrostatically (Figure 5-1d). The amphiphilic peptide 
Ac-K6-gA (K = lysine, pKa 10.2), the positively charged analogue of Ac-E6-gA, exhibits the same 
amphiphilic design and hydrophilic-to-hydrophobic ratio as Ac-E6-gA but lacks carboxyl 
dimerization. Not surprisingly, we found that it assembles into micelles and solid spherical objects, 
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but not into vesicles (data not shown). However, when mixed with Ac-E6-gA, it did generate multi-
lamellar structures at molar ratios of Ac-K6-gA between 0.3 and 0.8 (Figure 5-5). Electron 
micrographs showed a lamellar thickness of 8.3 ± 1.3 nm, which is double the length of the 
amphiphiles. Thus, lateral association of neighbouring, oppositely charged hydrophilic peptide 
blocks induced membrane formation. Moreover, perpendicular dimerization took place despite 
the hydrophilic chain end of the gA block. The interaction of both types of dimerization resulted in 
lamellar structures and not in vesicles.  
 
Figure 5-5: TEM of Ac-E6-gA and Ac-K6-gA mixtures with molar ratios of a) 0.2 b) 0.4 and c) 0.6. 
Once having obtained vesicles from short amphiphilic peptides, these peptosomes were explored 
in initial experiments to investigate their use as functional, nano-sized containers, e.g. for drug 
delivery. 
The introduction of pH-sensitive glutamic acid was expected to lead to a pH-responsive “smart” 
material. Therefore, the response to a change in acidity was monitored by DLS. The self-assembled 
structures were stable over a wide range of pH, but they precipitated when the pKa was exceeded 
(Figure 5-4b).  
Vesicles possess the potential to encapsulate hydrophilic moieties within aqueous cores and to 
integrate hydrophilic compounds within the hydrophobic membrane layer. In an initial trial, we 
successfully accomplished this, respectively, with hydrophilic Alexa Fluor 488 and hydrophobic 
BODIPY 650/665 within Ac-E6-gA assemblies (Figure 5-6). The co-localization of both fluorophores 
indicates the presence of vesicles. Not all fluorescent spots that showed fluorescence of the 
hydrophobic fluorophore showed fluoresce in the green channel. Therefore, micelles were also 
present next to vesicles, because the micelles are only able to accommodate the hydrophobic 
fluorophore in their cores. 
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Figure 5-6: Laser scanning microscopy images of Ac-E6-gA-based vesicles and micelles loaded with BODIPY 
650/665 and Alexa Fluor 488; a) red fluorescence of the hydrophobic BODIPY, b) green fluorescence of the 
hydrophilic Alexa Fluor, and c) overlay, co-localized fluorophores, which indicate vesicles. Scale bars = 10 
µm. 
5.3 Conclusion 
In conclusion, we found that additional intermolecular non-covalent bonds and interactions are 
necessary to stabilize vesicles formed from small amphiphilic peptides. A crucial requirement for 
the formation of stable peptide membranes appears to be the dimerization of peptides, which 
were specifically designed into the amphiphiles (Figure 5-1). Dimerization in the lateral or 
perpendicular directions, and thus the formation of a stabilized membrane subunit, produced 
stable, purely peptidic vesicles and may well apply to other systems. 
The novel systems presented here offer hydrophilic and hydrophobic compartments to 
encapsulated different drugs and could be used e.g. for gene delivery, since the design includes 
charged moieties. Furthermore, the peptidic vesicles are expected to be biodegradable and thus 
have great potential as a DDS. 
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Fluorescently stained human liver cancer cells with internalized siRNA-loaded peptide beads in 
confocal laser scanning microscopy.  
 
Red: siRNA in peptide beads, green: membrane, blue: nucleus. 
 
 
 
 
  
Dirk de Bruyn Ouboter Peptide beads: applications and biocompatibility 
92 Rational Design of Purely Peptidic Amphiphiles for Drug Delivery Applications 
6.1 Abstract 
Chapter 6 presents the drug delivery applications potential of self-assembled peptide beads. 
Internalization of hydrophobic and hydrophilic payload-filled peptide beads by THP-1 
macrophages, THP-1 monocytes, and hepatocellular carcinoma cells (HuH-7) was demonstrated. In 
addition to the bead-forming peptide Ac-X3-gT, a positively charged lysine peptide analogue was 
used and, as a result of charge compensation, increased the embedding efficiency of RNA/DNA 
material to 99%. Internalization of the resulting gene delivery vehicles by HuH-7 cells led to 
specific gene silencing, for the case of siRNA, and antibiotic resistance and shRNA production, 
followed by gene silencing for the case of a delivered plasmid (DNA). Furthermore, the co-
embedded drugs, paclitaxel and doxorubicin, inside the peptide beads were delivered to THP-1 
monocytes, causing the intended cell death, due to the activity of the anti-cancer drugs. The new 
class of peptidic drug delivery material did not cause any measurable toxicity during the 
experiments and therefore suggests a biocompatible drug delivery vehicle for multi-drug delivery 
and gene therapy. 
6.2 Introduction 
Novel medications will require advanced, functional delivery systems to allow efficient drug 
delivery, protect sensitive ingredients, reduce side-effects, and increased time in circulation (cf. 
chapter 1.3). Hydrophilic drugs often possess good solubility, but are quickly degraded or 
eliminated from the body. Hydrophobic drugs, on the other hand, lack solubility and accumulate in 
hydrophobic organelles[1]. Several diseases are known to require multi-drug treatment[2], leading 
to the necessity of delivering and releasing the hydrophobic as well as the hydrophilic drugs 
simultaneously to a specific target. One example of such a need is cancer treatment in a 
combination therapy using hydrophilic doxorubicin and hydrophobic paclitaxel[3]. Doxil and 
Abraxane represent nano-carrier based drug delivery formulations of these drugs[4]; however, they 
remain separated as individual formulations, while they potentially could be even more efficient in 
combination. Multicompartmentized delivery systems – capable of embedding both drugs – would 
enable a deposition of only one formulation containing two drugs into a tumor and therefore 
allowing the simultaneous release of the two active ingredients[5]. 
Another important task of nano-sized delivery systems is protecting drug molecules from the 
environment, where they are exposed to degradation processes. Gene therapy has been 
promoted as having outstanding potential to cure diseases on a genetic level[6]. The use of siRNA – 
small interfering RNAs composed of only 15 to 25 base pairs – can temporarily stop, i.e. silence the 
transcription of specific genes into their peptides/proteins[7]. The technology virtually enables the 
treatment of almost every disease that has a basis established in gene hyperactivity, whereby the 
full decryption of the human genome becomes of great advantage. The use of plasmids – carrying 
the sequences for small hairpin RNA (shRNA) that is cleaved by the cellular machinery into siRNA – 
can permanently silence a gene[2]. In contrast to siRNA, a plasmid reproduces during mitosis and 
therefore represents a very powerful method for gene therapy. Both siRNA and the DNA plasmids 
are prone to degradation before reaching their destination in such an application, which seems 
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logical, because the body naturally protects itself from foreign genetic information. This fact, 
however, corroborates the need for a surrounding, protective layer to enable successful delivery 
into cells[2]. In nature, viruses perform this task. Synthesis of empty viruses and filling them with 
selected genetic information is possible[7-8], but this is a formidable task associated with high costs 
and, unfortunately, cannot be considered for large-scale production of pharmaceuticals. Classical 
transfection reagents allow gene delivery in cell models, but they tend to be toxic and cause – 
depending on the dose and time – partial or full cell death, which is incompatible with human 
gene therapy. 
In recent years, great efforts have been made in research to develop smart material drug delivery 
vehicles capable of delivering RNA/DNA. An example is the covalent binding of a photolytic 
chromophore to siRNA [9]. In such a construct, the photocaged compound is inactive and protected 
from biochemical or biological degradation until released by light treatment. Another example is 
the encapsulation of RNA/DNA material in poly(D,L-lactide-co-glycolide)(PLGA) microspheres[10]. 
When internalized, the payload is released by degradation of the polymer and diffusion through 
the polymer matrix. Gary et al.[11] provide a good overview of polymer-based siRNA delivery in a 
recent review. 
Besides their main task of encapsulation and delivery of active components, the material used 
ideally exhibits biocompatibility and biodegradability. These are very important properties and 
their absence has caused several potentially applicable systems to fail (cf. chapter 1.3). Amino acid 
based materials are generally considered biocompatible and biodegradable, due to the fact that 
they are an intrinsic component of the human body and they have established degradation 
pathways. This chapter presents the development of the peptide beads as referred to in chapters 
2 and 3 for drug delivery applications. The nano-sized peptide beads used herein are formed by 
aqueous self-assembly of purely peptidic amphiphiles dissolved in ethanol[12]. Their structure was 
investigated and described earlier and was referred to as a multicompartment micelle (chapter 3) 
capable of embedding hydrophilic and hydrophobic payloads[13]. 
6.3 Results and discussion 
6.3.1 Peptide bead formation and payload embedding 
The results presented herein were produced with two short, purely peptidic amphiphiles. Both 
peptides consist of an hydrophobic part, representing a seven amino acid long, alternating D-
leucine / L-tryptophan sequence (gT) and a hydrophilic part of either three lysines or acetylated 
lysines (see Table 6-1). The charged peptide K3-gT forms micelles with a radius of ~10 nm in 
aqueous solutions. The acetylated and uncharged analogue Ac-X3-gT is soluble in ethanol and 
forms spherical peptide particles, termed “peptide beads”, having adjustable diameters between 
200 and 1500 nm when solvent is displaced by water. The beads exhibit solid character at ethanol 
concentrations below ~20 % wt. Above this concentration, the peptide is a loose aggregate of 
micelles or individual micelles. The exact behavior as a function of ethanol concentration and 
temperature was described earlier [12] (cf. chapter 2). 
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Table 6-1: Code, sequence, and charge of charged (K) and uncharged (X = LK(Ac)) amphiphilic peptides. 
Code Sequence Charge (at pH 7) 
K3-gT H-LK3-[LW-DL]3-LW-NH2 4+ 
Ac-X3-gT Ac-[LK(Ac)]3-[LW-DL]3-LW-NH2 0 
 
With the embedding method as used – a straight forward co-encapsulation – the payload was 
dissolved in ethanol or water, followed by mixing with the ethanol solution of the peptide to 
obtain solutions of at least 50 % ethanol. Subsequent dialysis against water yielded peptide beads 
with embedded payloads. As reported earlier for the hydrophobic and hydrophilic dyes, rose 
bengal and carboxy fluorescein[13], respectively, the payloads are not only embedded but 
considerably enriched inside the peptide beads. We observed identical embedding behavior for 
other payloads also, namely BODIPY630 (hydrophobic), Alexa488 (hydrophilic), doxorubicin, 
paclitaxel, siRNA, and plasmids (DNA), examples shown in Figure 6-1. 
We observed no measurable influence on the self-assembled structure of the peptide within the 
range of the concentrations used for hydrophobic or for RNA/DNA payloads. For hydrophilic 
doxorubicin, however, we noted an impairment in self-assembly when more than 50 % of payload 
mass was used relative to peptide. Above such concentrations, the size of the resulting peptide 
beads was drastically reduced, presumably due to shielding of the stabilizing peptide-peptide π-π-
interactions by the payload (cf. chapter 5). However, such high payload-to-carrier ratios are usually 
not necessary. 
 
Figure 6-1: Confocal laser scanning micrographs of peptide beads with embedded payload, scale bars 
20 µm. A) BODIPY 633 (red), peptide (blue), differential interfering contrast (DIC) (grey), overlay. B) Alexa 
488 (green), peptide (blue), DIC (grey), overlay. 
The enrichment of payloads in the peptide beads reduces the need for a method to separate non-
embedded payloads from the aqueous dispersion. However, the fact that the peptide beads have 
a higher density than the surrounding water (1.4 g/cm3) [12] allows easy separation of non-
embedded molecules by multiple centrifugation and decantation.  
Embedding efficiency (%ee) is defined as %ee = [c]embedded/[c]total*100. In case of RNA/DNA 
payloads embedded in Ac-X3-gT peptide beads, the measured embedding efficiency was only  
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2 – 4 %ee, which speaks for a passive embedding effect (embedding the available payload with the 
same concentration as on the surrounding solution in the volume of the carrier)[14]. Premixing RNA 
with the positively charged peptide analog K3-gT followed by peptide bead formation with Ac-X3-
gT enabled active embedding and raised the embedding efficiency to as high as 99.8 %ee 
(enrichment of the available payload within the carrier). Within the precision of the experiment, 
this represents a complete embedding of all available RNA, making any further step for separation 
of payload-filled beads and free payload dispensable. The low embedding efficiency when using 
Ac-X3-gT only was obviously caused by the repulsive negative charges of the base pairs. However, 
the use of both the charged and the uncharged peptide (K3-gT and Ac-X3-gT) was found to 
influence peptide bead self-assembly: An excess of positive charges (from the K3-gT) also led to the 
formation of peptide beads of the usual dimensions, but within 24 hours the beads aggregated 
and developed a strong affinity for glass. A balanced, overall charge, and therefore an 
equilibrated, mutual compensation of the positive charges from the peptide and the negative 
charges of the RNA, was found to be necessary to yield finely dispersed but heavily loaded peptide 
beads (Figure 6-2).  
 
Figure 6-2: CLSM of siRNA-cy3 (red) loaded peptide beads (blue) and overlay (purple) at different ratios of 
positively charged peptide to negatively charged siRNA, revealing aggregation of the beads at ratios with an 
excess of positive charges. Embedding efficiencies >99.5%. Scale bars 10 µm. 
Payloads such as the siRNA have a length of approximately 6 nm, whereas plasmids are larger and 
have a spherical diameter of ~500 nm. However, neither was seen in TEM of the payload-
embedded peptide beads. In contrast, the loaded peptide beads looked similar to the unloaded 
beads (Figure 6-3). Thus, the large plasmids obviously curled-up during embedding, fitting into one 
bead, a phenomenon that was induced by the charge compensation and the peptide 
amphiphilicity. 
  
Figure 6-3: Representative TEM showing the similarity of unloaded (A) and siRNA loaded (B) peptide beads. 
The difference in size is within the common size distribution of the beads.  
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6.3.2 Cell internalization  
Three different cell lines were used in order to test cellular uptake of the K3-gT/Ac-X3-gT peptide 
beads: THP-1 (human acute monocytic leukemia cell line) monocytes, THP-1 macrophages, and 
HuH-7 hepatocytes (hepato cellular carcinoma cells). To visualize the internalization of the 
potential drug delivery vehicles, cy3-labeled siRNA (250 nM, 99%ee) as well as BODIPY633 (75 nM) 
were used as payloads for 0.25 mg/ml and 0.5 mg/ml peptide beads, respectively. The cells were 
incubated with the peptide beads in a 1:5 dilution in cell growth media for 48 h. As revealed by 
confocal laser scanning microscopy (CLSM), shown by way of example in Figure 6-4, both kinds of 
beads were internalized by the cells. Internalization of the carrier is a necessary step in the 
development of a drug delivery system. However, after internalization, the functional payload 
preserved in this way has to be released at its site of action. In the case of siRNA, this is the 
cytosol. Diffuse fluorescence in cells indicated a release of the payload from the peptide beads to 
the cytosol. However, in the case of the siRNA, whether this diffuse fluorescence in the cytosol is 
from intact siRNA or from the remaining cy3 molecules after the decomposition of the siRNA 
cannot be determined. Therefore, it could not be determined whether functional siRNA was 
released. In order to clarify this, specific gene silencing using siRNA or a plasmid, as well as the 
toxic effect of doxorubicin and paclitaxel were tested. 
 
Figure 6-4: CLSM of hepatocytes. A) Internalization of BODIPY633 (green) loaded peptide beads (blue) into 
hepatocytes visualized in transmission channel (grey). B) Internalization of cy3-siRNA (red) loaded peptide 
beads into hepatocytes; nucleus (blue) and plasma membrane (green) fluorescently stained for 
visualisation. 
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6.3.3 Toxicity and therapeutic effect 
We compared pure (unloaded) peptide beads with control samples (no beads added) during all 
experiments and always obtained similar results within the limits of experimental error. The 
resulting absence of any toxic effect by the peptide beads (see Figure 6-5 & Figure 6-6) is an 
indication of the biocompatibility of the purely peptidic amphiphiles used. 
 
Figure 6-5: Comparison of cell viability (by MTS assay) between THP-1 macrophages and THP-1 monocytes 
after 3-day treatment with peptide beads loaded with the anti-cancer drugs paclitaxel and doxorubicin. 
Different dilutions shown. Plots visualize the lack of toxic effect by the pure peptide beads as seen form the 
“beads only” samples (left and right), and the desired effect of the drugs in monocytes (right).  
The therapeutic effect of potentially delivered drugs was tested in order to determine not only the 
internalization of the peptide beads but also a functional drug delivery system at a cellular level. 
Therefore, cell viability tests were performed with doxorubicin, paclitaxel, and 
doxorubicin/paclitaxel-loaded peptide beads using THP-1 macrophages and THP-1 monocytes. To 
minimize non-specific delivery of the drugs, the prepared peptide beads were separated from non-
embedded drugs by triple centrifugation/decantation and offered to the cells for 24 h and 72 h in 
two different concentrations. As Figure 6-5 reveals, all drug-loaded samples significantly reduced 
cell viability, as expected from doxorubicin and paclitaxel residing in monocytes. However, for the 
mixture of doxorubicin and paclitaxel, a reduced effect with higher bead concentrations was 
observed. This is puzzling and might be related to concentration dependent embedding 
properties. In any case, further experiments are needed to understand and fully clarify this 
behavior. Since the mechanisms of action of both drugs take place during cell multiplication, no 
effect was monitored in the non-multiplying macrophages, also indicating no toxic effect of the 
material used. 
In principle, paclitaxel and doxorubicin can enter a cell without a drug vehicle. Although such 
behavior was minimized by separating free drug from the beads, it cannot be ruled out 
completely. Therefore the specific silencing of a target gene with siRNA as well as the delivery of a 
vector in the form of a plasmid was tested in hepatocytes. Neither of these payloads can enter a 
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cell without the help of a vehicle, because the material would be degraded. Gene silencing by the 
siRNA as well as effects of the delivered plasmid sequence (siRNA production and antibiotic 
resistance) are capable of demonstrating successful delivery and therefore show the potential of 
the peptide beads as a drug delivery system. 
We used GAPDH siRNA (silencing the transcription of the housekeeping gene glyceraldehyde 3-
phosphate dehydrogenase (GAPDH)), negative control siRNA (a scrambled sequence, causing no 
silencing), a psiSTRIKE-Neomycin vector (containing a hairpin target sequence of PP2Acα that 
allows expression of siRNA against PP2Acα, and a sequence coding for antibiotic resistance), and 
as control, the same vector with a scrambled sequence for the siRNA (causing no silencing)[15]. 
Overexpression of PP2Acα in hepatocytes has recently been shown to play an important role in 
liver cancer development. Although we used the silencing of this gene only as proof of principle, it 
raises the possibility of finding application in hepatitis C-induced liver cancer treatment[15-16].  
As Figure 6-6 A&B show, the siRNA as well as the plasmid caused gene silencing compared to the 
negative control siRNA, negative control plasmid, and the control, measured by quantitative real 
time polymerase chain reaction (qRT-PCR). The monitored silencing was at the limit of significance. 
However, it appeared that there was always more silencing in the samples than in the controls. To 
prove the statistical significance of the silencing – which, at 15%, was highest for the plasmid – the 
cells were cultivated for three weeks after being kept in the presence of plasmid-loaded peptide 
beads for 96 h (Figure 6-6C). Plasmid transfected cells also replicated the plasmid itself during 
multiplication. To prove the successful delivery, cells transfected with plasmid were selected by 
addition of antibiotic in culture medium, which caused the non-transfected cells to die. The 
survival of the selected cells, resulting from the delivered antibiotic resistance, alone indicates the 
capacity of the peptide bead system to deliver a payload into the cells. The performed qRT-PCR of 
the stability-selected cells showed a significant silencing of 33%, caused by the siRNA produced by 
the delivered plasmids. The effective gene delivery capacity of the peptide beads was therefore 
demonstrated. 
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Figure 6-6: Real-Time-PCR results of gene silencing in HuH-7 hepatocytes. The comparison between control 
experiments, peptide beads, conventional transfection agent Lipofectamine 2000 (Lipo), siRNA (A) and 
plasmid (B) loaded peptide beads shows the lack of toxicity by the delivery system as well as gene silencing. 
The effect was significantly increased by cell stability selection of plasmid transfected cells (C), proving gene 
delivery effective. 
In order to understand the uptake pathway, and to explain the low silencing with siRNA and with 
the plasmid after 96 h incubation, preliminary trafficking experiments were performed to locate 
the peptide beads within the cell. CLSM with cy3-siRNA and a Lysotracker assay (a fluorescent dye, 
labeling the acidic conditions of the lysosome) was performed.  
A large fraction of the beads – especially the bigger beads – was found in the lysosome after 48 h 
of treatment with the peptide particles. However, small beads or released payload were also 
found outside the lysosome, obviously the cause for the silencing (Figure 6-7). Current findings 
allow two explanations that can be approached to increase the silencing. Firstly, bigger beads are 
being trapped and, together with payload, decompose in the lysosome, while smaller beads 
undergo different uptake-pathways and release the payload in the cytoplasm. The low fraction of 
the small beads would explain the low amount of siRNA delivered and the low silencing. The 
second possibility is that the solid peptide beads are trapped in the lysosome and, due to their 
solid character, protect the payload from decomposition. However, this intense protection might 
also hinder the payload from being released. Nevertheless, the monitored silencing and 
transfection with the plasmid proves the delivery to be functional. To understand the process, 
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further experiments are necessary, e.g. trafficking, quantifying the internalization efficiency, and 
analyzing the release mechanism. Although such experiments are very interesting, they are out of 
the scope of this thesis, which started with the synthesis of the peptides from scratch. 
 
Figure 6-7: CLSM of stained hepatocytes, plasma membrane (green), nucleus (blue), lysotracker (yellow), 
delivered siRNA(red). A) Cell culture with internalized cy3-siRNA filled peptide beads. B) Control without 
peptide beads/siRNA. 
6.4 Conclusion 
The presented uncharged, short, and purely peptidic amphiphile is capable of embedding various 
payloads with different hydrophilic and hydrophobic properties in peptide beads of 100 – 1500 nm 
in size. Such a capacity is useful to simultaneous deliver drugs of variable solubilities, as shown 
with doxorubicin and paclitaxel. The drugs were embedded separately as well as in combination in 
the peptide beads. The delivery of the drugs to THP-1 monocytes caused the death of the cells due 
to the toxic intervention of the guest molecules within the cancer cell amplification. In THP-1 
macrophages, no effect was monitored, since the non-dividing cells are not prone to the 
mechanism of action of the two anti-cancer drugs. For the embedding of RNA/DNA related 
materials, the embedding efficiency was increased from 3% to 99.5% by compensating the 
payloads’ charges with counter-charged peptide amphiphiles. Thus, the embedding of all available 
payload molecules made post-embedding purifications unnecessary. It further allows for a very 
high payload concentration to be delivered. Therefore, the peptide beads fulfill the highly aspired 
requirements for drug delivery vehicles regarding encapsulation efficiency[14]. 
The capacity of the presented peptide bead system to deliver and release RNA/DNA payloads, 
causing delivery of a gene and silencing with siRNA, respectively, reflects a first indication of the 
peptide amphiphiles’ capacity as a carrier in gene therapy/delivery. The currently achieved 33% of 
specific gene silencing reflects proof of principle and does not diminish the value of the system, 
because the material caused no measurable toxic effect during the experiments. Therefore, and 
due to its amino acid based nature, it can currently be viewed as a biocompatible system. The 
mechanism of uptake of the peptide beads as well as the release of the payloads are both not yet 
understood. Combinations of peptide degradation, diffusion, counter ion exchange, or 
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deprotonation due to a changing pH are possible to release the RNA/DNA material. A better 
understanding of these mechanisms in regard to the used system might lead to modifications to 
enhance the delivery/release efficiency. From the current results, we assume that good protection 
of the payloads, due to the solid character of the beads, helps the payload resist the harsh 
lysosomal conditions until escape from the lysosome. However, this also leads to a slow release of 
the payloads. It would therefore be favorable to include a trigger in the beads, allowing controlled 
and accelerated release. As an example, the co-encapsulation of gold-nanoparticles within the 
beads could introduce an IR-excitable heat source that would allow triggering of payload release. 
In final summation, we have presented a biocompatible, non-toxic, purely peptidic drug-delivery 
system that is capable of hosting hydrophilic and hydrophobic molecules, RNA, and DNA, 
delivering the host into cells without the need of additional uptake-stimulating substances. 
Therefore, we showed the potential of purely peptidic amphiphiles for drug delivery applications.  
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7 Densely packed composite peptide-gold nanoparticles 
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Figure 7-1: Illustration of the formation process, showing the coating of 5 nm gold nanoparticles 
with the peptide Ac-X3-gT-C, and the subsequent formation of the composite peptide-gold 
nanoparticles enabled by the self-assembly features of the peptide. Additionally, transmission- 
and scanning electron micrographs (TEM & SEM) demonstrate the composite peptide-gold 
nanoparticles in actuality.  
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7.1 Abstract 
In chapter 7, the use of a self-assembled peptide superstructure as template for nano-patterned 
objects is presented. The bead-forming peptide Ac-X3-gT was C-terminally modified with a cysteine 
and linked to gold nanoparticles. Subsequent self-assembly of the peptide-coated gold 
nanoparticles led to controlled aggregation of the gold core micelles to form composite peptide-
gold nanoparticles, in which the individual gold nanoparticles are close together but still separated 
from one another. Microscopic and spectroscopic examination revealed dense packing of the gold 
nanoparticles within the peptide beads, offering the opportunity for exceptional optical- and 
electronic properties as well as the use of the composite material for a potential triggered 
destruction of the peptide beads by the typical radiation absorption effect of gold nanoparticles. 
7.2 Introduction 
Colloidal, inorganic nanoparticles have gained ever more attention in recent years due to their 
exceptional properties: In addition to their total vast surface area, they possess various interesting 
properties such as fluorescence (quantum dots, e.g. CdTe, CdSe), phosphorescence (e.g. Y2O3), 
magnetism (e.g. iron oxide, cobalt), high electron density, and strong optical absorption (e.g. Ag, 
Au). In particular, the exceptional electronic- and optical properties of gold nanoparticles (GNPs)[1] 
has led to the development of various applications[2]. Similar to mystic Greek hybrid creatures (e.g. 
centaurs, griffins, etc.), in nanosciences the idea of combining two features into one has also led to 
composites that reduce limitations of individual materials while expanding their virtues. This fact 
has given rise to steadily increasing industrial and academic interest in composite materials that 
exploit the properties of magnetic nanoparticles[3], MRI contrast agents[4], quantum dots[5], and 
GNPs [2, 6] to improve e.g., medical imaging or diagnostics[7].  
An approach taken to reduce the drawbacks of inorganic materials (e.g., toxicity, fast 
distribution/dilution) while preserving their above mentioned unique features is coating or 
embedding the inorganic nanoparticles with materials with advantageous properties. As an 
example, Azzam and Eisenberg[6f] recently coated GNPs with poly(ethylen oxide)-b-
poly(caprolactone) to better localize macromolecular assemblies in biological applications. On the 
other hand, composite materials can generated new features, as is the case with recently 
presented shell-in-shell multicompartment capsules[8]: The incorporation of near-infrared light 
(NIR) absorbing GNPs in the membrane of the inner shell allowed membrane degradation by heat, 
produced by the absorption of near-infrared laser light, leading to mixing of initially separated 
payloads. These examples show that beneficial new materials might result from expanding the 
properties of known (nano-sized) materials by incorporation of inorganic nanoparticles. 
Consequently, we herein show how peptide beads and their self-assembly can be combined with 
GNPs to allow structural templating of gold nanoparticles, but also to include new functions, as 
e.g., NIR triggered destruction of the beads in order to speedup payload release. 
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7.3 Results and discussion 
We recently presented the amphiphilic undecapeptide Ac-X3-gT, which – depending on the state 
of charge – is capable of forming micelles or peptide beads[9] (cf. chapter 2). The spherical peptide 
particles, termed “peptide beads”, have controllable radii ranging from 100 to 800 nm and are 
formed during a self-assembly process that takes place when exchanging the peptide-dissolving 
ethanol for water. The formation process is a hierarchical self-assembly from micelles to 
multicompartment micelles (cf. chapter 2 & 3).  
Peptides exhibiting a cysteine are capable of forming well-known thiol – gold bonds[6d, 10]. In order 
to transfer self-assembly properties of Ac-X3-gT to GNPs, we attached a thiol functional group 
(cysteine) to the peptide’s hydrophobic part (Table 7-1)Table 7-1 Code and sequence of the use 
amphiphilic peptide and its precursor [X = LK(Ac)].. The thusly obtained Ac-X3-gT-C was then used 
to coat commercially available GNPs (5 nm and 25 nm) in ethanol solutions, followed by the self-
assembly of the so-obtained gold core micelles into composite peptide-gold nanoparticles during 
dialysis, exchanging ethanol with water (see Figure 7-1). 
Table 7-1 Code and sequence of the use amphiphilic peptide and its precursor [X = LK(Ac)]. 
Code Sequence 
Ac-X3-gT 
Ac-X3-gT-C 
Ac-[LK(Ac)]3-[LW-DL]3-LW-NH2 
Ac-[LK(Ac)]3-[LW-DL]3-LW-LC-NH2 
7.3.1 Self-Assembly of the pure Ac-X3-gT-C 
As indicated earlier, cysteine functionalization on the hydrophilic part of the peptide did not 
change the self-assembly behavior with any of the methods used[9] (cf. chapter 2). In order to 
ensure comparable self-assembly behavior of the newly formed peptide, we investigated the 
impact of cysteine elongation on the hydrophobic part on the self-assembly properties. These 
investigations revealed that Ac-X3-gT-C similarly self-assembled into peptide beads as AcC-X3-gT 
and the non-cysteinated analogue Ac-X3-gT (Figure 7-2). The size distribution of the formed beads 
was relatively large. Nevertheless, the hydrodynamic radius, as determined by dynamic light 
scattering (DLS), at 256 nm, is consistent with SEM and in the same range as the peptide beads of 
the other analogues. Although the formed beads exhibit a rougher surface and obviously a looser 
packing of the micellar subunits – which is presumably caused by additional disulfide stabilization 
of the micelles (cf. chapter 3) – the self-assembly behavior in general is identical to the earlier 
described peptide beads[9]. 
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Figure 7-2: SEM of self-assembled peptide beads from Ac-X3-gT-C, showing bead formation comparable to 
the N-terminally- and non-cysteinated analogues, with a slightly rougher surface, and a looser packing of 
the micellar subunits. 
7.3.2 Self-assembly of the Ac-X3-gT-C–GNP composite material 
The coating of the GNPs with the peptide, separation of free peptide by centrifugation, and the 
subsequent self-assembly into composite peptide-gold nanoparticles (CPGNPs) was successful, as 
the slow sedimentation of the reddish CPGNPs, resulting from the color of the GNPs, already 
suggested. DLS showed a hydrodynamic radius of 350 nm for the CPGNPs. Fortunately, the large 
size distribution provided the small particles that permitted a view by TEM and showed that the 
newly formed CPGNPs exhibit homogenously distributed GNPs in a dense arrangement (Figure 
7-3). The approx. 3 nm thick peptide layer is in agreement with the length of one peptide. SEM 
showed similar sizes of the particles, further it allowed a closer look to the formation process, 
since differently matured particles were present in the sample (Figure 7-4). As appearing from the 
measurements, the particles were formed by aggregation of the gold-cored micelles. Due to the 
covalent attachment of the peptide to the GNPs, the micelles were hindered to produce a smooth 
surface by pronounced sintering-like processes (cf. chapter 3), which led to better visible individual 
micelles, but also to gaps between bigger islands in the material. Such bigger islands may have 
formed first and then aggregated into the final CPGNPs.  
 
Figure 7-3: TEM micrographs of self-assembled CPGNPs, showing the dense packing of 5 nm GNPs (A,B) and 
25 nm GNPs (C,D) within the particles. Small particles reveal a look inside (A, C), in large particles the 
embedded gold is visible only at the edge due to the high electron density (B, D). The inset in C shows the 
peptide surrounding the GNP. 
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Figure 7-4: CPGNPs in SEM. Produced by aggregation of gold core (5 nm) micelles. The covalent peptide-
gold bond prevents the micelles from sintering together in a smooth fashion. 
During the first experiments to explore the properties of the composite material we monitored no 
shift in the size dependent, characteristic gold absorption[11] in UV/Vis (Figure 7-5). This speaks for 
closely packed but still separated GNPs within the CPGNPs. The close distance of the individual 
gold nanoparticles lets us assume interesting quantum size effects[1]. However, further 
experiments are necessary to explore such features.  
 
Figure 7-5: Diffuse reflectance UV/Vis spectra of peptide beads (dashed line), gold nanoparticles (dotted 
line), and composite peptide-gold nanoparticles (solid line) in comparison, showing the characteristic 
absorption of gold nanoparticles in the range of 500 - 550 nm. 
During preliminary experiments we also observed high sensitivity of the material upon irradiation 
with 532 nm laser light, leading to rapid decomposition of the peptide in a dry state, even at weak 
laser intensities. This is no surprise, because the incorporation of light absorbing GNPs allows the 
local production of heat and can be used as a trigger[8]. The earlier reported capacity of the 
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peptide beads as a drug-delivery system (cf. chapter 6) in combination with the light absorbing, 
heat producing effect could be used to enable an NIR-triggered local release of payload from the 
peptide beads or simply to adjust the release profile towards a faster release, and therefore 
release of a higher concentration of the payload. Furthermore, the enhanced contrast of the 
peptide beads (due to the embedded gold) and the consequently better visibility in optical- and 
electron microscopes can enhance the study of uptake mechanisms of the beads by cells. The fact 
that the beads still present the peptide to the outside would make such results particularly 
interesting for drug delivery applications. 
7.4 Conclusion 
The introduction of a cysteine to the hydrophobic part of the amphiphilic peptide Ac-X3-gT led to 
similar self-assembled peptide beads as with its analogues but with slightly looser packing. The 
cysteine on the new peptide Ac-X3-gT-C allowed the linkage of the peptide to gold nanoparticles. 
In this way, the self-assembly properties of the peptide were transferred to the new composite 
material, leading to the aggregation of the obtained gold core micelles to form particles with 
similar sizes as the original peptide beads without gold. We showed that the newly formed 
composite peptide-gold nanoparticles are a dense package of gold nanoparticles in close 
association with one another, while the individual gold nanoparticles are still separated by a thin 
peptide layer.  
Preliminary results have shown that the packed gold nanoparticles maintain the properties of the 
colloidal gold in terms of light absorption. However, energy transferred to the gold by laser light 
led to local heat production, which may find application as a trigger for the release of payloads 
embedded in the peptide beads. Since the exceptional optical- and electronic properties of gold 
nanoparticles[1] have recently led to the development of various concepts for applications[2], the 
small distance between the individual gold nanoparticles within our particles let us also assume 
new features that might be explored using our straight forward production process for the new 
composite material. 
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8 General conclusion and outlook 
This thesis began with the concept of building purely peptidic amphiphiles of small size that are 
able to self-assemble into supramolecular aggregates. Since potential applications are focused on 
drug delivery systems, the use of natural amino acids could be a crucial factor, giving the designed 
materials a high probability of being biocompatible and biodegradable. The general difficulty of 
producing a purely peptidic, hydrophobic component was overcome by a gramicidin A-inspired 
peptide sequence. Its β-helical secondary structure permitted hiding the hydrophilic backbone 
within its interior while presenting hydrophobic residues to the environment. The richness in 
tryptophan further allowed intermolecular stabilization and alignment of the peptides, while the 
hydrophilic part can comprise a sequence of variously available hydrophilic amino acids, 
containing the desired chemical functional group. In the work presented, charged lysine, charged 
glutamic acid, or the uncharged acetylated lysine served as hydrophilic contributors. 
During this research we developed what became an established synthesis and purification 
procedure, based on Fmoc solid phase peptide synthesis and reversed phase chromatography. The 
general difficulties that come along with very hydrophobic or amphiphilic sequences –often 
leading to the rejection of product orders by peptide manufacturers – were overcome by 
introducing small adaptions to the purification methods and considerable laboratory work. The 
resulting production process not only produces purely peptidic amphiphiles with a controlled 
primary structure and purities above 96%, but also allowed the controlled introduction of point 
mutations, labels, and other modifications. Thus, the process can be used for the production of 
further amphiphilic peptides to explore the capacity of purely peptidic amphiphiles. 
The aspired self-assembly capacity of the new class of peptidic material was demonstrated with 
the peptides K3-gT/C-K3-gT, and Ac-X3-gT/AcC-X3-gT (the fully acetylated analogues), which formed 
micelles and peptide beads in aqueous solution, respectively. Farther-reaching experiments with 
these structures revealed a detailed view of the formation process and the inner structure of the 
beads. As a result, we gained not only the understanding that the peptide beads’ size is 
controllable, but also identified the hierarchically self-assembled peptide beads as 
multicompartment micelles, having the capacity to embed various payloads in their segregated 
hydrophobic and hydrophilic compartments. 
The positive results of exploring the tuneable, purely peptidic amphiphile system encouraged us to 
produce a library of peptides by inducing point mutations (stepwise acetylation of the lysines) into 
the hydrophilic part of the sequence. The ten peptides produced in this manner possessed a 
slightly changing overall hydrophobicity. More importantly, a switch of the peptide’s secondary 
structure was accompanied by a switch in the self-assembled structure, going from micelles to 
fibers. At maximum degree of acetylation, peptide beads as well as triangular structures were also 
produced. The synthesized library showed how distinct, small changes in the primary structure 
(sequence) of the peptide can be used to control the supramolecular output. Therefore, this part 
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of the work provides direction as to how the self-assembled structures can be controlled by small 
chemical modifications, and the ease of sequence variations.  
With further variations in the sequence we exploited different dimerization effects to stabilize the 
vesicle formation of purely peptidic amphiphiles. Such additional stabilizing forces are 
indispensible, due to small molecule size. The drawn conclusions can be converted into a general 
recipe to form vesicles of a purely peptidic base. In particular for biotechnological and medical 
applications, the use of amino acid based materials is advantageous, because these possess 
generally better biocompatibility and biodegradability than competing synthetic macromolecules 
of polymeric character. As a result, long-term accumulation in a patient’s body can be avoided. 
The ability of the produced peptide beads to serve as a drug delivery system was evaluated within 
the scope of this thesis. The nano-sized beads have the great capacity to embed hydrophilic as 
well as hydrophobic guest molecules with relatively high embedding efficiency. Furthermore, the 
system was adapted to embed siRNA/DNA material for gene therapy purposes with embedding 
efficiencies over 99%. The conducted drug delivery tests on human cell models proved effective 
for both the delivery of hydrophilic and hydrophobic drugs, and siRNA/DNA material for gene 
silencing. The fact that no toxic effect of the peptide material was observed during testing strongly 
suggests that the peptidic drug delivery system should be taken to the next level in medical drug 
development. 
Compatibility of the peptide was tested with inorganic nanoparticles. The peptide self-assembly 
was used to template the dense packing of gold nanoparticles by using a thiol linker (cysteine) on 
the hydrophobic part of the peptide Ac-X3-gT-C. The thusly formed gold core micelles aggregated 
into composite peptide-gold nanoparticles. The straightforward production process for the 
composite material allowed the inclusion of a light trigger that produces heat and might be used 
to accelerate payload release in drug delivery applications of the peptide beads. Furthermore, the 
high electron density might allow better visibility of the peptide beads when probing cellular 
uptake pathways. The latter would be a logical consequence of the drug-delivery related results 
presented herein, because the knowledge of the uptake mechanisms and the pathways will help 
optimize the use of the peptide system in drug delivery. 
In summary, the presented work offers great potential for purely peptidic amphiphiles in drug 
delivery applications, while the production methods and the gained knowledge of peptide self-
assembly as describe here will hopefully lead to the production of further smart and advanced 
functional materials.  
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9 Experimental part 
9.1 Materials 
Materials and reagents were of the highest commercially available grade and were used without 
further purification, unless indicated. HCTU, Rink Amide AM resin (0.61 mmol/g) and Fmoc-
Trp(Boc)-OH was purchased from IRIS Biotech GmbH. All other amino acids were obtained from 
Novabiochem. Dichloromethane and ethanol (96%) F15 were provided by Brenntag Schweizerhall 
AG, DMF by J. T. Baker and acetonitrile (ACN) by Fischer Scientific. Fluorescent dyes were 
purchased from Invitrogen Inc. DMF was treated with aluminum oxide to reduce free amines prior 
to application in peptide synthesis. Solvent exchange was carried out in 24-well sitting-drop 
crystallization plates (HR3-158, Hampton Research) or by dialysis (Spectrum, cellulose ester (CE), 
MWCO=500-1000 Da) against double-distilled (dd) water. Fluorescently labeled and unlabeled 
GAPDH-siRNAs (AM4649, AM4624) were purchased from Ambion (Applied Biosystems). The 
psiSTRIKE-Neomycin vector and MTS-assay were purchased from Promega AG (Switzerland). The 
used vector was equipped with a hairpin target sequence for PP2Acα to express siRNA against 
PP2Acα. The sequences of the hairpin oligonucleotide for PP2acα messenger RNA were 5’-
ACCGGGATACCGTTTAATTTAATTCAAGAGATTAAATTAAACGGTAT CCCTTTTTC-3’ and 5’-
TGCAGAAAAAGGGATACCGTTTAATTTAATCTCTTGAATTAAATTAAACGGTATCC-3’ (loop is 
underlined). For control, scrambled sequences for the siRNA sequence designed to human PP2Acα 
were used. The oligonucleotide sequences were 5’-ACCGTTAATGGCTACGAATTATTTCAAGAGA 
ATAATTCGTAGCCATTAACTTTTTC-3‘ and 5‘-TGCAGAAAAAGTTAATGGCTACGAATTATTCTCTTGAAAT 
AATTCGTAGCCATTAA-3‘. Remaining chemicals and buffers were purchased from Sigma-Aldrich. 
9.2 Peptide synthesis 
All peptides were synthesized on a Syro I Peptide Synthesizer (MulitSynTech GmbH, Witten, 
Germany) on solid phase using Fmoc-strategy. 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-
tetramethylaminium hexafluorophosphate (HCTU) as the coupling reagent and N-
ethyldiisopropylamine (DIPEA) dissolved in N-methyl-2-pyrrolidone (NMP) as the base were used 
to couple α-N-Fmoc-protected amino acids to the resins (220 mg, Rink Amide AM, 0.61 mmol/g, 
equals 1 equiv.). 
For elongation, Fmoc-Xxx-OH (0.5 mol/L, 4 equiv.), HCTU (0.5 mol/L, 4 equiv.) dissolved in 
dimethylformamide (DMF), and DIPEA (12 equiv.) were added to the resin. The mixture was 
agitated for 1 h and washed with DMF (3x3 mL). Fmoc deprotection was performed with 20% 
piperidine in DMF followed by 3 min agitation, draining, and repetition of deprotection for 10 min. 
Resin was subsequently washed with DMF (5x3 mL). Acetylation of unreacted amine groups was 
performed following each coupling using acetic anhydride/DIPEA (3 mol/L, 5 equiv.) in DMF. After 
synthesis, the peptide resin was washed alternating with DMF (3x6 mL), isopropanol (3x6 mL), and 
dichloromethane (3x6 mL), and dried under vacuum. For Ac-E6-gA and Ac-K6-gA, N-terminal 
acetylation was performed after the completed reaction with 30 equivalents of Ac2O/DIPEA for 1 
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hour. Partially acetylated peptides were produced by using Fmoc-Lys(Ac) and Fmoc-Lys(Boc) 
during synthesis. Ac-X8-gA, the precursor for Ac-X8-gA-OEt, was synthesized by post purification 
acetylation from K8-gA.  
In a scaled up synthesis using 5 g of Rink Amide AM resin, the same protocol was followed in 
manual steps. For washing isopropanol was used alternating with DMF. Due to the size, reactions 
were carried out in a 500 ml glass solid phase reactor using only 3 equiv. of amino acids and 
coupling reagents for the reaction. The pH was controlled and kept above 9 during reaction, after 
each amino acid coupling and cleavage of the Fmoc-protection group, the resin was probed for 
free amine groups using a Kaiser- and TNBS (trinitrobenzene sulfonate)-test. There was no need 
for NMP as a co-solvent. 
Cleavage from the resin and removal of protective groups was performed with a mixture of 95% 
trifluoroacetic acid (TFA), 2.5% triisopropylsilane (TIS), and 2.5% H2O. In case of cysteine 
containing peptides a mixture of 94% TFA, 2.5% TIS, 2.5% ethanedithiol and 1% H2O was used. The 
cleavage cocktail was filtered and resin was washed additional two times with cold cleavage 
cocktail (2 mL) and precipitated in 40 mL cold diisopropylether (IPE). The precipitated crude 
peptide was washed with cold IPE three times by centrifugation and decantation, before being 
dried under vacuum. 
9.3 Peptide purification, post modification and characterization  
Purification and analysis of the peptides were carried out by HPLC (Shimadzu Prominence 20A, 
Japan) on reverse phase (RP) columns (Merck Chromolith, RP-18e, 100 mm x 10 mm and 100 mm x 
4.6 mm; Merck LiChrospher 100, RP-18e, 5 μm, 250 mm x 10 mm and 250 mm x 4.6 mm). The 
ground crude peptides were dissolved in 2 mL DMF, diluted with H2O (0.1% TFA, 8 M urea) to a 
final volume of 20 mL. If necessary, acetonitrile (ACN) was added to dissolve peptide assemblies. 
The resulting solution was filtered through a 0.45 μm PTFE syringe filter and pumped to the HPLC. 
Two runs were necessary to yield sample purities higher than 95%. Linear gradients of solvent A 
(ACN) and solvent B (first run: 0.1% TFA, second run: 2 % AcOH or 0.23% formic acid in dd H20) 
(example given in Figure 9-1). The eluted sample was collected in fixed volume fractions which 
were subsequently analyzed for purity and molecular weight. Fractions containing more than 80% 
product (HPLC with 280 nm absorption) were applied to the second purification run. AcC-X3-gT and 
C-K3-gT disulfides were reduced with 1,3-propanedithiol (5 equiv.) in methanol or tris(2-
carboxyethyl)phospine (5 equiv.) in water/ACN solution before the second run. Final fractions with 
purities higher than 95% were combined, neutralised with ammonia and lyophilized until leaving a 
fluffy, white final product.  
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Figure 9-1: Preparative HPLC elution profile of K3-gT A) first run with ACN/dd H2O 0.1 % TFA B) second run 
using ACN/dd H2O 2 % AcOH. Published in [1] , Reproduced by permission of the Royal Chemical Society. 
Purification of Ac-E6-gA was carried out by HPLC on a PRP-3 column (10 µm 300 Å, 4.1 x 250 mm, 
Hamilton) for peptide/protein/DNA purification. Also here, two runs were necessary and following 
conditions were used: in run one, ACN/0.5% aqueous TRIS·HCl solution (pH 7), in run two, 
ACN/50 mM NH4OAc/HOAc (pH 7).  
For verification, final products were again analyzed by HPLC for purity and MALDI-TOF-MS for 
mass confirmation. Examples are illustrated in Table 9-1 and Figure 9-2. Products were stored 
under argon at -18 °C.  
Table 9-1: Exemplary mass confirmation by MALDI-TOF-MS and HPLC purities of selected peptides. 
Code[a] Mass[b] 
(g mol-1) 
Mass 
(MALDI-TOF-MS) 
Purity[c] 
 
Ac-X8-gA 3328.1 3329.9 >99.5%* 
Ac-X8-gA-OEt 3358.1 3357.1 >99.5%* 
Ac-E6-gA 2684.0 2682.5 95% 
Ac-K6-gA 2678.3 2677.4 96% 
[a] one letter code with abbreviations for gramicidin (gA), acetylated lysine (X) and acetylated N-terminus 
(Ac) [b] calculated with Pinsoft32 [c] Area% on an analytical RP-HPLC [*] HPLC purity from precursor K8-gA. 
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Figure 9-2: Analysis of C-K3-gT A) HPLC profile B) MALDI-TOF-MS and AcC-X3-gT C) HPLC profile D) MALDI-
ToF-MS. Published in [1] , reproduced by permission of the Royal Chemical Society. 
Overall yields of the synthesis and purification were generally between 10-15 %, overall yields of 
the synthesis, purification, post-purification acetylation and end-purification were generally 
between 6-10 %, and therefore in the normal range for solid phase peptide synthesis and HPLC 
purification. 
Post-purification acetylation of the free N-terminal and lysine amines was performed on the 
purified peptide dissolved in DMF using a 40-fold excess of acetic anhydride and DIPEA. 
Completeness of the reaction was controlled by MALDI-TOF-MS. The reaction mixture was 
repurified according to the procedure described above.  
Transesterification of the Ac-X8-gA amide to the Ac-X8-gA-OEt was performed in ethanol/0.1M HCl 
at 70°C for 3 x 10 min and intermediate ultrasonic treatment for 3 x 30 s at 70°C.  
MALDI-TOF-MS was performed on Voyager-DETM System (Applied Biosystems, USA) with α-cyano-
4-hydroxycinnamic acid as the matrix in positive ion reflector mode for lysine-rich peptides and 
negative ion reflector mode for glutamate-rich peptides, respectively, an accelerating voltage of 
25 kV, grid voltage of 75% and 300 ns extraction delay time. These standard values were optimized 
according to the sample. A 100-well stainless steel or gold plate was used. 
Hydrophobicity was calculated using Pinsoft32 (Chiron Technologies Pty Ltd., Australia) which uses 
the hydrophobicity algorithm from Fauchere & Pliska[2] (for X = Lys(Ac) a value of - 0.55 was 
used[3]). 
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9.4 Nanostructure formation  
Either the peptide or the corresponding mixtures (e.g. AcC-X3-gT / AcC(sl)-X3-gT, Ac-X3-gT / K3-gT) 
were dissolved in ethanol at the appropriate concentration and filtered through a 0.2 µm 
hydrophilic PTFE filter. The self-assembly process was initiated by solvent exchange from the 
organic solvent to dd H2O, the corresponding dd H2O/ethanol mixture, or buffer [NaCl (140 mM), 
EDTA (0.5 mM), TRIS (10 mM), NaN3 (0.003 mM) adjusted to pH 7.4 with HCl and filtered through a 
0.2 µm hydrophilic PTFE filter)]. A change in polarity was usually accompanied by opalescence. 
Solvent exchange (in dialysis tubes or on crystallization plates) was performed within 24 h with dd 
H2O exchanged three times. Since K3X5-gA to K8-gA are water soluble, they were dissolved directly 
in water or buffer for surface tension measurements. Composite gold nanoparticles were 
produced by dissolving the cysteinated peptide in ethanol at 1 mg/ml and filtered through a 0.2 
µm hydrophilic PTFE filter. Aqueous dispersions of gold nanoparticles (5 nm or 25 nm, Sigma-
Aldrich) were mixed added to the peptide solution 1:1 and shaken during reaction for one week. 
The remaining non-reacted peptide was removed by centrifugation and decantation, and refilled 
with fresh ethanol. Self-assembly was induced by solvent exchange as described above.  
9.5 Nanostructure characterization 
9.5.1 Microscopic methods 
Transmission electron microscopy (TEM) images were taken on an FEI Morgani 268D operated at 
80 keV. 5 µL of the sample was deposited on carbon-coated, parlodion (2% in n-butyl acetate)-
covered copper grids, blotted after 2 min with a filter paper and dried in air. If necessary, staining 
was performed with uranylacetat (2%) for 10 s before drying. 
For cryo-transmission electron microscopy (CryoTEM) a holey carbon-coated grid (Quantifol, 
Germany) was used to adsorb 4 µL of an aqueous Ac-E6-gA solution (~5 mg mL-1) which was 
blotted with Whatman 1 filter paper and vitrified in liquid ethane at -178°C using a Vitrobot (FEI 
company, Netherlands). After transferring the frozen grids onto a Philips CM200-FEG electron 
microscope using a Gatan 626 cryo-holder, measurements were performed at an acceleration 
voltage of 200 kV and a 20k magnification. Micrographs were recorded on a 2K x 2K CCD camera 
(Gatan, USA) using a low-dose system (10 e-/Å2) while keeping the sample at -172°C.  
Scanning Electron Microscopy (SEM) was performed on a Philips XL 30 ESEM operating between 2 
and 5 kV. The aqueous peptide samples were frozen with liquid nitrogen and lyophilized directly 
on the SEM grid, or lyophilized powder was put on a double-sided carbon sticker before being 
sputtered with gold or platinum (2-5 nm). 
Atomic force microscopy (AFM) measurements were carried out using a 5100 Agilent system 
(formerly PicoLE Molecular Imaging) equipped with a multi-purpose scanner. Images were 
acquired using a silicon cantilever (type-NCHR PointProbe® Plus, force constant 42 N/m) as 
indicated by the manufacturer for acoustic mode images. Samples were prepared by exposing 
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aqueous peptide sample to a freshly cleaved mica surface for 5 min, removing the supernatant 
solution, and drying. 
Confocal laser scanning microscopy measurements were performed on a Zeiss Confocor 2 LSM 
equipment. For the peptide vesicles, BODIPY 650/665 and Alexa488 solutions were added to an 
ethanol solution with Ac-E6-gA (0.5 mg mL-1) to reach a concentration of 0.2 µmol L-1 and 
0.5 µmol L-1 respectively before vesicle formation and dialysis (MWCO=100 kDa). For peptide 
beads and cell imaging, the appropriate filter/channel settings were applied and combined to fit 
the demands of the fluorophores: tryptophan (ex. 405 nm, em. 420 nm), Cy3-labeled siRNA (Ex. 
543 nm, Em. 573 nm), Hoechst 33342 (Ex. 350 nm, Em. 461 nm), CellMask DeepRed (Ex. 649 nm, 
Em. 666 nm), Lystotracker DND-99 (Ex. 577 nm, Em. 590 nm), and transmission channel (DIC). Cell 
staining was performed directly before the microscopy measurements according to the 
manufacturer’s protocol. Shortly, the tempered dye solutions were added simultaneously to the 
cells in 2 ml PBS buffer and incubated for the needed time at 37 °C (Hoechst 33342: 6 µl 16.2 mM 
30 min, Lysotracker: 2 µl 1 mM 30 min, DeepRed: 2 µl 5 mg/ml 5 min). The cells were rinsed with 
fresh PBS buffer and instantly used for microscopy at room temperature. 
9.5.2 Scattering methods 
Dynamic and static light scattering (DLS and SLS) measurements were performed with an 
ALV/CGS-8F platform-based goniometer system equipped with an ALV/-5000/E correlator and a 
HeNe-laser with a wavelength of 633 nm (35 mW). Measurements were made at 20 °C and at a 
scattering angle 𝜃 from 30° − 150° in steps of 10°. 
DLS correlation functions were fitted with the 2nd cumulant function or the CONTIN algorithm. The 
resulting hydrodynamic radii (mass weighted) were extrapolated to zero wave vector (q = 
(4πn0/λ0) sin (𝜃/2)) and to zero concentration. The Stokes-Einstein equation was used to calculate 
the hydrodynamic radius. To determine the size dependence of the peptide beads, 2nd cumulant 
fit analysis at 90° with measurement times of 300 s was used. For the pH dependent size evolution 
of the peptide vesicles, the initial peptide concentration was 0.34 mg mL-1. Here, also the 2nd 
cumulant function (90°, 300 s) was used. Aliquots of 2-10 µL of corresponding molarities (10-3 to 
1 mol L-1) NaOH or HCl were used to adjust the pH of the 800 µL peptide solution. 
SLS data analysis was done with ALVStat 4.31 software (ALV, Langen, Germany) by constructing a 
Guinier plot (second order in q and linear concentration dependency) 
 𝑙𝑛 �
𝐾∙𝑐
𝑅𝜃
� = 𝑙𝑛 � 1
𝑀𝑊∙𝑒
−
1
3𝑅𝑔∙𝑞
2 + 2𝐴2𝑐� (1) 
with the optical constant (K), concentration (c), Rayleigh ratio (𝑅𝜃), molar mass (MW), radius of 
gyration (Rg) and 2nd virial coefficient (A2). The refractive increment (dn/dc) was set to 0.185 mL/g 
(commonly used for peptides[4]). The deviation in dn/dc, caused by the different ethanol 
concentrations[5], provided negligibly different results.  
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The scattering intensity 𝑖(𝜃) was normalized to zero angle, yielding the particle scattering factor P.  
 𝑃(𝜃) = 𝑖(𝜃)
𝑖(𝜃=0) (2) 
This provided information on the shape and internal structure of the particles in solution. 
Structural differences become apparent by plotting P versus u = q·Rg. For analysis, the 
experimental data from the present system were compared to well-known particle scattering 
factors for hard spheres and monodispersed coils, given in eq. 3 and 4 respectively. 
 𝑃(𝜃) = � 3
𝑥3
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2
− 1 + 𝑢2��2 (4) 
More detail on theoretical background and SLS data analysis can be found in the literature[6].  
ζ-potential measurements of peptide solutions in dd H2O were performed with a Malvern 
Instruments Zetasizer Nano ZS, using the identical samples as for DLS measurements. The pHs of 
the solutions were determined in advance to range from 7.0 to 7.8 using a Mettler Toledo MP 220 
pH meter with an InLab micro electrode.  
Small-Angle X-ray scattering (SAXS) was performed using the µSpot Beamline at BESSY[7], using a 
wavelength of λ = 1.0000 Å. Samples were measured using an ultrasonic levitator. The scattering 
pattern of silver behenate served as an external calibration standard, and 2D data were converted 
using the program FIT2D[8]. Bidistilled water was used as blank, and data were analyzed using a 
two level Beaucage method[9] as implemented in the Irena SANS package[10] and Igor Pro 6.11 
(Wavemetrics). IPG-TNNLS[11] (Internal Point Gradient - Total Non-Negative Least Square) analysis 
was performed as implemented in the Irena Package[10] version 2.38 using Igor Pro 6.11 
(Wavemetrics). Data were fitted for a nanoparticle population with sizes starting from 3 nm to 50 
nm and a logarithmic binning. The NNLS approach parameter was set to 0.5 and the maximum 
number of iterations was set to 400, which proved to be satisfactory to obtain a convergence. 
9.5.3 Spectroscopic methods 
Fluorescence spectroscopy was carried out at room temperature (293 K) on a Perkin Elmer LS55 
Luminescence Spectrometer with a 1 mm quartz glass cuvette in a 90° arrangement. The quencher 
acrylamide (c = 2.26 mol/L) was added stepwise to the peptide solutions (c = 0.04 to 0.31 mol/L) in 
2 to 40 µL quantities and intensity was corrected for dilution. High tryptophan and peptide 
concentrations required the use of a built-in 1% filter to prevent detector saturation. Data analysis 
was performed by plotting F0/F (fluorescence intensities without and with the presence of 
quencher) vs. the concentration of the quencher [Q] according to the modified Stern-Volmer 
law[12]. It can be divided into collisional and static components characterized by KSV (Stern-Volmer 
constant) and V (active volume)[13]. For encapsulation efficiency measurements, the cy3-payload 
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filled beads were centrifuged and the supernatant separated from the beads. The peptide beads 
were dissolved in ethanol (50%) to release the payload. The supernatant was filled up with the 
same amount of ethanol (50%). Fluorescence of both samples was measured at maximum 
emission/excitation and taken to calculate the encapsulation efficiency. 
UV-VIS absorbance spectroscopy was performed on a Perkin Elmer Lambda 35 UV/VIS 
Spectrometer, equipped with a Peltier temperature control element and a 1 mm quartz glass 
cuvette. For temperature dependent peptide bead formation, detection at 280 nm was used to 
monitor the onset of scattering due to bead formation. Diffuse reflection was measured on a 
Varian Cary 5000 UV-VIS-NIR spectrophotometer equipped with an integrating sphere and PTFE as 
white standard and a 1 mm quartz glass cuvette in front of the standard. 
Circular Dichroism (CD) was measured using a Chirascan CD Spectrometer (Applied Biophysics Ltd., 
Leatherhead, UK) using 1 mm path length quartz glass cuvettes. The peptide concentration was 
adjusted according to an HT voltage between 300 and 600 V in the far UV and subsequently 
determined by analytical HPLC to be in the range of 0.1 to 0.25 mg mL-1. Spectra were acquired at 
22°C from 190 – 320 nm in 0.2 nm steps, with a bandwidth of 1 nm, and averaged over five points 
and two scans. Measurements of assembled structures in dd H2O are excluded due to scattering. 
9.5.4 Electron paramagnetic resonance 
To measure electron paramagnetic resonance (EPR), a spin label (sl) was attached to the 
amphiphilic peptide by dissolving AcC-X3-gT and 3-(2-iodoacetamido)-2,2,5,5-tetramethyl-1-
pyrrolidinyloxy in a mixture of 58% ethanol in TRIS buffer (25 mM) and 12 h reaction time. The 
spin labeled peptide was separated from the reaction mixture by using solid phase extraction 
cartridges (Whatman Inc., ODS-5 Octadecyl; 18%; EC), leading to a purity of 97% (HPLC). 
All continuous wave (cw) EPR experiments were performed at X-band frequencies (9.3 – 9.4 GHz) 
with a Bruker Elexsys 500 spectrometer equipped with a Bruker Elexsys Super High Sensitive probe 
head equipped with a continuous flow N2 cryostat controlled by a Bruker Er 4111 VT temperature 
controller. Samples were loaded into EPR glass capillaries (0.9 mm inner diameter, sample volume 
15 µL) and recorded with 100-kHz field modulation, 2 mW microwave power, 0.15 mT modulation 
amplitude. For low temperature (160 K) cw EPR spectra, samples were loaded into EPR quartz 
capillaries (3.8 mm inner diameter, sample volume 30 µL) and recorded with 100-kHz field 
modulation, 0.08 mW microwave power, 0.2 mT modulation amplitude. 
Pulse EPR experiments were performed at X-band frequencies (9.3 – 9.4 GHz) at 50 K with a Bruker 
Elexsys 580 spectrometer equipped with a Bruker Flexline split-ring resonator ER 4118X-MS3 that 
included a continuous flow He cryostat (ESR900; Oxford Instruments) controlled by an Oxford 
Instruments temperature controller ITC 503S. 
Dipolar time evolution data were recorded using a four-pulse DEER (double electron-electron 
resonance) experiment[14]. The measurements were performed at 50 K with observer pulse 
lengths of 32 ns for π/2 and π pulses, with the ELDOR π pulse set to 12 ns. Deuterium nuclear 
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modulations were averaged (50 volume % (v %) of deuterated glycerol was added to the ethanol 
sample to increase the signal to noise ratio). Traces were accumulated for 24 hours. Data analysis 
of the DEER traces was performed with DeerAnalysis 2009 software[15]. 
The following parameters were used to calculate micelle rotational time so as to compare DLS 
with EPR: R = 5.65 nm, T = 293 K and n = 1.3583, η = 2.84 103 kgs-1m-1 for 40 weight % (wt %) 
ethanol. 
9.5.5 Gel permeation chromatography (GPC) 
Measurements of gramicidin A (gA) and Ac-X3-gT (c = 1 mg/mL) were performed on a Shimadzu 
Prominence HPLC, using an Agilent PLgel column (5 µm, 103 Å, 2 x 250 mm) and isocratic elution 
with THF/10% H2O. Stabilizer-free solvent improved detection at the tryptophan adsorption 
maximum of 280 nm. For the comparison of gA, Ac-X8-gA, and Ac-X8-gA-OEt two GPC-columns 
were mounted in series (1. CATSEC-100, 5µm, 250 x4.6 mm, 2. GPCPEP 5µm, 250 x 4.6 mm, 
Eprogen Inc.). Isocratic elution (1mL min-1) was performed with 95% THF (without stabilizer for UV 
detection at 220 nm, T=295K) and 5% dd H2O. 
9.5.6 Tensiometry 
Surface tension was measured on a Sigma 703D Tensiometer (KSV Instruments, Finland) with a 
platinum Wilhelmy plate, pre-cleaned with ethanol and water, followed by flame annealing. 
Solutions were prepared 24 h prior to measurements by dissolving the peptides in dd H2O or 
buffer and subsequent dilution. All measurements were performed at room temperature. 
9.6 Biological experiments 
9.6.1 Cell viability tests on THP-1 cells (MTS assay) 
Peptide beads were produced by using filtered (0.2 µm hydrophilic PTFE) ethanol solutions of the 
peptide and the payloads to produce the mixtures in ethanol with Ac-X3-gT (0.25mg/ml), Ac-X3-gT 
(0.25mg/ml) / paclitaxel (150 µM), Ac-X3-gT (0.25mg/ml) / doxorubicin (275 µM), and Ac-X3-gT 
(0.25mg/ml) / doxorubicin (138 µM) / paclitaxel (75 µM). Self-assembly was induced according to 
chapter 9.4 (Nanostructure formation). The payload filled peptide beads were separated from 
potentially free payload by triple centrifugation in Amicon Ultra 15 Centrifugal Filter Units (15 ml, 
100’000 Da MWCO, Millipore), and refilling with dd H2O. 
Cell viability tests for payload filled and unfilled peptide beads were performed using THP-1 
monocytes and macrophages. Monocytes were split and prepared in complete RPMI medium 
(2 ml well, 20’000 cells/well). Peptide bead samples were added to the medium according to the 
experimental setup in 1:10 and 1:100 dilutions and incubated at 37 °C for 3 days. Experiment was 
performed in triplicate. For THP-1 macrophages, the same procedure was performed with 50’000 
cells/well after differentiation of the THP-1 monocytes to macrophages in the presence of 100 nM 
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PMA (phorbol 12-myristate 13-acetate, Sigma-Aldrich 79346). After incubation, MTS was added 
(20 µl/well, MTS kit CellTiter 96 Aqueous One Solution Cell Proliferation Assay, PROMEGA G3580). 
After incubation for 1 h at 37 °C, the absorbance at 490 nm was measured according to the 
manufacturer and compared corrected using a blank sample (medium without cells).  
9.6.2 Gene silencing 
Peptide beads were produced by using filtered (0.2 µm hydrophilic PTFE) ethanol solutions of the 
peptides and aqueous solutions of the payloads to produce mixtures in ethanol with Ac-X3-gT 
(0.25mg/ml), siRNA (250 nM) or same mass of plasmid, K3-gT to neutralize the basepairs 
(3.57 µg/ml for 1:1 charge compensation according to the amount of siRNA/plasmid). Self-
assembly was induced according to chapter 9.4 (Nanostructure formation). Encapsulation 
efficiency was measured according to the fluorescence method described above. 
The translucent peptide beads were added to the growth media of the HuH-7 cells in the 
appropriate concentrations and incubated for the indicated times at 37 °C and 5% CO2. 
RNA isolation, reverse transcription, and SYBR-PCR: Cells were washed twice with PBS. The total 
RNA was isolated from the cells using Trizol according to the manufacturer instructions 
(Invitrogen, USA). RNA was reverse transcribed by M-MLV reverse transcriptase (Promega, 
Switzerland) in presence of random hexamers (Promega) and dNTPs. After incubation for 5 min at 
70 °C and 1 h at 37 °C, the reaction was stopped by heating at 95 °C for 5 min. SYBR-PCR was 
performed based on SYBR-Green Fluorescence (Applied Biosystems). To prevent influence from 
genomic DNA amplification, the primers were designed across exon-exon junctions. The forward 
and reverse primers for GAPDH were 5’-CTCCTCCTGTTCGACAGTCA-3’ and 5’-
ACCTTCCCCATGGTGTCTGA-3’, respectively. The forward and reverse primers for PP2Acα were 5`-
CCACAGCAAGTCACACATTGG-3` and 5`-CAGAGCACTTGA TCGCCTACAA-3`, respectively. The ∆CT 
value was derived by subtracting the threshold cycle (CT) value for GAPDH, which served as an 
internal control, from the CT values for PP2Acα. For GAPDH, only arbitrary values were used. All 
reactions were run in duplicate using the ABI 7000 Sequence Detection System (Applied 
Biosystems). The mRNA expression level of PP2Acα was expressed as a fold increase or fold 
decrease according to the formula 2∆CT(PBS)-∆CT(Treatment). 
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12 List of synthesized and remaining peptides 
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13 Abbreviations 
AA amino acid 
ACN acetonitrile 
AFM atom force microscope 
Alox aluminium oxide 
API active pharmaceutical ingredient 
Boc tert-butyloxycarbonyl  
CCA α-cyano-4-hydroxycinnamic acid 
CD circular dichroism 
CLSM confocal laser scanning microscope 
cmc critical micelle concentration 
CPGNPs composite peptide-gold nanoparticles 
cw continuous wave 
Da Dalton, molecular weight 
DA degree of acetylation 
DCC N,N′-dicyclohexylcarbodiimide 
DCM dichloro methane 
dd H2O double distilled water 
DDS(s) drug delivery system(s) 
DEER double electron-electron resonance 
DIPEA N,N-diisopropylethylamine 
DLS dynamic light scattering 
DMF N,N-dimethylformamide 
DMPC dimyristoylphosphatidylcholine  
DNA deoxyribonucleic acid 
DQC double-quantum coherence 
EDT ethanedithiol 
EPR electron paramagnetic resonance 
Eq equivalent 
EtOH ethanol 
FDA Food and Drug Administration (U.S. Department of Health & Human Services) 
Fmoc 9-fluorenylmethyloxycarbonyl 
gA gramicidin A 
GAPDH glyceraldehyde-3-phosphate dehydrogenase 
GNP gold nano particle 
GPC gel permeation chromatography 
HCTU 2-(6-chloro-1H-benzotriazole-1-yl)-1,1,3,3-tetramethylaminium 
hexafluorophosphate 
HOBt N-hydroxybenzotriazole 
HPLC high pressure (performance) liquid chromatography 
IPE diisopropylether 
IR infrared spectroscopy 
Ksv Stern-Volmer constant 
LCM large compound micelle 
LCST low critical solution temperature 
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MALDI-TOF-MS matrix assisted laser desorption/ionization - time of flight – mass spectroscopy 
MCM multicompartment micelle 
Mw molecular weight 
NCA N-carboxy anhydride 
NIR near infrared 
NMP N-methyl-2-pyrrolidone 
PAA poly(acrylic acid) 
PD.I. polydispersity index 
PDDF pair distance distribution function 
PDMS poly(dimethylsiloxane) 
PEG see PEO 
PEO poly(ethylene oxide) 
PGA poly glutamic acid 
PLGA poly(L glutamic acid) 
PLL poly(L lysine) 
PMOXA poly(2-methyloxazoline) 
PNIPAM poly (N-isopropylacrylamide) 
PS polystyrene 
PyBOP benzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate 
qRT-PCR quantitative real time polymerase chain reaction 
Rg radius of gyration 
Rh hydrodynamic radius 
RNA ribonucleic acid 
RP reversed phase 
Rs spherical radius 
RT room temperature 
SAXS small angle X-ray scattering 
SEM scanning electron microscope 
shRNA small hairpin RNA / short hairpin RNA 
siRNA short interfering RNA / small interfering RNA / silencing RNA 
SLS static light scattering 
SPPS solid-phase peptide synthesis 
TBTU O-(benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium tetrafluoroborate 
TEAP triethyl ammonium phosphate 
TEM transmission electron microscope 
TES triethylsilane 
TFA trifluoroacetic acid 
TFE trifluoro ethanol 
THF tetrahydrofuran 
TIS triisopropylsilane 
TNBS 2,4,6-trinitrobenzenesulphonic acid 
TNNLS Total Non-Negative Least Square analysis 
Tris tris-(hydroxymethyl)aminomethan 
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Amino acids (one letter code) and  sequences: 
 
Ac Acetylated 
DL D-leucine 
LC L-cysteine  
LK L-lysine 
LE L-glutamic acid 
LV L-valine 
LW L-tryptophan 
LX acetylated L-lysine  
G glycine 
-gA gramicidin A inspired hydrophobic part of the amphiphile 
-gT truncated version of gA 
 
 
